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Abstract 
Opalescence and liquid-liquid phase separation reduce physical stability of a 
therapeutic protein formulation and have been recently reported for high concentration 
monoclonal antibody solutions. Liquid-liquid phase separation resulting in opalescence can 
be attributed to attractive intermolecular interactions; formulation factors that mitigate these 
interactions reduce solution opalescence and tendency to phase separate. Protein-protein 
interactions in solution have also been reported to enhance reversible/irreversible aggregation 
and viscosity of the solution. These formulation challenges are further enhanced for the 
second generation of antibodies due to the increased complexity of the molecules. Current 
work focuses on understanding the formulation factors and nature of intermolecular 
interactions that result in opalescence and liquid-liquid phase separation for monoclonal 
antibody (mAb) and Dual variable domain immunoglobulin antibody (DVD-Ig
TM
) protein 
solutions. Opalescence for protein solution was measured as a function of formulation factors 
and correlated to interactions in dilute and concentrated solutions.  Results show that 
presence of attractive interactions (enthalpy effect) and strong temperature dependence 
(entropy effect) result in liquid-liquid phase separation in solution. On undergoing phase 
separation, solutions attain thermodynamic equilibrium, and protein does not exhibit 
structural changes. Other than the traditional non-specific interactions, the presence of 
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specific protein interactions also affects phase separation and was investigated for DVD-Ig
TM 
protein. Determining the nature of these attractive protein-protein interactions is of utmost 
significance so as to facilitate the selection of appropriate excipients. The effect of different 
excipients to suppress phase separation and irreversible aggregation in solution was also 
studied. The mechanism by which these excipients affect aggregation and liquid-liquid phase 
separation in solution is different, as both these phenomena show a strong and opposite 
temperature dependence. The effect of size of the molecule with respect to intrinsic viscosity 
and excluded volume effect, electroviscous effect and interactions, on the viscous behavior of 
DVD-Ig
TM
 protein was investigated. Interplay of more than one factor contributes to 
significantly high viscosity of DVD-Ig
TM
 protein compared to mAb solutions.  
The overall results demonstrated that opalescence and liquid-liquid phase separation 
are a concern in formulation development of therapeutic protein solutions. Excipients and 
solution conditions (pH, ionic strength, concentration and temperature) that reduce non-
covalent interactions in solution provide physically stable products. 
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Introduction, Aims and Organization of the Thesis 
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1. Introduction 
Since their first approval over 25 years ago, monoclonal antibodies (mAbs) have 
emerged as the fastest growing and most successful biotherapeutics in the treatment of 
several terminal diseases including cancer and auto-immune disorders.
1
 Second generation of 
antibody-based therapeutics such as ADCs, bispecific antibodies, engineered antibodies and 
antibody fragments or domains have generated quite an interest over last few years. These 
newer molecules have further enhanced the therapeutic efficacy of the first generation of 
antibodies and have vastly improved their safety profiles.
2,3
 Dual Variable Domain 
immunoglobulin (DVD-Ig
TM
) protein is a bispecific antibody and is engineered from two 
mAbs by adding an additional binding domain to variable domain of the parent mAb 
molecule. This structural design enables DVD-Ig
TM
 protein to achieve dual-targeting 
resulting in the improved overall efficacy.
4,5
 Therapeutic proteins are generally formulated at 
high concentrations (>100 mg/mL) because of their low potency and low volume restriction 
(<1.5 mL) imposed by the subcutaneous route of administration. At high concentrations, 
inter-separation distance between the molecules decreases, thereby increasing their tendency 
to interact with each other resulting in several formulation challenges including high 
viscosity, formation of reversible and/or irreversible aggregates, solubility, opalescence and 
phase transitions.
6-10
 These challenges become more exaggerated in DVD-Ig
TM 
protein 
solutions since these molecules are larger and more complex. 
Opalescence at high concentrations reduces aesthetic appeal of the formulation and 
can be a precursor to phase separation or indicator of the presence of aggregates in solution 
signifying reduced product stability.
11
 Solution conditions where proteins exhibit solid-liquid 
phase separation (crystallization or amorphous precipitation) or liquid-liquid phase 
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separation (formation of protein-rich and protein-poor phase) is related to reduced solubility 
of the proteins.
12
 From a pharmaceutical point of view, liquid-liquid phase separation (LLPS) 
is a concern for formulation development since various protein solutions are stored at 
refrigerated condition (2-8˚C) where proteins show a higher tendency to phase separate. 
Protein-rich phase (high concentration) formed on phase separation can promote formation of 
reversible or irreversible aggregates in solution which compromises physical stability of the 
formulation, and can reduce safety and efficacy of the product. 
Depending on the solution conditions and molecular properties, attractive and 
repulsive protein-protein interactions (PPI) are present in solution. Opalescence and LLPS in 
solution can be attributed to attractive interactions which may be specific or non-specific in 
nature. These interactions depend on the electrostatic charge, dipole moments in 
macromolecules (charge-dipole, charge–induced dipole, and van der Waals forces), surface 
amino acids and/or the hydrophobic patches on the surface of the protein (hydrophobic 
interactions).
13,14
 Repulsive interactions in solution result in increased viscosity due to 
electroviscous effect and excluded volume interactions. Determination of the nature of these 
interactions in protein solution is of utmost significance so as to select appropriate solution 
conditions and excipients that reduce these PPI and develop an optimal formulation. 
Development of a stable and efficacious therapeutic protein formulation requires a 
thorough understanding of the problems associated with high concentrations, especially for 
newer molecules such as DVD-Ig
TM
 protein, which are larger than the naturally occurring 
IgG molecules. Literature review shows that, extrinsic factors such as pH, ionic strength, 
excipients, protein concentration and temperature affect opalescence and phase separation in 
solution. However, there is a lack of clear understanding on how these factors affect the 
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nature of protein-protein interactions resulting in opalescence and phase separation. Similar 
factors also play a role in increased viscosity and potential aggregation in protein solutions 
and needs to be thoroughly investigated. In the view of the available literature, following 
problems need to be further investigated: 
1. Is opalescence in solution due to liquid-liquid phase separation or increased Rayleigh 
scattering? 
2. How do the extrinsic factors affect protein-protein interactions resulting in 
opalescence and liquid-liquid phase separation? 
3. Do DVD-IgTM protein molecules have a greater propensity to show concentration 
based effects (phase separation and increased viscosity) at much lower concentrations 
as compared to mAbs? 
4. Does liquid-liquid phase separation in solution result in increased tendency to form 
aggregates? 
 
2. Objective 
The overall objective of the work is to investigate the factors and the nature of 
intermolecular interactions resulting in opalescence and phase separation for mAb and DVD-
Ig
TM
 protein molecules, and understand their relation with increased viscosity and 
aggregation in solution. 
Specific aims of the project are: 
1. To study the effect of solution conditions on opalescence in mAb solutions and 
correlating opalescence with the nature of protein-protein interactions in dilute and 
concentrated solutions 
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2. To determine the formulation factors affecting liquid-liquid phase separation in DVD-
Ig
TM
 protein solutions 
3. To investigate the effect of excipients on liquid-liquid phase separation and 
aggregation in DVD-Ig
TM
 protein solutions 
4. To characterize viscous behavior of DVD-IgTM protein solutions and understand the 
role of size, charges and interactions in solution resulting in the increased viscosity 
 
3. Chapter Organization and Outline 
A detailed review with the theoretical basis and literature examples of opalescence 
and liquid-liquid phase separation in protein solutions is presented in Chapter 2. Review 
briefly highlights the theory of opalescence and liquid-liquid phase separation with focus on 
thermodynamic, kinetic, and light scattering aspects. Overview of intermolecular interactions 
resulting in physical instability and the relevant parameters (B2 and Tcloud) to measure these 
interactions in solution is presented in the review. Formulation factors affecting opalescence 
and phase separation resulting in protein instability are discussed with relevant examples 
from the literature.  
Opalescence in protein solutions can be due to the presence of aggregates in solution 
or liquid-liquid phase separation (LLPS). Chapter 3 discusses the solution factors affecting 
opalescence of a monoclonal antibody (mAb) solution; temperature dependence indicates 
that LLPS results in opalescent appearance. From literature studies, opalescence is attributed 
to attractive interactions in solution, however, protein-protein interactions are routinely 
measured in dilute solutions using techniques including light scattering, while opalescence is 
observed at relatively higher concentrations. Opalescence was correlated to protein-protein 
6 
 
interactions measured in dilute and concentrated monoclonal antibody solutions. Results 
indicate that high opalescence and liquid-liquid phase separation are due to the attractive 
interactions in solution, however, the presence of attractive interactions do not always imply 
phase separation.  
Chapter 4 presents factors influencing liquid-liquid phase separation resulting in 
opalescence for a DVD-Ig
TM
 protein solution. Larger size and increased asymmetry of the 
molecule (with respect to shape and surface charge distribution) results in many fold increase 
in formulation challenges for DVD-Ig
TM
 protein. We first established the thermodynamic 
basis for phase separation and then studied the effect of different formulation factors on 
LLPS. No structural changes were observed in the protein before and after phase separation. 
Interaction parameter, kD, and Tcloud (temperature that marks onset of LLPS in solution) were 
measured to assess specific and non-specific attractive interactions in solution. A good 
correlation exists between kD measured in dilute solution with Tcloud measured in the critical 
concentration range. 
Investigation of the effect of different excipients (PEG, Sucrose and Tween) on 
liquid-liquid phase separation and aggregation in a DVD-Ig
TM
 protein solution is presented in 
Chapter 5. PEG is a precipitant, while other excipients are reported to reduce aggregation in 
protein solutions; however their effect on LLPS is not known. Results indicate that the 
mechanism by which different excipients exert their stabilizing/destabilizing effect varies for 
LLPS and aggregation. Stability studies were performed as a function of temperature to 
investigate if the systems that undergo phase separation promote aggregate formation in the 
protein-rich (high concentration) phase. LLPS may promote aggregation in protein solution; 
however, both show phenomenon strong temperature dependence. 
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Increased viscosity of solution is observed at high concentration that causes 
challenges in successful manufacturing and delivery of the therapeutic proteins. Role of the 
size of the molecule, electroviscous effect and protein-protein interactions on viscosity of 
DVD-Ig
TM
 protein is discussed in Chapter 6. We first established that increased size and 
asymmetry of the molecule for DVD-Ig
TM
 protein compared to mAb by itself is a significant 
contributor to the increased viscosity in the form of intrinsic viscosity and excluded volume 
effects; however, these size effects are significant at higher concentrations. Significant 
increase in viscosity due to electroviscous effect was observed in the absence of ions in 
solution, while the presence of ions show minimal electroviscous effect. Intermolecular 
interactions were studied by changing pH and ionic strength of the solution. Interplay of 
more than one factor modulates viscosity behavior at high concentration; hence, rank-
ordering these factors can provide valuable information on how to approach the high 
viscosity problem for protein formulations. 
Chapter 7 presents a summary of the entire work.   
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Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in 
Protein Solutions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
Contents 
Chapter 2 
1. Abstract and Keywords 
2. Introduction 
3. Theoretical Aspects of Opalescence and Liquid-Liquid Phase Separation 
3.1 Thermodynamics of Phase Separation 
3.2 Kinetics of Phase Separation  
3.3 Light Scattering from Solution 
4. Characterizing Opalescence and Phase separation 
4.1 Opalescence Measurements 
4.2 Constructing a Phase Diagram 
4.3 Characterizing Critical Opalescence  
5. Protein-Protein Interactions 
5.1 Nature of Interactions 
5.2 Second virial coefficient: B2  
5.3 Critical/Cloud-point temperature: Tcloud 
6. Factors Affecting Opalescence and Phase separation 
7. Implications 
8. Summary 
9. References 
10. List of Symbols 
11. Tables and Figures  
 
11 
 
1. Abstract  
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be 
an indicator of the presence of aggregates or precursor to phase separation in solution 
signifying reduced product stability. Liquid-liquid phase separation of a protein solution into 
a protein-rich and a protein-poor phase has been well documented for globular proteins and 
recently observed for monoclonal antibody solutions, resulting in physical instability of the 
formulation. The present review discusses opalescence and liquid-liquid phase separation 
(LLPS) for therapeutic protein formulations. A brief discussion on the theoretical concepts 
based on thermodynamics, kinetics and light scattering is presented. Review also discusses 
theoretical concepts behind intense light scattering in the vicinity of the critical point termed 
as ‘critical opalescence’. Both opalescence and LLPS are affected by the formulation factors 
including pH, ionic strength, protein concentration, temperature and excipients. Literature 
reports for the effect of these formulation factors on attractive protein-protein interactions in 
solution as assessed by B2 and Tcloud measurements are also presented. The review also 
highlights some physiological and mainly pharmaceutical implications of LLPS in protein 
solutions. 
 
Keyword: opalescence, liquid-liquid phase separation, aggregation, light scattering, 
thermodynamics, phase diagram, formulation, stability, protein-protein interactions, 
crystallization, B2, Tcloud 
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2. Introduction 
Monoclonal antibodies (mAbs) have emerged as successful bio-therapeutics in the 
treatment of several terminal diseases.
1
 Continual efforts to enhance the safety and efficacy 
of these molecules against numerous indications have led to a growing interest in the second 
generation of antibody-based therapeutics such as ADCs, bispecific antibodies, engineered 
antibodies and antibody fragments or domains.
2,3
 Therapeutic proteins are generally 
formulated at high concentrations (>100 mg/mL) because of their low potency and low 
volume restriction (<1.5 mL) imposed by the subcutaneous route of administration. Such 
formulations present many challenges in the analytical characterization, manufacturing, 
delivery to the patient, and maintaining stability across the shelf-life.
4
 At high concentrations, 
interactions between the molecules increases,
5,6
 resulting in increased opalescence, 
significantly higher solution viscosity and increased tendency of proteins to undergo phase 
separation and aggregation, which pose major challenges in the formulation development.
7,8
  
Opalescent/turbid appearance of the solution compromises aesthetic appeal of the 
protein formulation. Opalescence also indicates the presence of aggregates in solution or that 
the system shows a tendency to undergo phase separation (solid-liquid or liquid-liquid phase 
separation), both, signifying reduced product stability.
9-15
 Presence of higher order reversible 
(native) or irreversible (non-native) aggregates can compromise protein activity, physical 
stability of the product and cause immunogenicity concerns.
16-18
 Solid-liquid phase 
separation results in formation of protein crystals or amorphous precipitate indicating 
reduced solubility of the protein in solution. Liquid-liquid phase separation into a protein-
rich and protein-poor phase is a concern from pharmaceutical point of view as most 
13 
 
therapeutic proteins are stored at refrigerated conditions, where tendency to phase separate is 
much higher.  
Dictionary definition of opalescence is “reflection of iridescent light (dichroism) 
similar to opal”. The solution exhibits different colors depending on the angle between 
incident light and transmitted light. However, in the pharmaceutical literature, turbidity or 
opacity of the solution i.e. cloudy-whitish appearance is also termed as opalescence. Solution 
opalescence/turbidity can be attributed to the increased scattering from the solution due to 
presence of particles (termed as aggregates) or it may also be due to fluctuations of density 
and concentration (liquid-liquid phase separation). Figure 1 shows opalescence in a protein 
solution due to liquid-liquid phase separation after the solution was stored at refrigerated 
condition. For a system exhibiting liquid-liquid phase separation, fluctuations of the 
thermodynamic quantities increase enormously in the vicinity of the critical point which 
results in intense scattering from the solutions and is termed as critical opalescence.
19
  
Increased opalescence in solution due to insoluble aggregates has been reported for 
globular proteins
20-24
 as well as monoclonal antibodies.
25-28
 Examples for opalescence in 
mAb solution due to liquid-liquid phase separation, which may or may not be associated with 
critical opalescence, are also present in the literature.
12,13,15
 Opalescence has been observed 
for monoclonal antibody formulation without any aggregate formation or phase separation in 
solution.
9-11,29
 In another case, soluble aggregates of monoclonal antibody resulted in 
increased turbidity at lower temperatures, which reversed on increasing the temperature. The 
authors confirmed that the turbidity in solution was indeed due to soluble aggregates (and not 
phase separation) by performing SEC and DSC studies.
14
 Liquid-liquid phase separation 
(LLPS) in solution is characterized by a temperature-concentration phase diagram (also 
14 
 
termed as coexistence curve) and the presence of aggregates in solution can change the 
apparent position of the liquid–liquid coexistence curve, affecting the accurate determination 
of the temperature at which phase separation occurs.
30,31
 Opalescence, LLPS and irreversible 
aggregation for therapeutic protein solutions are well documented in literature, especially for 
globular proteins; however there is no clear understanding of the inter-relationships between 
these phenomena. 
Aggregation and phase separation result in physical instabilities in solution; however, 
the underlying thermodynamic and kinetic principles are different for these two phenomena. 
While on phase separation, protein retains its native structure; aggregation may be associated 
with formation of native or non-native species in solution. Phase separation is reversible, 
while aggregation can either be reversible and/or irreversible in nature.
32
 Schematic in Figure 
2 highlights the difference between these two aspects in protein solution based on protein-
protein interactions and temperature. Both aggregation and LLPS in solution result in 
opalescent appearance of the formulation; however the theoretical basis for light scattering is 
different for the two i.e, particles in solution and fluctuation of thermodynamic quantities, 
respectively. Aggregation in protein solutions has been extensively studied and reported in 
the literature
33-38
 and hence in this review, the focus will be on LLPS and its relation to 
solution opalescence. The review discusses following aspects of opalescence and LLPS: 
i. Theoretical aspects 
ii. Characterizing opalescence and phase separation  
iii. Protein-protein interactions 
iv. Factors affecting opalescence and LLPS 
v. Implications 
15 
 
3. Theoretical Aspects of Opalescence and Liquid-Liquid Phase Separation  
Opalescence and phase separation in solution are thoroughly studied in binary liquid 
systems and in polymer (colloidal) solutions,
19,39-41
 and the knowledge gained has been of 
immense help in understanding the physical instabilities in protein solutions. In this section, 
we briefly discuss the thermodynamics defined in terms of free energy and the kinetic 
mechanism resulting in phase separation for protein solutions. The theoretical concepts of 
opalescence or light scattering due to particles in solution (aggregates), fluctuation in 
solution and in the vicinity of the critical point resulting in critical opalescence are also 
discussed.
40,42
 
 
3.1. Thermodynamics  
3.1.1. Phase Diagram 
The thermodynamic quantity that undergoes continuous change resulting in phase 
transitions is termed as the order parameter- Φ (as defined by Landau).43 For pure liquids 
(one-component system), the change in density or density fluctuations is the order parameter, 
while for the binary systems (protein-water system), concentration fluctuation is the order 
parameter. Phase separation in pure liquid and binary system are commonly described by a 
pressure-volume and temperature-concentration phase diagram, respectively.
41,43-47
 Phase 
diagram for a binary system (Figure 3) has a liquidus or solubility line, corresponding to the 
solid-liquid phase transition in one-component system, and a liquid–liquid coexistence line 
(binodal curve/miscibility curve), corresponding to the gas-liquid phase transition in one-
component system. Liquid-liquid phase separation curve lies below the solid-liquid curve and 
is metastable with respect to crystallization and amorphous precipitate formation.
48,49
 Binodal 
16 
 
or coexistence curve is the phase boundary, above which the solution exists as stable one 
phase system over the entire concentration range. In the area between the binodal and the 
spinodal curve the system exists in the metastable phase (formation of two phases is 
kinetically hindered). Inside the spinodal curve, system is thermodynamically unstable and 
separates into two phases at all conditions of temperature and concentration. The cross-over 
point of binodal and spinodal is termed as the Critical point defined by a Critical temperature 
(Tc) and Critical concentration (Cc). Solid-liquid curve do not exhibit a critical point.
50
 
Most of the globular proteins
51-56
 and monoclonal antibodies
10,12,13,15
 studied, exhibit 
an upper critical solution temperature (UCST) type of phase behavior as illustrated in Figure 
3, i.e, phase separation occurs at lower temperatures and system is homogeneous at higher 
temperatures. Hemoglobin exhibits lower critical solution temperature (LCST) type of phase 
behavior, where phase separation occurs at higher temperature and system is homogenous at 
lower temperatures (also termed as retrograde solubility).
57,58
      
                                                                                                                                                               
3.1.2. Fluctuation of Thermodynamic Quantities  
A system is said to be thermodynamically stable when the free energy of the system 
is minimum. Fluctuations of the order parameter (density and concentration fluctuations) 
results in a change in the free energy of the system.
43,59
 Landau, defined the Helmholz free 
energy of the system (F) in the form of power expansion with respect to order parameter (Φ) 
and temperature (T). At equilibrium, free energy of the system is minimum (∂F /∂Φ=0) and 
the equation is given as,  
                                              𝛷± = ± (
𝑎
𝑏
)
1/2
(𝑇𝑐 − 𝑇)
1/2                                                           (1)  
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where, Tc is the critical temperature, and T is the temperature above or below the critical 
temperature, a and b are constants. At T>>Tc there is only one solution to equation 1 and 
hence one phase exists, while at T≤Tc two solutions exist for the order parameter (positive 
and negative), forming two points of the coexistence curve. For a binary system, where 
concentration fluctuation is the order parameter, Equation 1 can be rearranged to define the 
coexistence curve in terms of distance from the critical point as, 
                                                  
𝐶 − 𝐶𝐶
𝐶𝐶
=  𝐴(
𝑇 − 𝑇𝑐
𝑇𝑐
)−𝛽                                                                      (2) 
where, Cc is the critical concentration, C is any concentration on the coexistence curve, Tc 
and T are as defined in Equation 1, A is a constant that defines the width of the coexistence 
curve and β is the critical exponent that describes the critical behavior close to the critical 
point. Scaling laws relate all these critical exponents of various thermodynamic quantities.
43
 
 For binary systems, concentration fluctuations result in liquid-liquid phase separation 
of the system into two phases of different concentrations. Concentration of the solute in 
solution is related to its chemical potential, which is defined as partial molar Gibbs free 
energy and expressed as, 
                                                        𝜇𝑝 = (
𝜕𝛥𝐺
𝜕𝑛𝑝
)                                                                      (3) 
where, μp is the chemical potential of the protein (solute) in solution and np is the total 
number of protein (solute) molecules in solution (related to protein concentration by mole 
fraction). Change in free energy of the system for transfer of ∂np amount of substance from 
phase 1 to phase 2 is given by; 
                                                      𝜕𝐺 = (𝜇𝑝
1 − 𝜇𝑝
2)𝜕𝑛𝑝                                                          (4)             
18 
 
At Equilibrium, 𝜕𝐺/𝜕𝑛𝑝=0 and hence, chemical potential of the solute is same 
throughout the system (𝜇𝑝
1 = 𝜇𝑝
2), regardless of the number of phases present.41 Therefore, on 
phase separation, the chemical potential for protein is same in both the phases. Figure 4 
illustrates the phase diagram for a binary system in terms of free energy (upper part). At any 
temperature T1 above Tc, ΔG is negative with one minimum indicating that the solution exists 
as homogenous one phase system over the entire concentration range. At T2, which is below 
Tc, the system has a tendency to phase separate and hence, even though ΔG of the entire 
system is negative, it has two local minima indicating that the system will separate into two 
thermodynamically stable phases. Concentrations of these phases are determined by the 
tangent point on ΔG curve, and are called as binodal points which define the binodal curve. 
At inflexion point, second derivative of free energy is zero (𝜕2𝛥𝐺 𝜕𝑐2⁄ = 0) and these points 
are the spinodal points which define the spinodal curve. Critical point is defined as the point 
where binodal and spinodal curves cross and second as well as third derivative of free energy 
is zero, 
                                                         
𝜕2𝛥𝐺
𝜕𝑐2
=
𝜕3𝛥𝐺
𝜕𝑐3
= 0                                                                      (5)  
At extremely low temperature T3, within the spinodal curve, there is no energy barrier (free 
energy of mixing is positive) and system spontaneously phase separates in two 
thermodynamically stable phases.
41,45
 
                                                                            
3.1.3. Free Energy of Mixing: Enthalpic and Entropic Effect 
Phase separation ideally means lower solubility of the system or that the system is 
immiscible.
60-63
 Miscibility/immiscibility of the system taking into account enthalpic and 
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entropic contributions to the free energy of the mixing can be represented as,                                              
                                                  𝛥𝐺𝑚𝑖𝑥 = 𝛥𝐻𝑚𝑖𝑥 − 𝑇𝛥𝑆𝑚𝑖𝑥                                                                (6) 
For a dilute/ideal system, where energy of solute-solvent interactions is greater than 
the solute-solute interactions, enthalpy of the system is negative (ΔHmix < 0). ΔGmix depends 
on the entropy of the system; mixing of a solute in solvent increases the disorder of the 
system and hence promotes mixing by decreasing the free energy. For a system, where 
enthalpy is positive (ΔHmix > 0), i.e., the energy of interactions between solute-solute and 
solvent-solvent is greater than the solute-solvent interactions, ΔGmix shows a strong 
temperature dependence. As observed in Figure 4, at some temperature T1 >>>Tc, entropic 
contribution (-T∆S) balances the positive enthalpic contributions resulting in negative ΔGmix, 
hence promotes mixing. As temperature T2 approaches and decreases below the critical 
temperature (T→Tc), entropic contribution decreases and does not compensate for the 
positive mixing enthalpy resulting in phase separation. At an extremely low temperature, 
T3<<<Tc, ΔGmix is positive and system spontaneously phase separates. On undergoing LLPS, 
protein separates into a protein rich phase with higher enthalpy (attractive protein-protein 
interactions) and lower entropy, while protein-poor phase has lower enthalpy and higher 
entropy. This enthalpy-entropy effect, balances the free energy of the system, hence 
stabilizing the two phases.
15,64
 
 
3.2. Kinetics of Phase Separation 
Attaining thermodynamic equilibrium forms the basis of separation of a binary 
mixture; however, kinetics controls the ultimate phase separation process. This section 
discusses the basic kinetic mechanism by which binary system undergoes phase separation as 
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solution conditions change and a system transitions from stable region to metastable or 
unstable region. Phase separation of a binary mixture into a protein-rich and protein-poor 
phase occurs in the metastable region by Nucleation and Growth process while the kinetics of 
phase separation in spinodal or unstable region is by Spinodal Decomposition.
47
 Table 1, 
outlines the fundamental difference between the two kinetic mechanisms for phase 
separation. 
 
3.2.1. Nucleation and Growth Process 
As the system transitions in the metastable region, formation of a protein-rich phase is 
initiated, either by homogeneous or heterogeneous nucleation. Phase separation occurs down 
the concentration gradient as the fluctuation of thermodynamic quantities in the solution 
increases and diffusion coefficient is positive. Protein-rich phase is surrounded by the 
protein-poor phase, which is different from the bulk phase and hence results in the formation 
of an interface, and increases the interfacial free energy (4𝜋𝑟2𝜎) of the system, which is 
proportional to the surface area. Formation of two phases reduces the bulk energy (4/3𝜋𝑟3𝜀) 
of the system and is proportional to the volume associated with the formation of a new phase. 
Free energy term is always negative while interfacial energy term is always positive and 
hence there are variations in the energy. Total energy of the system is the sum of the two 
energies and is presented as,
43
                                                                                                                                                                                              
                                                         ∆𝐹 = 4𝜋𝑟2𝜎 +
4
3
𝜋𝑟3𝜀                                                                (7) 
 where, ΔF is a function of size of the nucleus of the new phase. Smaller sized clusters 
formed on smaller fluctuations, revert back to one-phase; however as the size of the nucleus 
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reaches a critical size called as critical radius represented by equation 8, these clusters 
become stable and grow further resulting in the formation of new phase droplets.
65
  
                                                                  𝑅 =
2𝜎
𝜀
                                                                                   (8) 
The growth of the nucleus or the nucleation rate is as follows,
66
  
                                                                𝐽 = 𝐴𝑒−
𝜔
𝑘𝑇                                                                                                              (9) 
where, ‘A’ is a factor that depends on many parameters such as the size, surface area and 
total number of droplets.
67
 Nucleation rate increases as the system goes further down the 
coexistence curve i.e, as the temperature of the system is lowered. Due to the formation of 
spherical droplets on nucleation, the two phases so formed have a sharp interface between 
them.
67
  
 
3.2.2. Spinodal Decomposition 
The phase separation process inside the unstable region occurs by spinodal 
decomposition mechanism. Since, there is no kinetic barrier, small fluctuations in density or 
concentration grow in time and space and follow an uphill diffusion (against the 
concentration gradient). Diffusion coefficient obtained by the Cahn Hilliard approximation is 
negative.
67
 While, nucleation and growth is a local phenomenon, systems exhibiting spinodal 
decomposition have long-range order. Hence, instead of the formation of droplets there is 
formation of domains in the unstable region and initially there is no sharp interface between 
the two phases so formed.
43,63,67
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3.3. Light Scattering from Solution 
Opalescence in solution is due to scattering of light, which can either be due to 
presence of particles or fluctuations in the solution. Theoretical concepts behind both are 
briefly discussed below, and readers are directed to general references on the topics focusing 
on light scattering from protein/colloid solutions for further details.
68-74
  
 
3.3.1. Scattering due to Particles in Solution 
Intensity of scattering from solution increases with increasing size of the particles. 
Scattering in the presence of small, isotropic particles (size < λ/10) is described by Rayleigh 
theory as,  
                                           𝐼𝑠 = 𝐼0
2𝜋2
𝑟2𝜆4
𝑛𝑝𝑁𝐴𝛼
2
𝑉
(1 + 𝑐𝑜𝑠2𝜃)                                                       (10) 
where, Is is the intensity of scattered light, I0 is the intensity of incident light, r is the distance 
from the scattering center, λ is the wavelength of the light, np is the number of particles, α is 
the polarizability of molecule, V is the molar volume and θ is the scattering angle. Scattering 
intensity can also be expressed in terms of Turbidity (τ) defined as the total relative amount 
of light scattered by unit volume in all directions. Particles scattering light in accordance with 
the Rayleigh theory exhibit an angular symmetry, intensity of light scattered in forward 
directions is equal to light scattered in backward direction. Maximum scattering intensity is 
at θ = 0° and 180°, while minimum scattering intensity is at θ= 90°.74As the size of the 
particles increases, more than one site acts as scattering center. Larger particles exhibit an 
angular asymmetry, the scattering intensity in the forward direction is greater than the 
intensity for back scattering. At θ = 0°, path lengths are identical, absence of destructive 
interference results in maximum scattering intensity; while, as scattering angle increases, the 
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scattering intensity decreases due to destructive interference. Several theories including Mie, 
Rayleigh-Gans, Debye provide a general correction for scattering intensity in solution for 
larger particles by considering a form factor.
71
  
Table 2 briefly summarizes the size and wavelength dependence of scattering from 
the solution.
70
 According to Rayleigh theory, intensity of scattered light is inversely 
proportional to the fourth power of wavelength (𝐼𝑆 ∝ 𝜆
−4) and hence, shorter wavelengths 
scatter more light, resulting in bluish appearance of the solution. As the size of the particles 
increases above that defined by the Rayleigh theory, but smaller than the wavelength of light, 
scattering intensity exhibits an inverse dependence on second power (𝐼𝑆 ∝ 𝜆
−2) of the 
wavelength of the incident light.  As the size of the particles increases and becomes larger 
than the wavelength of the light, intensity is independent of the wavelength; hence, solution 
appears whitish instead of bluish as seen in Rayleigh scattering.  
 
3.3.2. Scattering due to Fluctuations in Solution 
There are constant density and concentration fluctuations in solution due to thermal 
(Brownian) motions. Scattering of light in solution occurs due to fluctuations of refractive 
index  ⟨𝛥𝜂̅̅̅̅ ⟩2 in the volume element, ΔV, which in turn depends on fluctuations of density 
(Δρ) and concentrations (Δc) in solution and are represented as,70  
                       ⟨𝛥𝜂̅̅̅̅ ⟩2 = (
𝜕𝜂
𝜕𝜌
𝛥𝜌 +
𝜕𝜂
𝜕𝑐
𝛥𝑐
̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅
)
2
= (
𝜕𝜂
𝜕𝜌
)
2
⟨𝛥𝜌̅̅̅̅ ⟩2 +  (
𝜕𝜂
𝜕𝑐
)
2
⟨𝛥𝑐̅̅ ̅⟩2                           (11) 
The scattering intensity as obtained from Rayleigh theory (equation 10) is modified to 
accommodate the fluctuations term as,   
                                       𝐼𝑠 = 𝐼0
4𝜋2𝛥𝑉 𝜂2⟨𝛥𝜂̅̅̅̅ ⟩2
𝑟2𝜆4
(1 + 𝑐𝑜𝑠2𝜃)                                                      (12)  
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where, ƞ is the refractive index of the medium and is related to polarizability (α) by Clausius 
Mosotti relation. Eq. 11 can also be expressed in terms of turbidity (τ) of the solution as, 
                                               𝜏 =
32𝜋2𝜂2⟨𝛥𝜂̅̅̅̅ ⟩2𝛥𝑉
3𝜆4
                                                                         (13) 
Density fluctuations in pure liquid and concentration fluctuations in binary mixtures are 
related to the turbidity of the solution and given by Einstein-Smoluchowski Equation; 
                             𝜏 =
4𝜋2
𝜆4
{(𝜌
𝑑𝑛
𝑑𝜌
)2𝑘𝑇𝜒 + (𝑛
𝑑𝑛
𝑑𝑐 
)2𝑘𝑇𝑉
𝑐
(
−𝑑𝜋𝑜𝑠𝑚
𝑑𝑐 )
}                                     (14) 
τ is the turbidity, λ is the wavelength of the light, ρ is the solvent density, χ is the isothermal 
compressibility, ƞ is the refractive index, 𝜋𝑜𝑠𝑚 is the osmotic pressure, V is the molar 
volume, c is the concentration. Isothermal compressibility (χ) is related to the density 
fluctuations in pure liquids and is defined as the change in volume as a response to change in 
pressure of the system.
19
 Osmotic pressure is related to the concentration fluctuations and as 
solute-solute interactions increases, osmotic pressure decreases. Increase in fluctuations from 
solutions due to liquid-liquid phase separation in binary systems results in increased 
scattering from the solution. 
 
3.3.3. Critical Opalescence 
Infinite increase in fluctuations close to the critical point results in increased 
scattering from the solution termed as critical opalescence.
19,39,75-77
 Scattering of light due to 
fluctuations in solution is given by Einstein equation (equation 14); however, Einstein 
assumed that the fluctuations in solution were independent or there are no correlations 
between these fluctuations. In that case, in the vicinity of critical point, fluctuations would be 
infinite (1/χ and dπosm/dc are zero from pressure-volume and temperature-concentrations 
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phase diagram, respectively) and hence the intensity of scattered light would be infinite; but 
in real solutions, intensity of scattering is finite. Ornstein-Zernike accounted for finite 
correlation between the fluctuations in the volume element ΔV characterized by a correlation 
length (ξ). 43 By definition, Correlation length is the spatial extent of correlations between the 
fluctuations and is given by;  
                                                                      ξ ∝ (
𝑇 − 𝑇𝑐
𝑇𝑐
)−𝜈                                                            (15)    
where, T is any temperature, Tc is the Critical temperature and ν is the critical exponent. 
Figure 5 represents schematic for correlation length of fluctuations in solution as temperature 
approaches critical temperature. At some temperature T >> Tc, fluctuations are correlated in 
small volume element as observed in Figure 5a. As T approaches Tc, correlation between 
fluctuations increases (Figure 5b) and at Tc, ξ diverges i.e.; fluctuations become correlated 
over the entire volume element (Figure 5c). This correlation length is related to the intensity 
of scattered light by a correlation factor and equation 11 is modified as;  
                         
𝐼𝑠
𝐼0
=
4𝜋2
𝜆4𝑟2
(𝜂
𝑑𝑛
𝑑𝑐 
)
2
(
𝑘𝑇𝑐
(
−𝑑𝜋𝑜𝑠𝑚
𝑑𝑐 )
)
1
1 + (𝜉
4𝜋
𝜆 𝑠𝑖𝑛
𝜃
2)
2  (1 + 𝑐𝑜𝑠
2𝜃)                (16) 
Near critical point, scattering intensity due to concentration fluctuations is much larger than 
density fluctuations.
78
 As T → Tc, scattering intensity depends on λ
-2
 as compared to λ-4, in 
simple/regular solutions; hence solution appears opalescent in the vicinity of the critical 
point.
77
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4. Characterizing Opalescence and Phase Separation in Protein Solutions 
4.1. Opalescence Measurements 
Opalescence in solution is routinely measured using turbidity meter, nephelometer or 
spectrophotometer and depends on the size and concentration of the particles. Nephelometric 
turbidity units (NTUs), Formazin turbidity units (FTUs), absorbance (optical density) or 
percent transmittance are the commonly used units representing opalescence in solution. 
Opalescence measured in different units can be expressed in standard NTU’s by using 
appropriate calibration standards.
10,13
 Opalescence or turbidity of the solution is measured at 
a fixed wavelength, usually between 450-650 nm, were protein is non-absorbing.
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Opalescence in solution can also be measured using phase contrast or polarized light 
microscope.
13,53,79
 LLPS and critical opalescence are further characterized by measuring 
opalescence as a function of temperature and determining correlation length between the 
fluctuations. 
 
4.2. Phase Separation- Constructing a Phase diagram 
Two techniques are generally employed to study phase separation in solution: 1) 
Temperature quenching and centrifugation method and 2) Cloud-point measurement.
52,80
 In 
temperature quenching method, samples are placed in tubes and then centrifuged at certain 
speed and time. If there is a phase separation in the sample, concentration is determined in 
the protein-rich and protein-poor phase by UV-spectrophotometer. Samples are then gently 
inverted and centrifuged again at lower temperatures. Phase diagram is then constructed by 
plotting temperature against the concentrations measured in two phases. Tc and Cc are then 
determined from the phase diagram using equation 2.  
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In Cloud-point measurement, sample is placed in temperature controlled water 
bath/chamber and turbidity of the sample is measured as temperature is lowered. Onset of the 
liquid-liquid phase separation is characterized by a dramatic increase in solution turbidity; 
this temperature is marked as Topacity. Temperature is then increased step wise till solution 
becomes clear, and this temperature is marked as Tclear. Average temperature between Topacity 
and Tclear is the Tcloud temperature.
81
 Cloud point measurements can also be performed using 
microscope fitted with a temperature control. On lowering the temperature, onset of phase 
separation can be visually assessed by darkening of the field.
79
 The spinodal temperatures are 
determined by extrapolating inverse of the intensity measured at 90° angle to zero at varying 
concentrations.
80,81
 The coexistence curve and spinodal curve are then fitted to equation 2 to 
determine the Critical point. 
 
4.3. Characterizing Critical Opalescence  
Several studies are reported in the literature where LLPS for globular proteins was 
related to critical opalescence in solution.
80-82
 Though there are speculations for increased 
solution opalescence for mAb as critical opalescence,
10
 there are very few studies were 
divergence of thermodynamic properties close to the critical point are actually quantified.
83
 
Earliest studies on liquid-liquid phase separation in lysozyme-salt solution using light 
scattering methods were performed by Ishimoto and Tanaka, were they demonstrated 
existence of critical point for protein in binary solutions. They characterized the 
asymptomatic behavior of fluctuations close to the critical point, confirming critical 
opalescence for lysozyme solution. Authors also determined correlation length (ξ) of the 
fluctuations using mean-field approximation.
81
 In the vicinity of the critical point, scattering 
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at coexistence temperatures and spinodal temperatures are reported to be similar (and 
converge) for γ-crystallins.80 Detailed experimentation and relationships to determine 
osmotic isothermal compressibility (χ) and correlation length is described in the literature.82 
 
5. Protein-Protein Interactions and LLPS 
Liquid-liquid phase separation in a binary system occurs when solute-solute 
interactions are greater than solute-solvent interactions (enthalpy effect) and when 
temperature of the system is lowered (entropy effect). For a protein solution, attractive 
protein-protein interactions determine if a system will undergo liquid-liquid phase separation. 
Crystallization and its relation to protein-protein interactions in solution has been thoroughly 
studied and reported in the literature.
84
 LLPS is metastable with respect to crystal formation 
and hence, similar to solid-liquid phase transition, attractive interactions result in liquid-
liquid phase separation in solution. In this section, we briefly discuss different types of 
attractive interactions determined for protein solutions, followed by parameters that indicate 
attractions in solution, B2 (second virial coefficient) and Tcloud/Tc (cloud temperature/ critical 
temperature). 
 
5.1. Nature of Attractive PPI in Protein Solution 
Protein-protein interactions play a significant role in opalescence and phase 
separation in solutions and determining the nature of these interactions holds the key for the 
selection of appropriate solution conditions (pH, ionic strength, salt type, etc.) and excipients 
to formulate a physically stable product. Interactions in protein/colloidal solutions are a well-
researched area, and details for the same are extensively available in the literature.
5,74,85-87
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Molecular properties and solution conditions that strongly influence protein-protein 
interactions are discussed below. 
Charges 
Though the presence of charges on proteins results in repulsive interactions between 
them, as the inter-separation distance decreases and protein molecules approach each-other, 
charges on the protein molecule may interact with oppositely charge dipole/induced-dipole 
resulting in attractive interactions in solution.  
Dipolar interactions 
At high protein concentration, van der Waals interaction including dipole-dipole, 
dipole-induced dipole and induced dipole-induced dipole, are the dominant forces in 
solution. Dipole-mediated interactions in proteins are further enhanced for asymmetrical and 
larger molecules like mAb (and DVD-Ig
TM
) due to their geometry and 
orientation/asymmetric charge distribution on the protein surface.
88
 Dipolar interactions are 
dominant close to the pI of the molecule, while charge-dipole interactions dominate at pH 
away from the pI (where protein carries net charge). The mean potential force due to the 
charge and dipole interactions decreases on increasing the ionic strength of the solution.
89,90
 
Hydrophobic interactions 
Presence of hydrophobic amino acids/patches on protein surface results in attractive 
hydrophobic interactions in solution which are short-ranged in nature (i.e, proximity energy 
increases as protein molecules approach each other at high concentrations). Low ionic 
strengths have no effect on these interactions, however, high ionic strength, increases 
hydrophobic interactions. Any excipient that interacts with the surface hydrophobic amino 
acids reduces these attractive interactions in solution.
91-93
 
94 
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Specific interactions  
The presence of certain specific amino acids on protein surface results in specific-
interactions between the protein molecules; these interactions include cation-π, π-π aromatic 
interactions,
95
 etc. These attractive interactions decrease on addition of amino acids and its 
derivatives that bind specifically with amino acids on protein surface.
94,96-98
   
 
5.2. Second Virial Coefficient (B2) 
Second virial coefficient (B2) is routinely used to characterize protein-protein 
interactions in formulation development. B2 can be measured using various techniques 
including Membrane osmometry, Static Light scattering, Self-interaction chromatography, 
etc. Virial expansion for osmotic pressure in protein solution is presented as, 
𝜋 = 𝑅𝑇𝑐 (
1
𝑀𝑤
+ 2𝐵2𝑐 + 3𝐵3𝑐 
2 + 4𝐵4𝑐 
3 + ⋯ )                                  (17) 
where, π isosmotic pressure, R is the universal gas constant, T is the absolute temperature, c 
is the solute concentration, Mw is the average molecular weight. At infinite dilutions, higher 
order terms are neglected and equation 17 reduces to van’t Hoff equation for ideal solution. 
B2 is the first measure of deviation from ideality in solution and characterizes interactions in 
solutions. The value of B2 reflects the magnitude of the deviation from the ideality, while its 
sign reflects the nature of this deviation. A positive value corresponds to net repulsive 
interactions between the solute molecules wherein the osmotic pressure increases above that 
for an ideal solution whereas a negative value corresponds to net attractive interactions 
between the solute molecules with a consequent decrease in solution osmotic pressure below 
that for an ideal solution.
99
 Good correlation has been established between B2 and protein 
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solubility, 
100,101
 crystallization,
48,102,103
 and protein precipitation;
104
 all of which characterize 
phase separation in solution.
101,105
  
Several studies in the literature refer to a ‘crystallization slot’ i.e a range of B2 values 
which allows for the formation and growth of crystals in solution. Crystallization occurs only 
when B2 values are between -1 and -8*10
-4
 mol. mL/gm
2
; high B2 indicating strong attractive 
interactions would result in the formation of amorphous precipitate, while low B2 indicating 
weak interactions would prevent crystal formation.
106
 These B2 values are in good agreement 
with crystal formation for globular proteins; however as the complexity of the molecule 
increases as observed for mAb, crystallization slot may not be an ideal predictor of 
crystallization or LLPS in solution. There are several examples in the literature, where 
crystallization occurs in solution with B2 values outside the crystallization slot.
107,108
  
 
5.3. Critical Temperature Tc, Tcloud 
Critical temperature is the temperature at the critical concentrations, i.e., 
concentration indicating maximum opalescence and below which system is unstable, while 
Tcloud marks the onset of liquid-liquid phase separation in solution at any concentration on the 
coexistence curve. For a system exhibiting attractive interactions (positive enthalpy), the 
change in temperature modulates the entropy and hence the free energy of the system. On 
similar lines, the change in temperature of onset of LLPS indicates increased or decreased 
attractive interactions in solution. B2 is measured under dilute solution conditions, however 
LLPS occurs at relatively higher concentrations and hence Tcloud or Tc, which can be 
measured at high concentrations can be a better indicator of attractions at higher 
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concentrations. Tcloud can be determined by any of the opalescence measurement techniques 
mentioned earlier (Section 4).  
Taratuta and coworkers established the coexistence curve for lysozyme solution at 
various pHs and determined that the coexistence curve shifts parallel with temperature as a 
function of solution conditions. Shape and width of the coexistence curve as well as Critical 
concentration Cc (230±10 mg/mL) remains fairly constant. As a result, they optimized Tcloud 
as a parameter to asses LLPS in lysozyme solution with change in pH, ionic strength and salt 
type details of which are provided in the next section (Section 6). Shifts in Tcloud with 
solution conditions were modeled to thermodynamic Gibbs free energy with contribution 
from attractive interactions between the hard spheres. Authors suggested that Cc is similar for 
similar sized molecules while Tc is a physical property that changes with the solution 
conditions.
52
 Similar observations were reported by Broide et al., where Critical 
concentration (Cc ~289±20 mg/mL) and width of the coexistence curve (A ~2.6±0.1) remains 
same for different γ-crystallins, while Tc changes.
53
 In another study, authors investigated 
Tcloud for lysozyme as a function of different salt ions and correlated it to the strength of 
protein interactions using DLVO theory model for colloids.
109
 Similar studies are reported in 
the literature for globular proteins and monoclonal antibodies, where, critical temperature or 
Tcloud is measured as a function of solution conditions to assess attractive interactions in 
solution and are elaborated in the next section.  
 
6. Factors Affecting Opalescence and LLPS 
In this section, we briefly discuss the effect of formulation factors including pH, ionic 
strength, salt types and other excipients on LLPS in protein solutions with relevant examples. 
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These factors modulate the PPI in solution, thereby, increasing or decreasing opalescence and 
tendency to undergo LLPS.  
  
6.1. Effect of Excipients on Opalescence in mAb Solutions 
Formation of irreversible aggregates and LLPS in solution results in increased 
opalescence; however there are few studies, where mAb solution is opalescent and neither 
aggregation nor LLPS is observed in the solution. Salinas et al., reported increased 
opalescence at high ionic strength (due to attractive interactions as determined from B2) 
which decreased on reducing the ionic strength of the solution.
10
 Similar observations were 
reported by Wang et al., where solution was clear at low ionic strength and opalescence 
increased on addition of salt. They attributed increased opalescence to hydrophobic 
interactions, which become dominant on charge shielding; consequently, Tween 80 reduces 
opalescence by disrupting hydrophobic interactions between the protein molecules. They also 
concluded from their studies that ionic strength rather than specific ions from Hofmeister 
series influences opalescence in solution.
11
 On the contrary, Woods et al., concluded that at 
low salt concentration different salts affect opalescence differently; citrate and succinate 
buffers reduce opalescence, while, acetate increases opalescence. They rank ordered different 
buffer species on reducing opalescence by their ability to interact with hydrophobic regions 
and preventing mAb self-association.
29
 Though, LLPS was not observed in any of the above 
studies, opalescence in solution increased on lowering the temperature (Wang and coworkers 
did not study the temperature effect), and was reversible with changing solution conditions. 
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6.2. Effect of Excipients on LLPS in Protein Solution 
6.2.1. pH and Ionic Strength 
Maintaining a constant pH and ionic strength is necessary not only from physiological 
point of view, but for proper storage of the formulation and maintaining its stability and 
solubility throughout the shelf life. Most studies reported in the literature indicate increased 
tendency of a protein to undergo LLPS close to the pI of the molecule. Taratuta and 
coworkers observed Tcloud shifts to higher temperature for lysozyme solution as pH was 
adjusted close to the pI (~11.2) of the protein.
52
 Similar observation was reported for a 
certain mAb (IgG2), where solution opalescence was maximum close to the pI (pH ~7.1) and 
decreased on increasing the ionic strength, while at pH away from pI, opalescence increased 
at high ionic strength.
13
 This change in opalescence with changing pH and ionic strength 
correlated well with change in critical temperature at a constant critical concentration (Cc ~ 
90 mg/mL).
110
 Nishi et al., reported increased opalescence, due to LLPS, close to the pI 
(pH~6.5) of the molecule for another mAb (IgG1) at low ionic strength conditions, which 
reversed on increasing the ionic strength of the solution. 
This pH dependence of opalescence and phase separation is similar to the solubility 
of the protein, where, solubility increases at pH conditions away from pI and is minimal at 
the pI. At low ionic strength, strong attractive interactions are present close to the pI of the 
molecule and can be attributed to dipoles and multipoles on the molecule, which are shielded 
on increasing the ionic strength of the solution. At pH conditions away from the pI, 
molecules carry a net charge and hence repel each other resulting in increased solubility 
(salting-in) and lower tendency to phase separate. However, as ionic strength is increased, 
charges on the molecules are shielded and there may be attractions between the protein 
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molecules due to preferential exclusion of salts resulting in reduced solubility (salting-out). 
Broide et al., correlated the solubility of lysozyme with Tcloud measurements as a function of 
ionic strength and observed that point of minimal solubility correlated to the maximum Tcloud 
in the solution.
109
  
Though, pH and ionic strength result in increased or decreased tendency of protein to 
undergo LLPS, this behavior cannot be generalized as it also depends on the nature/identity 
of the salt-ion. For lysozyme protein, Taratuta and coworkers observed that the effect of 
anionic species is more prominent than cationic species as protein carries a net positive 
charge at the conditions studied.
52
 While in another study, it was determined that both 
cationic and anionic salt species have varying effect on Tcloud of lysozyme depending on the 
pH and ionic strength.
111
 Broide et al., reported the effect of two anions, Cl
-
 and Br
-
, on Tcloud, 
which reversed with ionic strength; below 1 M ionic strength, Tcloud  value for Br
-
 is larger 
than Tcloud for Cl
-
, while between 1 and 2 M ionic strength, Tcloud for Cl
-
 is larger than that for 
Br
-
.
109
 Mason and coworkers performed extensive studies on the effect of different salts from 
Hofmeister series on LLPS in mAb solution. Tc decreases with increasing ionic strength and 
anions have a non-monotonic (no particular trend observed) influence on LLPS in solution at 
pH conditions away from the pI.
110
 Salts and buffer species exert their effects mostly by 
electrostatic interactions which can be explained by DLVO theory. This is supported by 
several studies in the literature that discuss the differential hydration of the protein molecules 
in the presence of different salt ions as the cause for change in Tcloud.
109,111-113
 The exact 
mechanism by which salt-species affect salting-in vs. salting-out behavior is still under 
investigation and the discussion is beyond the scope of this review.  
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6.2.2. Polyethylene Glycol (PEG) 
Polyethylene glycol (PEG) is a known macromolecular crowder and a precipitating 
agent for proteins.
114,115
 It is frequently used in purification of proteins and production of 
protein crystals in the solution. PEG precipitation has also been reported as a method for 
solubility screening of proteins in solution.
116-118
 PEG exerts its effect by depletion force, 
thereby increasing protein-protein interactions in solution. This results in the increased 
tendency of proteins to precipitate out of the solution either as solid phase or liquid phase. 
Liquid-liquid coexistence curve shifts to higher or lower temperatures with change in pH or 
ionic strength of the solution; similarly, increasing concentration as well as molecular weight 
of PEG raises Tc to higher temperatures. Extensive work has been carried out for the 
determination of colloidal stability by assessing shifts in the coexistence curve of protein 
solutions using PEG-induced LLPS.
119-123
 Every proteins undergoes phase separation at some 
temperature, which depends on both, the intrinsic nature of the protein and solution 
conditions; for a few proteins phase separation temperatures is above freezing, while others 
do not exhibit phase separation at temperatures as low as 0 °C. PEG raises the phase 
separation temperature of the protein and hence is extensively used to study the solubility of 
proteins as a function of solution conditions. However, PEG is also known to bind with 
proteins resulting in uncertainties in LLPS determination. Also, screening of the excipients 
that have a mechanism similar to PEGs may increase the challenge to determine Tc as PEG 
may also interact with other added excipients.
124
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6.2.3. Other Proteins 
Wang et al., studied LLPS for a monoclonal antibody in the presence of Human 
Serum Albumin (HSA) at physiological pH (7.4) to mimic blood serum conditions where 
HSA forms a major component. At pH 7.4, the two molecules carry opposite charge resulting 
in interaction of HSA (pI ~5.7) with mAb (pI ~8.8) and hence partitioning into protein-rich 
phase.  Favorable interactions of mAb with HSA reduce attractive interactions/self-
association between the mAb molecules and shift the coexistence curve to lower 
temperatures. 
125 
 
6.2.4. Polyols  
Though, polyols are commonly used for reducing thermal aggregation in solution, its 
effect on phase separation are not well understood. There is only one study in the literature, 
where increasing concentration of glycerol has been reported to decrease the phase separation 
temperature for lysozyme, which was hypothesized to be due to specific binding of glycerol 
with protein.
79
 
 
6.3. Effect of Molecular Properties on LLPS 
Proteins that have a higher proximity energy of attractions will show an increased 
tendency to phase separate. Other than formulation factors, the inherent nature of the protein 
molecule including, its size, shape, surface charge heterogeneity, amino acid sequence, 
hydrophobicity etc., may result in increased interactions between them. Broide et al., 
compared LLPS for four different γ-crystallins which differed in their amino acid sequence. 
They observed that the coexistence curve for different γ-crystallins can be divided into low 
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Tc (5 °C) and high Tc  (38 °C) group; γ-crystallins with high Tc resulted in cataract at body 
temperature.
53
 
Wang et al., plotted a scaled coexistence curve (binodal curve of phase diagram) for 
three different proteins and hard-spheres.
125
 Globular proteins, crystallins (MW ~ 20 kDa) 
and lysozyme (MW ~ 14 kDa) have narrow and symmetrical coexistence curves, similar to 
that for a hard sphere, while monoclonal antibody (MW ~ 150 kDa) exhibits a wider and 
asymmetrical coexistence curve due to its non-spherical shape and increased flexibility. 
Critical concentration for crystallins and lysozyme are 240 ± 10 mg/mL and 230 ± 10 
mg/mL,
52
 respectively, while for the mAb the critical concentration is a range of 50- 100 
mg/mL.
10,13,15,125
 Our unpublished studies on a LLPS in bispecific antibody solution (Chapter 
4) indicates that as the size and the complexity of the protein molecules increases, it shows a 
higher tendency to phase separate even at lower protein concentrations.  
 
7. Implications of Liquid-Liquid Phase Separation 
Liquid-liquid phase separation of globular proteins under physiological conditions 
results in certain diseases and has been studied and reported in the literature from 
physiological point of view. However, recently, implications of liquid-liquid phase 
separation from pharmaceutical perspective are also accounted for and will be briefly 
discussed in this section. 
 
7.1. Physiological Consequences 
Phase separation of biological fluids has been reported to result in condensation 
diseases. Some examples include cold cataract 
31,126
, sickle-cell disease,
127-129
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neurodegenerative and amyloidogenic diseases
130
 and cryoimmunoglobinemia.
131
 Hence, 
investigation of a protein formulation for LLPS under solution conditions mimicking 
physiological conditions can provide a better picture and help in prevention of physiological 
disorders. 
 
7.2. Aesthetic Appeal 
Marketed protein formulations are generally stored at refrigerated conditions where 
they may exhibit slight turbidity or cloudiness in the solution. Though this 
cloudiness/haziness is reversible as the formulation is brought to the room temperature and 
may not be serious from a physical stability point of view, opalescent appearance of the 
solution reduces its aesthetic appeal. It can also raise concerns about the quality of the 
product leading to patient incompliance. Mahler et al., have compiled the 
description/definition of opalescence in solution as per European Pharmacopeia limits.
33
 Any 
solution above 3 FTUs is termed as opalescent and from formulation point of view should be 
investigated for possibility of presence of aggregates or phase separation. 
 
7.3. Physical Instability 
Phase separation, both solid-liquid and liquid-liquid, indicate reduced physical 
stability of a protein solution. Though, native structure of the protein is retained on phase 
separation, the overall integrity of the product is compromised. Also, formation of solid 
phase or solid-liquid phase separation in solutions is associated with reduced solubility of 
proteins. High concentration phase formed on LLPS can also promote formation of 
irreversible aggregate in solution which is of serious concern in formulation development. 
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On phase separation, the chemical potential of the protein is same in both phases even though 
their concentrations are different.
132,133
 To account for the Donnan effect, salts in the solution 
would also partition in two phases according to the concentration gradient and maintain the 
chemical potential across the solution.
134,135
 This can result in pH shift/ionic strength 
difference in two phases and may further enhance physical instability.
136 
 
7.4. Concentrating Proteins in Solution 
Phase separation is a concern for formulation development and results in physical 
instability, however, under controlled conditions LLPS can be used to concentrate proteins as 
the formation of a protein-rich phase in the solution is spontaneous.
56,137,138
 High 
concentrations of protein formulation can be easily achieved on a large scale compared to 
other such techniques as ultrafiltration, drying, chromatography and dialysis,
4
 which are time 
consuming and increase production cost. Nishi and coworkers studied the properties of 
concentrated phase obtained on phase separation and reported no change in physical or 
chemical properties and binding ability of the antibody before phase separation.
12
 
 
7.5. Crystallization in Solution 
Obtaining high quality crystals of proteins is one of the major challenges for 
crystallographers, as crystal formation occurs in very narrow range of conditions.
139
 Also, 
crystallization is a tedious process and nucleation and crystal growth may normally take 
weeks to occur and grow. LLPS is metastable with respect to protein crystallization and 
hence for systems that exhibit LLPS, crystallization follows a two-step nucleation 
mechanism where formation of dense phase is followed by nucleation within the phase.
138,140
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Process of nucleation can be hastened in the dense phase reducing the time and energy for 
crystal growth. For any protein solutions, formulation conditions where crystal growth can 
occur can be easily optimized by studying LLPS for that system.
141,142
 Measuring B2 and 
Tcloud, that exhibits a good correlation with LLPS, can also be easily optimized for high 
throughput techniques resulting in better and efficient formulation development process. 
 
8. Summary 
A thorough understanding of the opalescence and liquid-liquid phase separation in 
solution is important for formulation development of therapeutic proteins. This review 
addresses the basic theoretical difference between scattering of light due to aggregates in 
solution and due to liquid-liquid phase separation; understanding of which may help in better 
optimization of solution conditions to reduce physical instabilities. The thermodynamic and 
kinetic basis for phase separation is different from that of aggregation and is briefly discussed 
in this review. Nature of protein-protein interactions and parameters to measure the same, 
effect of formulation factors and molecular properties affecting opalescence and liquid-liquid 
phase separation in solutions is also discussed with relevant literature examples. Finally the 
review discusses the implications of these physical instabilities both from physiological and 
pharmaceutical point of view.  
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10. List of symbols 
Cc: Critical concentration 
Tc: Critical temperature 
Tcloud: Cloud-point temperature 
Φ: order parameter 
F: Helmholz free energy of the system  
*A: width of the coexistence curve  
(*A also represents factor that controls nucleation in solution as presented in in equation 9) 
β, υ: Critical exponent 
μp: Chemical potential of the protein  
np: total number of protein 
Gmix: Gibbs free energy of mixing 
Smix: Entropy of mixing 
Hmix : Enthalpy of mixing 
σ: Interfacial tension 
ε: Bulk energy 
R: Critical radius 
J: Nucleation rate 
Is: Intensity of scattered light 
I0: Intensity of incident light,  
λ: Wavelength of the light,  
α: Polarizability of molecule, 
V: Molar volume  
θ: Scattering angle 
ƞ: Refractive index of the medium 
τ: Turbidity of solution 
ξ: Correlation length 
χ: Isothermal compressibility,  
𝜋𝑜𝑠𝑚 : Osmotic pressure, 
B2: Second virial coefficient  
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11. Tables and Figures 
Table 1: Compare and contrast for kinetics of phase separation by Nucleation and growth 
mechanism and by Spinodal decomposition 
Nucleation and growth Spinodal decomposition 
Formation of a stable nucleus of a critical 
size is essential for growth of the phases 
No thermodynamic barrier, results in 
formation of domains  
Downhill diffusion down the concentration 
gradient 
Uphill diffusion against concentration 
gradient 
Sharp interface formation 
No sharp boundaries between the phases due 
to long range fluctuations 
Explained by Ostwald ripening Explained by Cahn-Hillard approximation 
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Table 2: Effect of particle size and wavelength dependence for light scattering from solution 
Size Diameter (d) Turbidity (τ) Wavelength (λ) 
Small (x<<1) 
(Rayleigh Theory) 
IS ∝ d
6 Turbidity (τ) depends 
on d
3
 
λ
-4
 
Large x~1 
(Mie Scattering, 
Rayleigh-Debye-
Gans Theory) 
IS ∝ d
4 τ increases linearly 
with d 
λ
-2
 
Very large x>>1 
(Fraunhofer 
Diffraction) 
IS ∝ d
2 τ decreases with 
increase in d 
Independent of λ 
x: dimensionless optical size parameter, 𝑥 =
𝜋𝑑
𝜆
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Figures 
 
Figure 1: Images showing opalescence and liquid-liquid phase separation for protein 
solutions after solution was stored at 4 °C for 30 min and 12 hours, respectively. Reproduced 
from Chapter 3.
15
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Figure 2: A schematic representation for Liquid-liquid phase separation and Aggregate 
formation in protein solution. 
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Figure 3: Temperature-concentration curve showing liquid-liquid phase separation (solid-
line) and Solid-liquid phase separation curve (dotted line) for binary systems. Adapted from 
general references.
41,44
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Figure 4: Schematic for Liquid-liquid phase separation in solution defined in terms of free 
energy (upper part) at temperatures above (T1) and below (T2 and T3) the critical temperature 
(Tc). Adapted from general references. 
41,43,63
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Figure 5: Correlations between fluctuations of thermodynamic quantity in a system (density 
fluctuations in pure liquids or concentration fluctuations in binary systems) in terms of 
correlation length ξ at (a) temperature above critical temperature, (b) temperature 
approaching critical temperature and (c) at critical temperature. Adapted from Beysens et 
al.
43
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Chapter 3 
 
Opalescence in Monoclonal Antibody Solutions and its Correlation with Intermolecular 
Interactions in Dilute and Concentrated Solutions 
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1. Abstract 
Opalescence indicates physical instability of a formulation because of the presence of 
aggregates or liquid-liquid phase separation in solution and has been reported for monoclonal 
antibody formulations. Increased solution opalescence can be attributed to attractive protein-
protein interactions. Techniques including light scattering, AUC or membrane osmometry are 
routinely employed to measure protein-protein interactions in dilute solutions, whereas 
opalescence is seen at relatively higher concentrations, where both long and short range 
forces contribute to overall protein-protein interactions. The monoclonal antibody molecule 
studied here shows a unique property of high opalescence due to liquid-liquid phase 
separation. In this study, opalescence measurements are correlated to protein-protein 
interactions measured in dilute and concentrated solutions using Light scattering (kD) and 
High frequency rheology (G'), respectively. Charges on the molecules were calculated using 
zeta potential measurements. Results indicate that high opalescence and phase separation are 
due to the attractive interactions in solution as measured using light scattering and rheology, 
however, the presence of attractive interactions do not always imply phase separation. 
Temperature dependence of opalescence, suggests that thermodynamic contribution to 
opalescence is significant and Tcloud can be utilized as a potential tool to assess attractive 
interactions in solution. 
 
Keywords: Protein, light scattering, stability, protein formulation, physical characterization, 
Opalescence, phase separation, rheology, protein-protein interactions, monoclonal antibody 
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2. Introduction 
The use of therapeutic proteins, especially monoclonal antibodies (mAbs) is growing 
at an exponential rate because of their target specificity and efficiency in the treatment of 
diseases including cancer and autoimmune disorders. Antibodies are low potency drugs 
which require daily doses ranging from 100-200 mg.
1,2
 Preferred route of administration for 
these drugs is subcutaneous route, as it provides convenience and ease of administration for 
the patient either as an out-patient at a clinic or self-administration at home. The major 
challenge of administration by this route is posed by the need of formulating these drugs at 
high concentrations, which is necessitated by low volume restriction of less than 1.5 mL and 
high drug dose.
3
 Such formulations present many challenges in analytical characterization, 
manufacturing, delivery to the patient, and maintaining stability across the shelf-life.
3-5
 At 
high concentrations, inter-separation distance between the protein molecules decreases, 
thereby increasing their tendency to interact with each other.
6,7
 This results in increased 
solution viscosity which leads to difficulties in pumping, filling, filtering and recovering 
product from vessels increasing both the time and production costs. High solution viscosity 
also possesses problems in the delivery of the formulations through syringes leading to 
patient inconvenience.
4,5
 The increased tendency of proteins to form higher order reversible 
(native) or irreversible (non-native) aggregates at high protein concentration can also 
compromise protein activity, physical stability of the product and cause immunogenicity 
concerns.
6,8,9
 
Recently, opalescence and liquid-liquid phase separation have also been observed as 
potential problems at high concentrations for monoclonal antibody solutions.
10-16
 
Opalescence at high concentrations not only compromises aesthetic appeal of the formulation 
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but also can be a precursor to phase separation or indicator of the presence of aggregates in 
solution signifying reduced product stability. Protein formulations under specific solution 
conditions can undergo phase transition resulting in solid-liquid phase separation 
(crystallization or amorphous precipitation) or liquid-liquid phase separation (formation of 
protein-rich and protein-poor phase).
17
 Phase separation of biological fluids is a reason for 
physiological conditions generally known as condensation diseases. Examples include cold 
cataract 
18,19
 sickle-cell diseases
20
, neurodegenerative and amyloidogenic diseases
21
 and 
cryoimmunoglobinemia.
22
  
The literature provides examples of solution opalescence followed by phase 
separation, and also examples of opalescence without phase separation. Sukumar et al., 
related the increased opalescence of IgG1 antibody to Rayleigh scattering at higher 
concentrations. They also observed that opalescence was temperature dependent which 
increased with decreasing temperature.
10
 In another study, Salinas and coworkers 
investigated the effect of ionic strength on solution opalescence and viscosity by measuring 
the osmotic second virial coefficient (B2) by light scattering and sedimentation techniques. 
Higher opalescence at high ionic strength was attributed to attractive interactions between the 
molecules, indicated by negative B2 values. The authors also pointed to the possibility of 
phase separation in solution on lowering the temperature, however, at the studied 
temperature, no such effect was observed.
11
 Woods et al., tried to correlate increased 
opalescence to aggregation and change in protein structure, but were not able to get 
conclusive results. They attributed increased opalescence to reversible self-association 
between the molecules.
12
 Wang and coworkers concluded from their studies that ionic 
strength rather than a specific ion influences the opalescence in solution.
15
 No phase 
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separation was observed in any of these scientific studies. Mason and coworkers observed 
opalescence for an IgG2 monoclonal antibody solution, which was mainly due to liquid-
liquid phase separation. They concluded that solution opalescence was maximum near the 
vicinity of the critical point (Cc: 87 mg/mL, Tc: 268.5K) and was due to increased 
concentration fluctuations.
14
 Nishi et al., attributed the increased opalescence and liquid-
liquid phase separation at low ionic strength to electrostatic interactions, which reversed on 
increasing the ionic strength of the solution.
13
 In another study by the same group, authors 
concluded that Fc-Fc region mediated attractive electrostatic interactions resulted in phase 
separation in the solution. This property of undergoing liquid-liquid phase separation, 
depending on the solution conditions, is unique to some proteins and depends on how Fc 
regions of a mAb interact with other Fc and Fab region.
16
 Opalescence observed in mAb 
solutions due to liquid-liquid phase separation is an important issue for product development. 
Hence, a thorough investigation of the formulation factors such as pH, ionic strength, protein 
concentration and temperature affecting opalescence because of phase separation in solution 
is needed. A detailed analysis of how these factors affect the nature of intermolecular 
interactions resulting in opalescence would help in developing stable formulations. 
The objective of the current work was to study the factors responsible for the 
observed opalescence in a monoclonal antibody solution and determine the nature of the 
protein-protein interactions (PPI). All recent studies mentioned in the literature have 
attempted to correlate the nature of intermolecular interactions as measured using techniques 
such as light scattering,
10-13
  analytical-ultracentrifuge 
10,13
 or membrane osmometry
11
  with 
opalescence in solution. However, all these techniques employed measure PPI in dilute 
solutions, whereas opalescence is seen at relatively higher concentrations. Hence, in the 
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current study ultrasonic shear rheometer was employed to study the nature of intermolecular 
interactions at higher protein concentrations.
23-29
 Zeta potentials were measured and charges 
on molecule were calculated in order to assess the role of electrostatic and dipole-mediated 
interactions between protein molecules on increased solution opalescence. Temperature 
studies were performed to determine Tcloud, temperature that marks the onset of phase 
separation in solution. The current study addresses the following questions related to 
opalescence in protein solutions  
1. Is opalescence in solution due to liquid-liquid phase separation or increased Rayleigh 
scattering? 
2. How do the extrinsic factors affect protein-protein interactions resulting in solution 
opalescence?  
3. Can interactions determined at low concentrations predict high concentration 
behavior? 
 
3. Materials and Methods 
3.1. Materials 
Monoclonal antibody (mAb-A, pI ~ 6.5) was supplied by Abbvie (Worcester, MA) as 
65 mg/mL solution in 15 mM Histidine buffer at pH 5.5. All chemicals used were reagent 
grade or higher. All chemicals including acetic acid, sodium acetate, sodium chloride, 
histidine hydrochloride, monobasic and dibasic sodium phosphate, sodium hydroxide and 
hydrochloric acid were obtained from Fisher Scientific (Fair Lawn, New Jersey). Histidine 
base was obtained from Sigma (St. Louis, MO). All the solutions were prepared with 
deionized water equivalent to Milli-Q
TM
. Solutions were dialyzed and concentrated in 
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Millipore (Billerica, Massachusetts) Amicon Ultra centrifugation tubes with a molecular 
weight cutoff of 10 kDa and were obtained from Fisher Scientific. Quartz crystal discs with 
gold plated electrodes on both sides and with fundamental vibrating frequencies of 10 MHz 
were acquired from International Crystal Manufacturing Company (Oklahoma City, 
Oklahoma). 
Acetate, Histidine and Phosphate buffers were prepared to maintain pH of the 
solution at 5.1, 6.1 and 7.0, respectively. At pH 5.1, buffer concentration of 8 and 23 mM; at 
pH 6.1, buffer concentration of 10 and 30 mM; and at pH 7.0, buffer concentration of 3 and 
8.5 mM were selected to maintain ionic strengths of 5 and 15 mM, respectively, without 
addition of any salt. Sodium chloride was used to adjust the ionic strength to 150 mM. 
Protein solutions with varying ionic strengths of 1, 2.5 and 10 mM were prepared at pH 6.1 
by maintaining appropriate buffer strength. To maintain ionic strength at 0 mM, the protein 
was extensively dialyzed in water in dialysis cassette over a period of 24 hrs; water was 
changed once during this period. To ensure complete removal of ions after dialysis, sample 
was recovered and dialyzed with water in Amicon Ultra centrifugation tubes and 
concentrated further. 
All antibody solutions were buffer exchanged with appropriate buffers and pH was 
checked for each dialyzed sample. Concentrations of the samples were determined using a 
UV-vis spectrophotometer with an extinction coefficient of 1.4 mg
-1
/mL
-1
cm
-1
 for mAb-A at 
280 nm for 0.1% (w/v) IgG solutions.  The pH of all the solutions was within ±0.1 of the 
target values as measured by a Denver Instrument pH meter. All analyses were conducted at 
room temperature (23 ± 1C). 
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3.2. Opalescence Measurements 
Opalescence of the solution was measured as percent transmittance using UV-vis 
spectrophotometer (Varian Cary 50) at 510 nm in a quartz cuvette with a path length of 3 mm 
(60 μL). 10 readings averaging over 2 seconds were recorded, and duplicate measurements 
were made at each sample concentration. Opalescence measured as percent transmittance can 
be expressed in standard NTU’s by using calibration standards. Opalescence was measured 
as function of concentration, pH and ionic strength. All measurements were made at room 
temperature (23 ± 1C). 
 
3.3. Zeta Potential Measurements 
Zeta potential measurements were performed using Malvern Zetasizer Nano Series 
(Worcestershire, UK). Dip cell (ZEN1002) and glass cuvette assembly was used to make the 
measurements that required a sample volume of 800 μL. Measurements were made in 
duplicate at 25 ± 0.1 ˚C, and at a concentration of 4 mg/mL.  Poisson–Boltzmann equation, 
also known as the Debye–Huckel approximation, was used to calculate the effective charge 
on the molecule assuming an equivalent sphere.
30,31
 Equation is given as, 
   𝑧 =
4𝜋𝜀𝑎(1 + 𝜅𝑎)𝜉
𝑒
                                                                           (1) 
where, e is the electronic charge, a is the particle radius and κ is the inverse Debye length. 
The linearized Poisson-Boltzman equation was used to calculate effective charge on a 
spherical particle and hence, for estimating charge on proteins, radius a was substituted by rH 
or hydrodynamic radius for equivalent sphere. Diffusion coefficient, Ds, obtained from 
dynamic light scattering was used to calculate rH using Stokes-Einstein equation.  
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3.4. Dynamic Light Scattering (DLS) 
DLS studies were performed using a Malvern Instrument’s Zetasizer Nano Series 
equipped with a 632.8 nm Helium–Neon laser and 173˚ Noninvasive Back-Scatter technique. 
Malvern Instrument’s DTS2145 low volume glass cuvette was used that requires a sample 
volume of 60 μL for analysis. For DLS analysis, the buffers and sample stock solutions were 
filtered through sterile 0.22 μm Millipore’s Durapore membrane filters before making the 
dilution to required concentrations. The protein solutions were then centrifuged using an 
Eppendorf minispin (Hamburg, Germany) mini-centrifuge at 12,110 x g for 5 min before 
every measurement. All the samples were analyzed in duplicate and measurements were 
made at 25 ± 0.1˚C.  Linear plot of mutual diffusion coefficient (Dm) obtained from software 
plotted against concentration was used to calculate self-diffusion coefficient (Ds) and 
interaction parameter (kD) using following relation,                           
                                                     𝐷𝑚 = 𝐷𝑠(1 + 𝑘𝐷𝑐)                                                                          (2) 
c is the concentration of the protein (g/mL).
32
 Hydrodynamic radius (rH) was calculated from 
Ds using Stokes-Einstein equation 
𝐷𝑠 =
𝑘𝑇
6𝜋𝜂 𝑟𝐻
                                                                                     (3) 
where, k is the Boltzmann constant, T is the absolute temperature, and η is the solution 
viscosity.  
 
3.5. Static Light Scattering (SLS) 
SLS studies were conducted at 25 ± 0.1˚C using a Malvern Instrument’s Zetasizer 
Nano Series to determine B2, which signifies first deviation from ideality. Sample 
preparation and experimental steps were similar to those used for DLS. A detailed procedure 
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to obtain correct average scattered intensities for measuring SLS parameters is discussed 
elsewhere.
33
 The average scattered intensities were used to calculate B2 by constructing the 
Debye plot according to the following equation,
34
  
𝐾𝑐
𝑅𝜃
=
1
𝑀𝑤
+ 2𝐵2𝑐                                                                            (4) 
where, K is the optical constant given by, 
𝐾 =
[2𝜋𝜂 (
𝑑𝑛
𝑑𝑐)]
2
𝑁𝐴𝜆0
4                                                                                (5) 
In the above equations, Rθ is the excess Rayleigh ratio, i.e., a measure of light scattered by 
the solute; η is the solvent refractive index, dn/dc is the refractive index increment of the 
solute, NA is the Avogadro number, and λ0 is the wavelength of the incident light. The 
average dn/dc value reported in the literature for mAb is 0.185 ml/g and was used for 
calculation of optical constant K in this study.
35,36
 
 
3.6. High Frequency Rheological Measurements 
Ultrasonic shear rheometer with quartz crystals vibrating at a fundamental frequency 
of 10 MHz was employed to determine the rheological properties of the protein molecule.
37
 
In this study, 30 μL samples of mAb A solution were analyzed in duplicate. A temperature 
controlled water jacket was used to maintain the temperature of the liquid samples at 25 ± 
0.2˚C during measurements. A brief description of the technique is presented in Appendix 1. 
Change in conductance (G) and the series resonance frequency (fmax), defined as the 
frequency where the conductance of the crystal is the highest, before and after loading the 
liquid on the crystal is used to calculate the change in the series resistance (R) and reactance 
(X) of the crystal, i.e., R2 and X2. The change in resistance and reactance is then used to 
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calculate storage modulus (G'), loss modulus (G") and complex viscosity (η*) using 
following equations,  
𝐺′(𝜔) =
𝑅2
2 − 𝑋2
2
𝐴2𝜌𝑙𝑖𝑞
                                                                        (6) 
𝐺"(𝜔) =
2𝑅2𝑋2
𝐴2𝜌𝑙𝑖𝑞
                                                                         (7) 
𝜂∗ =
(𝐺′2 + 𝐺"2)
1
2
𝜔
                                                                    (8) 
where, A is a crystal calibration constant, ρliq is liquid density, and ω is the quartz crystal 
frequency. A is determined by calibrating the crystal with glycerol-water mixtures of known 
density and viscosity.  
 
3.7. Temperature Studies 
Temperature studies were performed using temperature control peltier plate attached 
with UV-Vis spectrophotometer. Temperature was varied between 2-35 ºC. Samples were 
allowed to equilibrate at each temperature for 2 min before taking the measurements. 
Samples were subjected to heating-cooling cycles, by first decreasing the temperature to 5 ºC 
and then increasing the temperature, and percent transmittance was measured to assess the 
reversibility of the opalescence. Onset of the liquid-liquid phase separation is characterized 
by a dramatic increase in solution turbidity; this temperature is marked as Tcloud. All the 
studies were done at pH 6.1 and ionic strengths of 5 and15 mM. Three concentrations were 
studied: 25, 75 and 125 mg/mL. 
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4. Results and Discussion 
Systems that exhibit liquid-liquid phase separation are characterized by a 
temperature-concentration phase diagram which has a critical point defined by a critical 
temperature (Tc) and a critical concentration (Cc). As the solution conditions are changed, 
intensity of concentration fluctuations in solution increases and reaches a maximum in the 
vicinity of the critical point. These concentration fluctuations cause a change in refractive 
index which in turn results in enormous increase in the scattering of light from the solution, 
making it appear opalescent. Increased scattering intensity in the vicinity of the critical point 
due to divergence of thermodynamic properties i.e, density and concentration fluctuations, is 
termed as ‘Critical Opalescence’.38-40 Figure 1 represents a typical temperature–concentration 
phase diagram. Binodal or coexistence curve is the phase boundary, above which the solution 
exists as stable one-phase system over the entire concentration range. In the area between the 
binodal and spinodal curves, the system exists in the metastable phase (formation of two 
phases is kinetically hindered). Inside the spinodal curve, the system is thermodynamically 
unstable, and there is no kinetic barrier; hence, the system spontaneously separates into two 
phases at all conditions of temperature and concentration.
17,39,41
 On attaining thermodynamic 
equilibrium, chemical potential of the substance is same throughout the sample regardless of 
the number of phases present. Therefore, in a protein solution upon phase separation, the 
chemical potential of the protein would be same in both phases even though their 
concentrations are different.
41,42
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4.1. Opalescence Measurements 
The protein solution does not absorb radiations at 510 nm. A reduction in transmitted 
light at this wavelength is caused by light scattering from the solution. A lower transmittance 
relates to higher opalescence. Figure 2 shows a plot of percent transmittance for mAb A as a 
function of protein concentration at pH 5.1, 6.1 and 7.0, and ionic strengths of 5 mM (♦), 15 
mM (▲) and 150 mM (■). At pH 5.1, for both 5 mM and 15 mM ionic strengths, percent 
transmittance recorded is close to 100, indicating that there is no solution opalescence under 
these conditions. A slight decrease in transmittance observed at this condition is due to 
Rayleigh scattering. At pH 6.1 and 7.0, the opalescence increases initially and then gradually 
decreases with increasing concentration at 5 and 15 mM ionic strength; however, at 150 mM 
ionic strength (pH 6.1) the solution exhibits extremely low opalescence.  
According to light scattering theory, scattering intensity is directly related to the 
number and size of the particles in solution.
43
 Hence, the concentration and presence of 
aggregates in solution result in increased scattering of light from the solution and are 
generally the cause of increased opalescence, which shows a gradual increase with 
concentration. In the present study, high opalescence is observed in an intermediate 
concentration range (50-75 mg/mL), which decreases at higher concentrations. Critical 
concentration range (concentrations where opalescence is maximum) is around 50-75 mg/mL 
similar to values reported in the literature for mAbs.
11,14,44
 This intermediate concentration 
dependence of opalescence in protein solutions may be critical opalescence, which increases 
close to the critical point. The correlations of fluctuations, which become infinitely large on 
approaching the critical point, are characterized by a correlation length. This correlation 
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length becomes comparable to the wavelength of light resulting in intense scattering from the 
solution resulting in critical opalescence.
39,40
  
 
4.2. Nature of Protein-Protein Interactions 
Opalescence in solution is attributed to attractive protein-protein interactions.
11,15,16
 
Determining the nature of these attractive interactions is important, so as to select suitable 
formulation conditions/excipients to reduce these PPI and develop a physically stable 
product. Protein-protein interactions in solution depend on the separation distance or 
proximity between them and the nature of these interactions are strongly influenced by 
molecular properties and solution conditions; and are briefly summarized in Table 1. Readers 
are referred to some excellent literature reviews that describe molecular crowding in solution, 
pair-wise interactions between protein molecules, the proximity energies of these interactions 
as a function of solution conditions and their implications in solutions.
6,45-47
  
The short-range, non-specific attractive interactions usually associated with proteins, 
include van der Waals interaction, interactions arising from permanent and induced dipole 
moment of the molecules and hydrophobic interactions associated with hydrophobic patches 
on protein surface. Presence of charges results in both repulsions in dilute solutions and 
attractions in concentrated solutions. Dipole mediated interactions are strongly influenced by 
orientation of the molecule, asymmetric charge distribution on protein surface and 
charge/proton fluctuations between acidic and basic groups on protein surface.
26
 Increasing 
ionic strength weakens all charge and dipole mediated interactions in solution.
29,48
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4.2.1. Zeta Potential and Charge Measurements 
The effective pI of the molecule was determined by linear interpolation of the zeta 
potential measured between pH 5.1 and 7.0 to find the x-intercept where zeta potential is 
zero. This method might induce some uncertainty in the exact value of the pI but for the 
discussion here this approximation will suffice. Theoretical pI of the molecule calculated 
from the amino acid sequence is 6.5, but the presence of various ions and their binding may 
affect the solution pI of the protein depending on the nature of the ions. This behavior 
(decrease in experimental pI due to ion binding as compared to theoretical pI) has been 
reported previously for mAbs and other proteins.
28
 Zeta potential values in millivolts for 
mAb A at different pH conditions in solutions with 5 mM ionic strength are plotted in Figure 
3. The crossover from positive to negative values occurs around pH 6.35 (obtained from 
linear interpolation) and is used as the effective pI of the molecule for this work.  
Values for the measured zeta potential and experimental charges calculated using 
Poisson-Boltzmann equation (equation 1) are compiled in Table A1.1 and elaborated in the 
Appendix 1. Zeta potential and charge values and the effect of changing the ionic strength 
from 5 mM to 15 mM follow the rank order pH 5.1 > 7.0 > 6.1. This indicates that the net 
charge on the molecule is high at pH 5.1, and changing the ionic strength has higher impact 
on charges at this pH. While, at pH 6.1, net charge on molecule is low and ionic strength has 
minimal effect at this pH. 
 
4.2.2. Interactions in Dilute Solutions 
The nature of the intermolecular interactions was measured in dilute solutions using 
Static and Dynamic light scattering to determine B2 (osmotic second virial coefficient) and kD 
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(interaction parameter), respectively. B2 and kD were further used to determine molecular 
weight, hydrodynamic diameter and self-diffusion coefficient for mAb A. A brief description 
of kD and B2 as important parameters to measure PPI in solution is provided in the Appendix 
1. B2 is the first measure of the deviation from ideality in the solution and characterizes 
interactions between the solute molecules. The value of B2 reflects the magnitude of 
deviation from ideality, while its sign reflects the nature of this deviation. A positive value 
corresponds to net repulsive interactions between the solute molecules and a negative value 
corresponds to net attractive interactions.
49
 DLS measures the diffusion coefficient of a solute 
molecule in solution and is used to find the interaction parameter kD using equation 2. kD is a 
measure of inter-particle interactions and has contributions from both the thermodynamic and 
hydrodynamic parameters. Similar to B2, a positive kD implies repulsive interactions, and a 
negative kD implies attractive intermolecular interactions in solution only if B2 is also 
negative.  There is a small range of negative kD values where interactions are repulsive in 
nature (where hydrodynamic contribution is larger than thermodynamic contribution), 
resulting in a negative kD.  
Figure A1.1, in Appendix 1 shows a plot of Dm obtained from DLS against 
concentration at varying solution conditions. kD and B2 values follow similar trend at all the 
pH and ionic strength conditions studied. Change in kD with change in ionic strength follow 
the trend as pH 6.1> pH 7.0 > pH 5.1, i.e. on changing ionic strength attractive interactions 
decrease significantly at pH 6.1 while, ionic strength has minimal effect on PPI at pH 5.1.  
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4.2.3. Correlation between kD and Opalescence 
Figure 4 shows a plot of kD values (obtained from the initial slopes of Dm versus 
concentration data in Figure A1) at different solution conditions. The numbers under the bars 
represent effective charges on the molecule calculated from the zeta potential measurements. 
Interactions in dilute solutions represented by kD and charges were correlated with 
opalescence measurements from Figure 2. At pH 5.1, no opalescence was observed in the 
solution. The molecules carry a net positive charge; however, the kD values were negative. 
Changing the ionic strength showed a significant effect on the calculated charges which were 
reduced by one-half (from +8.13 Z at 5 mM to +4.05 Z at 15 mM) but the magnitude of 
negative kD values increased (-18.04 mL/g and -26.69 mL/g at 5 and 15 mM, respectively). 
Since dipolar interactions should be screened by higher ionic strength in the solution, an 
increase in kD indicates the presence of hydrophobic interactions which become dominant at 
higher concentrations.  
Maximum opalescence (Figure 2) is recorded at pH 6.1 and 5 mM ionic strength and 
can be correlated to strong attractive interactions in solution (-99.92 mL/g). Both opalescence 
as well as attractive interactions decrease on increasing the ionic strength to 15 mM (-35.04 
mL/g).  The net effective charge on the protein is low (+2.82 Z at 5 mM and +1.13 at 15 
mM) at both ionic strengths compared to other pH conditions away from the pI. Low charge 
and strong attractive interactions at this condition indicate the possibility of the presence of 
mid-range dipole mediated interactions in solution, which decrease on increasing the ionic 
strength (Table 1). Similar trend is observed at pH 7.0 where interactions are attractive at 5 
mM (-35.42 mL/g) and molecule carries a net negative charge (-5.59 Z); both attractive 
interactions and charge decrease as ionic strength is increased to 15 mM (-20.46 mL/g and -
76 
 
3.17 Z, respectively). From Figure 2, opalescence shows a similar decrease from 5 to 15 mM. 
However, the change in the magnitude of attractive interactions on increasing the ionic 
strength from 5 mM to 15 mM at pH 6.1 is large (Δ kD ~ 65 mL/g ) and it is small at pH 7.0 
(Δ kD ~ 15 mL/g). While the change in the magnitude of opalescence, indicated by percent 
transmittance at 50 mg/mL is ~ 17 % at pH 6.1 and ~ 11 % at pH 7.0, on changing ionic 
strength from 5 mM to 15 mM.  
From kD and opalescence measurements, high opalescence can be attributed to strong 
attractive interactions in solution; however, no definite correlation could be established 
between magnitude of the change in interactions and opalescence, especially at pH 
conditions away from the pI. This discrepancy results due to the fact that attractive 
interactions in solution were assessed by light scattering in dilute conditions (concentration < 
10 mg/mL), while high opalescence is seen at relatively higher concentrations (~ 50- 75 
mg/mL). At higher concentrations, though the charge-charge repulsive interactions are 
present, the overall proximity energy increases and strengthens the short-range interactions, 
diminishing the effect of long-range repulsions.
29,46
 Hence, along with dilute solution 
measurement, intermolecular interactions were measured at high concentrations where the 
solution exhibits opalescence. 
 
4.2.4. Interactions in Concentrated Solutions 
Interactions at high concentrations were assessed using ultrasonic shear rheometer. 
The technique was developed and applied in our lab to measure and quantify the factors that 
are responsible for high solution viscosity at high protein concentrations.
23-29
 A brief 
explanation of the High frequency rheology and G' as a useful parameter to characterize the 
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nature of intermolecular protein-protein interactions at high concentrations is provided in the 
Appendix 1. Solution G', G", tan δ (G"/G') and complex viscosity were measured as a 
function of protein concentration. Data here is shown only for G' values and other parameters 
(G", tan δ and complex viscosity) follow similar trend. 
Figure 5 shows a plot of solution G' as a function of protein concentration between 20 
to 160 mg/mL at different pHs and ionic strengths. At pH 5.1 (Figure 5a), change in the ionic 
strength from 5 to 15 mM has almost no effect (within experimental error) on the magnitude 
of G'. As the ionic strength is increased to 150 mM, there is a significant decrease in the 
magnitude of G'. Light scattering measurements at pH 5.1 indicated the possibility of the 
presence of hydrophobic interactions in solution, which can be confirmed from rheology 
measurements; as interactions are highly attractive at high concentrations indicated by high 
G' values and do not change on increasing the ionic strength. However, these forces do not 
result in solution opalescence at pH 5.1. 
From Figure 5b, at pH 6.1, G' values are high at 5 mM and there is a significant 
decrease in the magnitude of G' on increasing the ionic strength to 15 mM. On further 
increasing the ionic strength to 150 mM, G' reduces considerably. This trend in the change in 
G' with changing ionic strength relates well with opalescence, where high opalescence is 
observed at low ionic strength and decreases at higher ionic strengths. Similar trend is 
observed at pH 7.0 (Figure 5c), where, change in the magnitude of G' is small when ionic 
strength is increased from 5 to 15 mM, but the magnitude of G' decreases significantly when 
ionic strength is increased to 150 mM. Dipole mediated specific interactions become 
dominant at high concentrations as they are strongly dependent on orientation and 
asymmetric charge distribution on the molecule and have been previously reported by Yadav 
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et al., for increased viscosity close to the pI of the molecule.
26
 In the current study, similar 
forces may be responsible for increased opalescence close to the pI of the molecule and are 
investigated further by studying the effect of ionic strength on the solution properties.  
From the opalescence measurements, light scattering and rheology studies, it can be 
concluded that attractive interactions are responsible for high solution opalescence, 
especially at pH close to the pI of the molecule. However, there is discrepancy in attractive 
interactions both in dilute and concentrated solutions and opalescence measured at pH 
conditions away from the pI (dilute- pH 7.0 and concentrated-pH 5.1). Also, maximum 
opalescence is observed in the concentration range of 50-75 mg/mL, there is no 
abnormal/abrupt change in G' observed in this concentration range. More than one type of 
intermolecular interactions are present in solution at high concentration (concentration 
dependent excluded-volume effect, hydrophobic and dipole interactions) which result in 
increased G' of the solution, however, opalescence cannot be explained just on the basis of 
protein-protein interactions and detailed investigation is necessary to understand this 
phenomena at the molecular level.  
 
4.3. Effect of Ionic Strength  
High opalescence was observed at low ionic strength, which decreased as the ionic 
strength was increased. To further understand the effect of ionic strength on opalescence, all 
studies (opalescence measurements, DLS, Rheology and zeta potential) were performed at 
pH 6.1 at varying ionic strengths.  
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4.3.1. Effect of Ionic Strength on Opalescence 
Opalescence was measured at different protein concentrations (horizontal axis) at pH 
6.1 as a function of ionic strengths (depth axis) as shown in Figure 6. Percent transmittance 
exhibits minima as a function of both concentration and ionic strength. Critical concentration 
range (concentration where opalescence is maximum) is around 50-75 mg/mL (from Figure 2 
and 6). Similar behavior is seen with respect to ionic strength, where solution opalescence 
initially increases and then decreases with increasing ionic strength, maximum being at 5 
mM (Figure 6- depth axis). 
 
4.3.2. Effect of Ionic Strength on Interaction Parameter (kD) and Charges on the 
Molecule 
Protein-protein interactions in dilute solutions were measured using DLS for mAb A 
at pH 6.1 and varying ionic strengths from 0-150 mM (Figure A1.2). A detailed explanation 
for the Dm plot obtained is provided in the Appendix 1. Interactions are highly repulsive at 0 
mM ionic strength (in the absence of any ions in solution) and become highly attractive on 
increasing the ionic strength, and follow the rank order as 1 mM > 2.5>5>10>15>150 mM. 
Charges on the molecule were also calculated from the zeta potential measurements as a 
function of ionic strength at pH 6.1 (complied in Table A1.2 in the Appendix 1). Zeta 
potential and charges decrease with an increase in the ionic strength; as Debye length is 
inversely related to the square root of the ionic strength.  
Figure 7 shows a plot of kD values obtained from DLS (primary axis) at pH 6.1 as a 
function of ionic strength and opalescence measured as percent transmittance at 50 mg/mL 
(secondary axis) at the same solution conditions. Interactions are strongly repulsive in nature 
80 
 
at 0 mM (data not plotted) indicated by large positive values (+591.98 mL/g) and can be 
attributed to high positive charge (calculated) on the molecule (~ +87.29 Z). Strong 
repulsions correlate with the absence of solution opalescence at 50 mg/mL protein 
concentration. As the ionic strength is increased to 1 mM, kD shows a large negative value (-
143.89 mL/g) indicating strong attractive protein-protein interactions. However, there is only 
a slight increase (transmittance decreases by 3 %) in solution opalescence at 50 mg/mL 
compared to 0 mM. Increasing the ionic strength to 2.5 mM increases opalescence but again 
to a very small extent (transmittance again decreases by 3 %), however kD values become 
less negative (-118.67 mL/g) indicating a decrease in attractive interactions. As the ionic 
strength is increased to 5 mM, kD values become less negative (-99.92 mL/g), and 
opalescence reaches maximum (transmittance decreases by 20 %). As the ionic strength is 
further increased to 10, 15 and 150 mM, kD values become less negative and opalescence 
decreases linearly. Similar to our previous observations correlating opalescence and 
interaction parameter kD, from Figure 7, opalescence can be correlated to attractive 
intermolecular interactions (5 mM), but there is a discrepancy in interactions at low ionic 
strengths (1 and 2.5 mM) and opalescence in solution.  
 
4.3.3. Effect of Ionic Strength on Viscoelasticity  
Viscoelastic solutions exhibit both G' (storage modulus) and G" (loss modulus); tan δ 
(the ratio of G"/G') serves as a measure of the viscoelastic nature of the liquid. Dilute and 
non-interacting systems exhibit higher tan δ values, while strongly interacting systems 
exhibit lower tan δ values. G' is expected to increase with solute concentration as the number 
of solute molecules in the system increases and irrespective of the interactions in solution, 
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excluded volume contribution is always present. Hence, tan δ is a better indicator of 
interactions in solutions as a function of ionic strength to relate it to the point of maximum 
interactions (indicated by low tan δ or high G') before protein solution undergoes change in 
some physical property.  
Figure 8 shows a plot of tan δ and storage modulus (G') for 60 mg/mL and 160 
mg/mL mAb A solutions as a function of ionic strength at pH of 6.1 versus opalescence 
measured as percent transmittance at similar concentrations (secondary axis). From Figure 
8a, at 60 mg/mL, tan δ values decreases slightly from 0 mM to 2.5 mM ionic strength and 
then increases on increasing the ionic strength up to 150 mM. Trend is similar for G' at 60 
mg/mL (Figure 8b), where G' increases up to 2.5 mM, indicating increased interactions in 
solutions, and then decrease as ionic strength is increased further to 150 mM. This indicates 
that rigidity of the system increases as ionic strength is increased from 0 mM up to 2.5 mM, 
and then as the ionic strength is increased further from 5 to 150 mM rigidity or attractive 
interactions decrease. While, opalescence indicated by percent transmittance for 50 mg/mL 
solutions, increases from 0 mM, reaches a maximum at 5 mM and then decrease with further 
increase in the ionic strength.  
At 150 mg/mL, mAb A did not exhibit any opalescence at any ionic strengths studied, 
while, tan δ values (Figure 8c) and G' (Figure 8d) at 160 mg/mL show a trend similar to 60 
mg/mL; initially decreases as ionic strength is increased from 0 mM, reaches a minimum at 
2.5 mM and then increases as the ionic strength is increased further up to 150 mM. However 
at 160 mg/mL, there is a sharp increase and decrease in G' values as the ionic strength is 
increased compared to that observed at 60 mg/mL. This sharp change in G' values with 
changing solution conditions can be attributed to the excluded volume effect at higher 
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concentrations. This shows that tan δ and G' indicates rigidity of the system with respect to 
ionic strength, where interactions reaches maximum and as the ionic strength is increased 
beyond this maximum point i.e. from 2.5 mM to 5 mM; system will exhibit change in certain 
physical property, as increased opalescence in the current study.   
Interactions measured in dilute solution by light scattering and at high concentration 
by high frequency rheology show that attractive interactions result in high solution 
opalescence, however; there is a discrepancy in attractive interactions and opalescence 
measured. As discussed above, critical opalescence show a concentration and ionic strength 
dependence, i.e, high opalescence occurs at intermediate concentration (~ 50-75 mg/mL) and 
at an intermediate ionic strength (5 mM) and decreases above and below this concentration 
and ionic strength. Similarly, from light scattering and rheology measurements as a function 
of ionic strength, it can be seen that high opalescence correlates with attractive interactions in 
an intermediate range with respect to kD and tan δ (G').  
This discrepancy in low opalescence and strong attractive interactions in solution 
especially at low ionic strength can be attributed to the Donnan effect in the solution. If a 
system undergoes liquid-liquid phase separation, protein separates in two phases with 
different concentrations, but same chemical potential.
41
 Hence salts in the system will 
partition themselves in the two phases according to the concentration gradient of the protein. 
Protein-rich phase will have a low salt concentration; while protein-poor phase will have a 
high-salt concentration. However, at low ionic strength of 1 and 2.5 mM, the overall salt 
present in the solution is so low that on partitioning not enough salt is present in lower phase 
to stabilize the protein-rich phase; system will revert back to being homogenous. At 5 mM 
ionic strength, even after partitioning ionic strength of the lower phase is sufficient enough to 
83 
 
promote formation of a stable phase and system phase separates. Hence at extremely low 
ionic strengths, phase separation is in transient state and never really occurs, resulting in the 
discrepancy in measurements.  
Another reason for discrepancy in attractive interactions and opalescence may be due 
to the fact that opalescence and hence liquid-liquid phase separation that follows it, show 
temperature dependence (influencing entropy of the system) and all interactions were 
measured at 25 ˚C/ room temperature. To get a better understanding of temperature 
dependence of opalescence, percent transmittance was measured as a function of 
temperature.  
 
4.4. Effect of Temperature  
The phase separation phenomenon assumes a great significance since various protein 
formulations are stored under refrigerated conditions (2-8 ºC), where tendency to phase 
separate is higher. A physically more stable product should exhibit a lower phase separation 
temperature (Tcloud). Taratuta and coworkers established the coexistence curve for lysozyme 
solution at various pH, ionic strengths and salt types, and found that the shift in the 
coexistence curve as a function of solution conditions affects only the critical temperature 
(Tc), while the critical concentration (Cc) remains constant (230 ± 10mg/mL).
50
 In another 
study, authors constructed the co-existence curve for four different γ-crystallin proteins, 
which differed in their amino acid residues, and concluded that Cc (240 ± 10 mg/mL) 
remains same for different γ-crystallin but Tc changes.
51
 Similar shift in coexistence curve of 
a monoclonal antibody solution with increasing concentration of Human serum albumin 
(HSA) was reported by Wang and coworkers.
44
 Critical concentration is assumed to be 
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dependent on the size of the molecule, and hence should be constant for similar sized 
molecule, while Tc is a physical parameter and depends on the solution conditions.
44,50,51
 
Hence, a change in pH, ionic strength and nature of the salt, determines the parallel shift in 
Tc, which in turn determines the opalescence in solution. A better understanding of the shift 
in the phase separation temperature (Tcloud) would help in better optimization of formulation 
conditions. 
Figure 9 shows a plot of percent transmittance against concentration as a function of 
temperature at pH 6.1 and ionic strengths of (a) 5 mM and (b) 15 mM. At both the ionic 
strengths studied, curve shifts with change in temperature. At 5 mM, the shift in curve to 
extremely low transmittance, indicating turbidity in solution, occurs at around 10 °C. No 
opalescence is observed at 125 mg/mL at any of the temperatures. At 25 mg/mL, low 
opalescence is observed at higher temperatures, however at 10 °C, there is sudden increase in 
opalescence. At 75 mg/mL solution opalescence increases consistently as temperature is 
decreased and then increases to a significant extent at 10 °C. Similar trend is observed at 15 
mM, however, only at 75 mg/mL, opalescence shows significant increase as temperature is 
lowered. From Figure 9, at 5 mM ionic strength, the phase separation temperature (Tcloud) lies 
around 10 ºC, while at higher ionic strength (15 mM), Tcloud decreases and lies between 2-5 
ºC. Percent transmittance measurements show that opalescence is reversible on increasing the 
temperature (data not shown).  
From these studies, it is confirmed that the opalescence in solution is due to liquid-
liquid phase separation. Shift in Tcloud to lower temperatures on increasing the ionic strength 
indicates better physical stability of the solution. Also, Tcloud marks the onset of liquid-liquid 
phase separation in solution indicating the presence of attractive interactions in solution. 
85 
 
Hence, it would serve as a better parameter to assess PPI than kD or G' or tan δ, as it takes 
into account, temperature dependence of opalescence and liquid-liquid phase separation. 
Figure 10 shows images for liquid-liquid phase separation in 65 mg/mL, mAb A solution at 
pH 6.1 and ionic strength of 15 mM at different conditions. Solution exhibited opalescence at 
room temperature (Figure 10a). Opalescence increased when sample was stored in 
refrigerator for 30 min (Figure 10b) and then ultimately separated in two distinct phases on 
storage in refrigerator for 12 hours (Figure 10c). 
On undergoing liquid-liquid phase separation, the protein-rich phase so formed will 
have higher interactions in solution (negative enthalpy) as compared to protein-poor phase 
(less negative enthalpy); while the entropic effect will be unfavorable in protein-rich phase 
(system will be more ordered at higher concentrations) and favorable in protein-poor phase 
(disordered system at low concentrations). This balance of entropic and enthalpy effect, 
which has strong temperature dependence, will influence the free energy of mixing of the 
solution. The change in miscibility or immiscibility with the change in solution conditions 
result in increased solution opalescence for mAb. While, protein-protein interactions 
measured in solution may simply represent self-association between two protein molecules, 
phase separation is due to formation of multimers in solution attributed to attractive 
interactions. Hence, though the presence of attractive interactions in solution is an important 
criterion for phase separation to occur, enthalpy-entropy balance is what controls the phase 
separation process. 
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5. Conclusion  
The monoclonal antibody molecule studied shows a unique property of high 
opalescence that can be attributed to Liquid-liquid phase separation. Temperature 
dependence of opalescence confirms that liquid-liquid phase separation results in 
opalescence for mAb A. Formulation factors like pH, ionic strength and concentration have a 
significant effect on solution opalescence; opalescence increases close to the pI of the 
molecule, in an intermediate concentration range and at an intermediate ionic strength. High 
opalescence and liquid-liquid phase separation can be attributed to attractive interactions in 
solutions measured in dilute and concentrated solutions, but attractive interactions do not 
always imply phase separation.  
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8. Tables and Figures 
Table 1: Effect of molecular properties and formulation factors on protein-protein 
interactions in solution. (Adapted from literature
29,46,47
 ) 
Interactions 
Range on 
Interactions 
Distance 
dependence
a
 
Molecular 
properties 
Formulation factors 
affecting PPI 
Repulsive Interactions 
Charge-Charge 
Long 
 
r
-1
 Charges 
Dominant away from 
pI, 
Ionic strength 
decreases PPI 
Excluded 
Volume
b
 
(Molecular 
crowding) 
Short r
-12
   
Attractive Interactions 
Charge-Dipole 
(fixed) 
Mid r
-2
 
Charge, 
Geometry 
and 
orientation   Dominant close to 
pI 
Ionic strength 
decreases PPI 
Charge-Dipole 
(freely rotating) 
Mid r
-4
 
Charge-Induced 
dipole 
Mid r
-4
 
Dipole-dipole
c
 Short r
-6
  
 
Geometry 
and 
orientation 
 
Dipole-induced 
dipole
c
 
Short r
-6
 
Induced dipole-
induced dipole
c
 
Short r
-6
 
Hydrophobic Short  
Surface 
amino acids 
(non-polar) 
Low ionic strength 
has no effect, high 
ionic strength 
increases attractions 
a: Distance dependence of mean potential W(r)between the interacting  molecules 
b:Distance dependence based on repulsive interactions term in the Lenard Jones potential
34,47
 
c:Dipole-dipole, dipole-induced dipole, induced dipole-induced dipole together constitute van der Waals 
interactions 
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Figures 
 
Figure 1: Temperature-concentration curve showing liquid-liquid phase separation. Adapted 
from general references.
38, 39, 41,42
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Figure 2: Percent transmittance as a function of protein concentration at various solution pH 
(pH 5.1- acetate, pH 6.1-histidine, pH 7.0-phosphate) and at ionic strengths of 5 mM (♦), 15 
mM (▲) and 150 mM (■). All solutions were analyzed at room temperature (23 ± 1˚C) in 
duplicate. Error bars if not visible are smaller than the symbols used.  
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Figure 3: Zeta potential of mAb A as a function of solution pH at 5mM ionic strength. The 
line connecting the data points is to guide the eye and is not a result of model fitting to the 
data. All solutions were analyzed at 25 ± 0.1˚C in duplicate. Error bars if not visible are 
smaller than the symbols used. 
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Figure 4: Plot of kD obtained from Dynamic light scattering as a function of pH and ionic 
strength. The numbers under the bar represent the effective charge on the molecule, 
calculated from linear correlation of electrophoretic mobility and zeta potential. Zeta 
potential and charges calculated in duplicates have been averaged. All solutions were 
analyzed at 25 ± 0.1˚C.  
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Figure 5: Solution G' as a function of concentration at ionic strengths of 5 mM (♦), 15 mM 
(▲) and 150 mM (■), at (a) pH 5.1 (acetate buffer), (b) 6.1 (histidine buffer) and (c) 7.0 
(phosphate buffer). All solutions were analyzed at 25 ± 0.1˚C in duplicate. Error bars if not 
visible are smaller than the symbols used.  
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Figure 6: Percent transmittance at pH 6.1 (histidine buffer) as a function of protein 
concentration (horizontal axis) and ionic strengths (depth axis). Ionic strength of 1, 2.5, 5, 10 
and 15 mM were maintained by preparing histidine solutions with appropriate buffer 
strength. Sodium chloride was added to maintain ionic strength of 150 mM. Ionic strength of 
0 mM, represents protein solution extensively dialyzed in water.  All solutions were analyzed 
at room temperature (23 ± 1˚C).  Plot represents averages of percent transmittance measured 
at all conditions in duplicate. 
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Figure 7: Plot of kD (primary axis) and percent transmittance at 50 mg/mL (secondary axis) 
as a function of ionic strength at pH 6.1. All solutions were analyzed at 25 ± 0.1˚C for light 
scattering and at room temperature (23 ± 1˚C) for opalescence in duplicate. Error bars if not 
visible are smaller than the symbols used. 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
 
100 
 
 
 
Figure 8: Plot of (a) tan δ (primary axis) at 60 mg/mL, and (b) G' (primary axis) at 60 
mg/mL versus percent transmittance at 50 mg/mL (secondary axis), (c) tan δ (primary axis) 
at 160 mg/mL and (d) G' (primary axis) at 160 mg/mL versus percent transmittance at 150 
mg/mL (secondary axis) as a function of ionic strength at pH 6.1. All solutions were 
analyzed at 25˚C ± 0.1˚C in duplicate. Error bars if not visible are smaller than the symbols 
used. 
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Figure 9: Plot of percent transmittance at pH 6.1 and at concentrations of 25 mg/mL, 75 
mg/mL and 125 mg/mL as a function of temperature and varying ionic strengths of (a) 5 mM 
and (b) 15 mM. All the samples were analyzed in duplicate. Error bars if not visible are 
smaller than the symbols used. The lines connecting the points have been added as a guide to 
the eye and are not the result of any model fitting to the data. 
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Figure 10: Images for mAb A at pH 6.1- 5 mM ionic strength and at a concentration of 65 
mg/mL at (a) Room temperature (~23 ˚C), (b) 4 ˚C after 30 min, and (c) 4 ˚C after 12 hours.   
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Chapter 4 
 
Liquid-Liquid Phase Separation in a Dual Variable Domain Immunoglobulin Protein 
Solution: Effect of Formulation Factors and Protein-Protein Interactions 
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1. Abstract 
Dual variable domain immunoglobulin proteins (DVD-Ig
TM 
proteins) are large 
molecules (MW~ 200 kDa) with increased asymmetry because of their extended Y-like 
shape, which results in increased formulation challenges. Liquid-liquid phase separation 
(LLPS) of protein solutions into protein-rich and protein-poor phases reduces solution 
stability at intermediate concentrations and lower temperatures, and is a serious concern in 
formulation development as therapeutic proteins are generally stored at refrigerated 
conditions. In the current work, LLPS was studied for a DVD-Ig
TM
 protein molecule as a 
function of solution conditions by measuring solution opalescence. LLPS of the protein was 
confirmed by equilibrium studies and by visually observing under microscope. The protein 
does not undergo any structural change after phase separation. Protein-protein interactions 
were measured by light scattering (kD) and Tcloud (temperature that marks the onset of phase 
separation). There is a good correlation between kD measured in dilute solution with Tcloud 
measured in critical concentration range. Results indicate that the increased asymmetry of the 
molecule (with respect to both size and charge distribution on the molecule) increases 
contribution of specific and non-specific interactions in solution, which are affected by 
formulation factors, resulting in LLPS for DVD-Ig
TM 
protein. 
 
Keywords: Liquid-liquid phase separation, opalescence, formulation development, physical 
stability, protein-protein interactions, light scattering, Tcloud, histidine buffer, phase diagram 
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2. Introduction 
Dual Variable Domain Immunoglobulin protein (DVD-Ig
TM 
protein) is a bispecific 
antibody-like molecule and is engineered from two monoclonal antibodies (mAbs) by adding 
an additional binding domain to each variable domain; thus making it specific for dual-
targeting resulting in improved therapeutic efficacy.
1, 2
 Antibody based therapeutics are 
generally administered by parenteral route at high concentrations.
3
 Protein-protein 
interactions at high concentrations result in several formulation challenges including high 
viscosity, formation of reversible and/or irreversible aggregates, reduced solubility, 
opalescence and phase transitions.
4-9
 These challenges become more exaggerated in DVD-
Ig
TM 
protein solutions since these molecules are larger and more complex. 
Liquid formulation of proteins can undergo solid-liquid phase transition resulting in 
the formation of crystals or amorphous precipitates, or liquid-liquid phase separation (LLPS) 
into protein-rich and protein-poor phases. Phase separation at physiological conditions is 
responsible for condensation diseases like cataract,
10
 sickle-cell anemia
11
 etc. From a 
pharmaceutical point of view, liquid-liquid phase separation is a concern for formulation 
development since most protein solutions are stored at refrigerated conditions (2-8˚C) where 
proteins show a higher tendency to phase separate. Protein-rich phase formed on phase 
separation can promote aggregation in solution which could compromise physical stability of 
the formulation. However, under controlled conditions, LLPS can be used to concentrate 
proteins as the formation of a protein-rich phase in the solution is spontaneous.
12, 13
 High 
concentrations of monoclonal antibody formulation can be easily achieved on a large scale 
compared to other such techniques as ultrafiltration, drying, chromatography and dialysis, 
which are time consuming and increase production cost.
14
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Phase diagram for a binary system has a liquidus or solubility line, corresponding to 
solid-liquid transition in one-component system, and a liquid–liquid coexistence line (binodal 
curve) corresponding to the gas-liquid phase transition in one-component system. Liquid-
liquid phase separation curve lies below the solid-liquid curve and is metastable with respect 
to crystallization and amorphous precipitate formation.
15
 Liquid-liquid phase separation 
(LLPS) of a protein solution into a protein-rich and protein-poor phase is both a 
thermodynamic and kinetic process.
16
 The two phases formed upon phase separation have 
different physical properties including concentration, density and refractive index. The phase 
separation is preceded by increased solution opalescence, which is due to dispersion of the 
protein-rich phase in protein-poor phase with different refractive indices and result in 
multiple scattering from the solution. Upon phase separation, the chemical potential of the 
protein would be same in both phases (thermodynamic equilibrium) even though their 
concentrations are different.
17, 18
 To account for the Donnan effect, salts in the solution would 
also partition in two phases according to the concentration gradient and maintain the 
chemical potential across the solution. This can result in pH shift/ionic strength difference in 
two phases and may further enhance physical instability. 
Coexistence curve which characterizes LLPS in solution has a critical point defined 
by a critical temperature (Tc) and critical concentration (Cc). Majority of the proteins that 
undergo phase separation exhibit an upper critical solution temperature (UCST) type of phase 
behavior i.e, phase separation occurs at lower temperatures and system is homogeneous at 
higher temperatures. Exception is hemoglobin that exhibits lower critical solution 
temperature (LCST) type of phase behavior, where phase separation occurs as temperature is 
raised and protein solubility increases at lower temperatures (also termed as retrograde 
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solubility).
19, 20
 Liquid-liquid phase separation has been reported for globular proteins
13, 21-25
 
and monoclonal antibody.
26-32
  
Though DVD-Ig
TM
 proteins (MW 200 kDa) may have therapeutic properties similar 
to parent mAbs, their larger size results in more complex physicochemical properties, and 
hence, the formulation and processing at high concentrations becomes even more 
challenging. The objective of this work is to investigate the effect of various formulation 
factors on liquid-liquid phase separation in DVD-Ig
TM
 protein solutions and understand the 
role of various protein-protein interactions affecting this phenomenon. 
 
3. Materials and Methods 
3.1. Materials 
Dual Variable Domain Immunoglobulin protein (pI ~7.0 - 7.5) was supplied by 
AbbVie (Worcester, MA) as 85 mg/mL solution in 15 mM Histidine buffer at pH 5.5. All 
chemicals including acetic acid, sodium acetate, sodium chloride, monobasic and dibasic 
sodium phosphate, sodium hydroxide and hydrochloric acid were obtained from Fisher 
Scientific (Fair Lawn, New Jersey). Histidine base and histidine hydrochloride were obtained 
from Sigma (St. Louis, MO). All chemicals used were reagent grade or higher. Solutions 
were prepared with deionized water equivalent to Milli-Q
TM
.  
Acetate and Histidine buffers were prepared to maintain pH of the solution at 5.0 and 
6.1, respectively, while Phosphate buffer was used to maintain pH at 6.5, 7.0 and 8.0. Ionic 
strength of 15 mM was maintained by selecting appropriate buffer concentration without the 
addition of any salt at all pHs. Sodium chloride was used to adjust the ionic strength to 50 
mM. To study the effect of ionic strength, phosphate buffers with ionic strengths of 5 and 15 
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mM were prepared at pH 6.5 by maintaining appropriate buffer strength, and sodium chloride 
was used to adjust the ionic strength to 50 and 100 mM. Three buffers were prepared at pH 
6.5 to study the effect of specific ions: (1) Phosphate buffer with ionic strength of 15 mM, (2) 
Histidine buffer with ionic strength of 15 mM, and (3) Histidine buffer with ionic strength of 
1 mM adjusted to 15 mM using sodium chloride. 
All solutions were buffer exchanged with appropriate buffers using Millipore 
(Billerica, Massachusetts) Amicon Ultra centrifugation tubes with a molecular weight cutoff 
of 10 kDa obtained from Fisher Scientific. Concentrations of the samples were determined 
using a UV-vis spectrophotometer with an extinction coefficient of 1.5 mg
-1
/mL
-1
cm
-1
 for 
DVD-Ig
TM
 protein at 280 nm for 0.1% (w/v) IgG solutions. The pH of all the above solutions 
was within ± 0.1 of the target values as measured by a Denver Instrument pH meter. 
 
3.2. Opalescence Measurements  
Opalescence of the solution was measured using UV-vis spectrophotometer (Varian 
Cary 50). Opalescence was measured as percent transmittance at 510 nm in a quartz cuvette 
with a path length of 3 mm, requiring a sample volume of 60 μL. All the studies were 
performed at 25 ˚C in duplicate. Opalescence of DVD-IgTM protein was measured as a 
function of protein concentration, pH and ionic strength. 
 
3.3. Sample Preparation for Equilibrium Studies 
For equilibrium studies, protein solutions were extensively dialyzed in water and 
concentrated using Amicon Ultra centrifugation tubes. Concentration of the protein stock 
solution prepared in water was 96.5 mg/mL. Stock solution of sodium phosphate (110 mM 
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buffer strength) was prepared at pH 6.5 with ionic strength of 150 mM. Effect of initial 
protein concentration on phase separation was studied by preparing protein solutions at 8, 16, 
30 and 60 mg/mL and ionic strength was maintained at 50 mM by appropriately diluting 
phosphate stock solution. Solutions were stored at 4 ˚C for 48 hours to induce phase 
separation. Effect of ionic strength (15 and 50 mM) and temperature (4 ˚C and 22˚C) were 
also studied for 16 mg/mL protein solutions. All the samples were checked for pHs. Protein 
concentration was measured using UV-Vis spectrophotometer after 48 hours by taking 
aliquots of sample from upper and lower phase and diluting appropriately. All the 
concentrations were measured in duplicate. 
 
3.4. Microscopy Studies  
Digital images were captured using a Polarized Light microscope (Olympus BH2) 
equipped with a digital camera (Q Imaging Micropublisher 3.3). 16 mg/mL of DVD-Ig
TM
 
protein samples were prepared in phosphate buffer at pH 6.5 and ionic strength was 
maintained at 15 and 50 mM. 20 μL of sample was placed on a microscope slide and 
observed under microscope without any coverslip, with 100X magnification. All studies were 
performed at ambient temperature (23 ± 1 ˚C). 
 
3.5. Circular Dichroism Measurements 
Secondary and tertiary structural changes in DVD-Ig
TM
 protein solution before and 
after phase separation were studied using far-UV (190-250 nm) and near-UV (240-340 nm) 
circular dichroism (CD) spectroscopy, respectively. CD spectra were recorded using a Jasco 
700 spectropolarimeter (Jasco, Inc., Easton, MD) for protein samples freshly dialyzed 
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(immediately diluted to low concentration to avoid phase separation) in phosphate buffer at 
pH 6.5 with ionic strength of 15 mM. Samples were allowed to phase separate for 24 hours at 
room temperature and CD spectra were recorded for the samples collected from the two 
phases (protein-rich and protein-poor phase) after phase separation. CD spectra were again 
recorded for previously diluted sample. Protein concentration of 0.3 mg/mL in 0.05 cm path 
length cells and 0.75 mg/mL in 1.0 cm path length were used for far-UV and near-UV 
analyses, respectively. An average of 10 scans was accumulated, at a resolution of 1.0 nm 
and a scan rate of 50 nm min
−1
. Buffer scans were also accumulated under the same 
measurement conditions and were subtracted from the protein scans prior to analysis. 
 
3.6. Tcloud Measurements  
Temperature ramp studies were performed using temperature control Peltier plate 
attached with the UV-vis spectrophotometer. Temperature was ramped down in steps from 
35 ºC to 3 ˚C and samples were allowed to equilibrate at each temperature for 2 min before 
recording the measurements as percent transmittance. Tcloud marks the onset of the liquid-
liquid phase separation in the solution. For the current study, the temperature where percent 
transmittance reaches 70 is termed as Tcloud. Concentrations of 16 and 60 mg/mL were 
studied as a function of the pH at ionic strengths of 15 and 50 mM. Samples were also 
analyzed to study the effect of ionic strength at a constant pH of 6.5. 
 
3.7. Dynamic Light Scattering (DLS) 
Malvern Instruments Zetasizer Nano Series (Worcestershire, UK) was used to 
perform DLS studies to determine kD. Instrument utilizes a 632.8 nm Helium–Neon laser and 
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analyzes scattered light at an angle of 173˚. For DLS analysis, the buffers and sample stock 
solutions were filtered through sterile 0.22 μm Millipore’s Durapore membrane filters before 
making the dilution to required concentrations. The protein solutions were then centrifuged 
using an Eppendorf minispin (Germany, HA) mini-centrifuge at 12,110×g for 5 min before 
every measurement. All the samples were analyzed in duplicate and measurements were 
made at 25 ± 0.1˚C. A detailed procedure and relevant equations to obtain correct DLS 
parameters to calculate interaction parameter (kD), and hydrodynamic radius (rH) is discussed 
elsewhere.
33
 
 
4. Results 
4.1. Opalescence Measurements 
Opalescence for the DVD-Ig
TM
 protein was measured as percent transmittance using 
UV-vis spectrophotometer at 510 nm, a non-absorbing wavelength.  Here, a lower 
transmittance relates to higher opalescence of the solution. Figure 1 shows a plot of 
opalescence of DVD-Ig
TM
 protein as a function of concentration and pH at 15 mM ionic 
strength. At pH 5.0, there is no opalescence in the solution as indicated by percent 
transmittance close to 100. Opalescence increases slightly at pH 6.1. At pH 6.5, solution 
exhibits high opalescence in the concentration range of 25-90 mg/mL. Even at a lower 
concentration of 10 mg/mL, solution exhibits opalescence where percent transmittance is 
around 85. High viscosity of the solution at higher concentrations (> 100 mg/mL) limited the 
concentration range that could be studied for opalescence. Solutions at pH 7.0 could not be 
analyzed as they showed high tendency to phase separate. As pH is further increased to 8.0, 
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solution exhibits high opalescence in the concentration range of 20-80 mg/mL.  However, 
above 80 mg/mL, solution opalescence decreases with increase in concentration. 
The effect of ionic strength and pH on opalescence at 60 mg/mL protein 
concentration is plotted in Figure 2. At pH 5.0, percent transmittance is close to 100, 
indicating the absence of solution opalescence at the two ionic strengths studied. The 
transmittance decreases slightly at pH 6.1. At pH 6.5, solution exhibits high opalescence at 5 
and 15 mM ionic strengths (percent transmittance is close to 0), which decreased 
significantly on increasing the ionic strength to 50 and 100 mM. At pH 7.0, 50 mM ionic 
strength solution exhibits higher opalescence compared to other pHs at 50 mM. At pH 8.0, 
DVD-Ig
TM
 protein exhibits high opalescence at 15 mM ionic strength which decreases as the 
ionic strength is increased to 50 mM. 
 
4.2. Equilibrium Studies 
Equilibrium studies were performed for DVD-Ig
TM
 protein molecule at different 
solution conditions to investigate the effect of concentration and temperature on liquid-liquid 
phase separation. The effect of the initial protein concentration before phase separation on 
the protein concentrations of the protein-rich phase and protein-poor phase at 4 ˚C is plotted 
in Figure 3. Protein concentration measured in the two phases after phase separation is nearly 
constant irrespective of the initial protein concentration. Average concentration in the upper 
phase (protein-poor) is ~ 4.5 mg/mL, while the concentration in the lower phase (protein-
rich) is ~127 mg/mL. Initial volume for all the samples was 150 μL, however, on phase 
separation, volumes for the two phases for each initial concentration are different (not 
analyzed, visually assessed). 
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Similar studies were performed at a constant concentration (16 mg/mL) to study the 
effect of temperature and ionic strength on LLPS. Figure 4 shows a plot of the effect of 
temperature on the protein concentration in protein-rich and protein-poor phases at 15 mM 
(Figure 4a) and 50 mM (Figure 4b) ionic strength in phosphate buffer at pH 6.5. Protein in 15 
mM ionic strength buffer phase separates at 4 ˚C and 22 ˚C. At 22 ˚C, protein concentration 
in the upper phase and lower phase are 4.3 mg/mL and 124.2 mg/mL, respectively. While at 
4 ˚C, protein concentration in the upper and lower phase are 0.8 mg/mL and 132.6 mg/mL, 
respectively. Protein sample in 50 mM ionic strength buffer does not undergo phase 
separation at 22 ˚C. However, at 4 ˚C protein phase separates and concentrations in the upper 
phase and lower phase are 4.4 mg/mL and 125 mg/mL, respectively.  
 
4.3. Microscopy 
LLPS in DVD-Ig
TM 
protein solution was confirmed by observing under microscope. 
From equilibrium studies, solution with ionic strength of 15 mM undergoes phase separation 
at room temperature while 50 mM solution remains homogenous. Figure 5 (a) and (b) are 
digital images captured for DVD-Ig
TM
 protein using polarized light microscope equipped 
with camera. In the 15 mM ionic strength solution, which undergoes phase separation (Figure 
5a), droplets of the protein-rich phase are dispersed in the protein poor-phase, while protein 
solution at 50 mM ionic strength remains homogeneous (Figure 5b).  
 
4.4. Circular Dichroism 
Circular dichroism studies were performed to detect structural changes in the protein 
before and after undergoing phase separation. Figure 6a shows near-UV CD spectra for 
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DVD-Ig
TM 
protein in pH 6.5 phosphate buffer with ionic strength of 15 mM. The near-UV 
CD spectra for most proteins are due to absorption by aromatic amino acid side chain 
chromophores between 250-300 nm. From the spectra, the characteristic peak at 293 nm can 
be attributed to Tryptophan residues in the molecule. Negative peak at 218 nm in the far-UV 
spectra (Figure 6b) indicates that DVD-Ig
TM
 protein has greater β sheet content. However, 
both the near and far-UV CD spectra for the protein before and after phase separation show 
similar intensities, suggesting that there are no major structural alterations in the secondary 
and tertiary structure of the protein on phase separation.  
 
4.5. Tcloud Measurements  
Temperature studies were performed for DVD-Ig
TM
 protein at different solution 
conditions by measuring percent transmittance as the solution temperature was lowered.
34
 
Onset of the liquid-liquid phase separation is characterized by a dramatic increase in solution 
turbidity; this temperature is marked as Topacity. Temperature is then increased step wise till 
solution becomes clear, and this temperature is marked as Tclear. Average temperature 
between Topacity and Tclear is the Tcloud temperature.
35
 For qualitative analysis, the temperature 
where percent transmittance reaches 70 is termed as Tcloud
36
; values for same are compiled in 
Table 1. Two concentrations, 16 mg/mL (below the critical concentration range) and 60 
mg/mL (in the critical concentration range), were analyzed.  
At pH 5.0, no phase separation was observed. At pH 6.1, Tcloud is around 10 ˚C at both 
16 and 60 mg/mL protein concentrations at 15 mM ionic strength. On increasing the ionic 
strength to 50 mM, Tcloud shifts to higher temperatures of 12 ˚C and 16 ˚C at 16 and 60 
mg/mL, respectively. At pH 6.5, for 16 mg/mL solution, a higher Tcloud of 33˚C was observed 
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at 15 mM ionic strength, which shifted to a lower temperature (19.3 ˚C) on increasing the 
ionic strength to 50 mM. At 15 mM ionic strength, 60 mg/mL protein solution exhibited very 
high opalescence even at 37 ˚C; higher temperatures were not studied to avoid protein 
denaturation and misinterpretation of the results. Tcloud decreased to 24.5 ˚C on increasing the 
ionic strength to 50 mM.  
Protein solutions at pH 7.0 and 15 mM ionic strength were not studied as they 
exhibited very high opalescence even at high temperatures. At 50 mM, both 16 and 60 
mg/mL solutions exhibited higher Tcloud of 21.0 ˚C and 25.0 ˚C, respectively, compared to 
other pH conditions at higher ionic strengths. Solutions at pH 8.0 showed a trend similar to 
that at pH 6.5, where higher Tcloud was observed at 15 mM ionic strength for both 16 and 60 
mg/mL solutions (27.5 ˚C and 32.5 ˚C, respectively), which shifted to lower temperatures 
(15.5 ˚C and 19.5 ˚C, respectively) on increasing the ionic strength to 50 mM.  
The effect of ionic strength on Tcloud at pH 6.5 was studied for 16 mg/mL (Figure 7a) 
and 60 mg/mL (Figure 7b) DVD-Ig
TM
 protein solutions. At 5 mM ionic strength, it was not 
possible to prepare the required concentrations because of a high tendency of the protein to 
undergo phase separation. Therefore, a lower concentration of 9.8 mg/mL (instead of 16 
mg/mL in Figure 7a) and a higher concentration of 78 mg/mL (instead of 60 mg/mL in 
Figure 7b) were analyzed. At 5 mM ionic strength, the solution exhibited higher opalescence 
and higher phase separation temperature compared to other ionic strengths, both at low and 
high concentrations studied. The errors in the measurements were large due to rapid phase 
separation. At 16 mg/mL, the protein showed a high phase separation temperature at 15 mM 
ionic strength (33 ˚C) and the curve shifted to lower temperatures on increasing the ionic 
strength to 50 and 100 mM (19.5 ˚C and 10.5 ˚C, respectively). Similar trend was observed 
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for 60 mg/mL solution where a high phase separation temperature was recorded at 15 mM (> 
37 ˚C) and shifted to lower temperatures at higher ionic strengths (24.5 ˚C at 50 mM and 
14.5 ˚C at 100 mM, respectively) indicating increased physical stability on increasing the 
ionic strength of the solution. Phase separation occurs at higher temperatures at 60 mg/mL 
protein solutions (temperature curves shifted to right) compared to 16 mg/mL at all ionic 
strengths. On approaching phase separation temperature, plot of percent transmittance against 
temperature showed steep decrease at 16 mg/mL while decrease was more gradual at 60 
mg/mL.  
 
4.6. Dynamic Light Scattering 
The nature of protein-protein interactions in solution is generally measured by 
determining interaction parameter, kD, from dynamic light scattering. The interaction 
parameter includes both the thermodynamic (second virial coefficient- B2) and hydrodynamic 
(frictional coefficient- ξ and partial specific volume- ʋsp) contributions. While the sign of kD 
values indicate nature of protein-protein interactions in solution, its magnitude indicates the 
strength of these interactions. A positive kD implies repulsive interactions, and a negative kD 
implies attractive intermolecular interactions in solution only if B2 is also negative.  There is 
a small range of negative kD values where interactions are repulsive in nature (where 
hydrodynamic contribution is larger than thermodynamic contribution resulting in a negative 
kD).
33
 
Figure 8a, shows a plot of kD for DVD-Ig
TM
 protein at varying pH and ionic strengths 
of 15 mM (solid line), and 50 mM (dashed line). At pH 5.0, kD is positive (+5.00 mL/g) at 15 
mM and become negative (-8.25 mL/g, B2= -0.49 *10
-5
 mol.ml/g
2
) at 50 mM ionic strength. 
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At all other pHs, kD values are negative indicating attractive interactions, with maximum 
attractive interactions being at pH 6.5. The interactions become less attractive when the ionic 
strength is increased to 50 mM except at pH 6.1 where ionic strength has no effect. The kD 
values were also measured for DVD-Ig
TM
 protein at pH 6.5 as a function of ionic strengths 
(Figure 8b). At 5 mM (-83.95 mL/g) and 15 mM (-76.51 mL/g), kD values are most negative 
indicating strong attractive interactions in solution. On increasing the ionic strength to 50 
mM and 100 mM, kD values decrease gradually (-42.25 mL/g and -30.95 mL/g, respectively) 
indicating decreased attractive interactions in solution. 
  
4.7. Effect of Histidine and Phosphate Buffer 
The effect of different buffer species (phosphate and histidine) on opalescence 
(Figure 9) and liquid-liquid phase separation was studied by measuring percent transmittance 
as a function of protein concentration at constant pH (6.5 ± 0.1) and constant ionic strength 
(15 mM). DVD-Ig
TM
 protein samples prepared in sodium phosphate buffer exhibited very 
high solution opalescence in the concentration range of 25-90 mg/mL, indicated by percent 
transmittance recorded close to 0. However, on changing the buffer species to histidine, 
opalescence decreased significantly. Maximum opalescence was observed at a concentration 
around 60 mg/mL (percent transmittance ~ 80) and decreased above and below this 
concentration. To confirm the effect of specific ions resulting in increased solution 
opalescence, protein samples were prepared in histidine buffer with 1 mM ionic strength 
adjusted to 15 mM using sodium chloride. Opalescence measurements showed similar trend 
as for the phosphate buffer, where solution was highly opalescent in the concentration range 
of 25 to 75 mg/mL, and decreased as the concentration was increased.  
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Protein-protein interactions were also analyzed for DVD-Ig
TM
 protein solutions 
prepared in phosphate, histidine and sodium chloride at pH 6.5 and 15 mM ionic strength by 
measuring interaction parameter, kD. Figure 10 shows a plot of Mutual diffusion coefficient 
(Dm) against concentration for three different ions. Slopes are negative for all three ions 
indicating attractive interactions in solution. Slopes overlap for phosphate (kD = -76.50 mL/g) 
and chloride ions (kD = -76.20 mL/g); the magnitude of the attractive interactions is similar in 
the two solutions. For histidine solutions, slope is slightly less negative than phosphate and 
chloride, and kD value is -61.45 mL/g.  
Figure 11 shows a plot of temperature studies performed for DVD-Ig
TM
 protein in 
phosphate and histidine buffers at 16 and 60 mg/mL. In phosphate buffer, 60 mg/mL solution 
shows very high opalescence even at 37 ˚C. Phase separation occurs at around 32 ˚C for 16 
mg/mL protein solutions. In the presence of histidine buffer species, phase separation 
temperature curve overlaps for 16 mg/mL and 60 mg/mL solutions and phase separation 
occurs at around 20 ˚C. 
 
5. Discussion 
Recent literature on opalescence in monoclonal antibody formulations attributes high 
opalescence to liquid-liquid phase separation of proteins in solution
27, 29, 37
 From Figure 1, 
high opalescence (low percent transmittance) is observed in the concentration range of 20-
100 mg/mL and opalescence decreases at concentrations above and below this range,
37
 a 
behavior similar to the concentration dependence observed in temperature-concentration 
phase diagram for LLPS.
17
 Literature reports for phase separation in protein solutions show 
that the critical concentration (Cc) is dependent on the size of the molecule (globular proteins 
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versus mAb), while, critical temperature (Tc) depends on the solution conditions.
22
 Wang et 
al., plotted a scaled coexistence curve (binodal curve of phase diagram) for three different 
proteins and hard-spheres.
30
 Globular proteins, crystallins (MW ~ 20 kDa) and lysozyme 
(MW ~ 14 kDa) have narrow and symmetrical coexistence curves, similar to that for a hard 
sphere, while monoclonal antibody (MW ~ 150 kDa) exhibits a wider and asymmetrical 
coexistence curve due to its non-spherical shape and increased flexibility. Critical 
concentration for crystallins and lysozyme are 240 ± 10 mg/mL
21
 and 230 ± 10 mg/mL
22
, 
respectively, while for the mAb the critical concentration is a range of 50- 100 mg/mL.
29, 30, 
37, 38
 From Figure 1, DVD-Ig
TM
 protein with a molecular weight of around 200 kDa has a 
coexistence curve wider (Cc is around 20 -100 mg/mL) than that reported for mAbs. From 
temperature studies (Figure 7), plot of percent transmittance against temperature shows steep 
decrease at 16 mg/mL while decrease was more gradual at 60 mg/mL indicating asymmetry 
of the coexistence curve at higher concentrations. This is consistent with the hypothesis that 
the width and asymmetry of coexistence curve (or concentration range in which solution 
exhibits opalescence and LLPS) increases as the size of the molecule increases. Therefore, 
bispecific antibody-like molecules, in general, will have a tendency to show a larger 
concentration range where they can phase separate, resulting in increased challenges to 
formulate physically stable products. 
 
5.1. Confirmation of Liquid-Liquid Phase Separation 
As described in the introduction, upon attaining thermodynamic equilibrium, 
chemical potential of the protein in two phases is equal, though their concentrations are 
different. At a fixed temperature, these two concentrations are the binodal points of the 
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binodal or the coexistence curve. Equilibrium studies were performed to determine the effect 
of initial protein concentrations, temperature and ionic strength on phase separation. From 
Figure 3, protein concentration in upper and lower phases of the phase separated sample 
remains constant irrespective of the initial protein concentration; i.e chemical potential of the 
protein is same in the two phases, while their volumes are different. Similar results have been 
reported in the literature for mAbs, confirming that LLPS is an equilibrium process.
27
 Figure 
4 shows the effect of temperature and ionic strength on phase separation. At 15 mM ionic 
strength, protein shows a higher tendency to phase separate (phase separation occurs at both 
4 ˚C and 22 ˚C) than at 50 mM ionic strength (phase separation occurs only at 4 ˚C), which is 
in agreement with opalescence measurements (Figure 2), where high opalescence is recorded 
at 15 mM compared to 50 mM. On undergoing phase separation at 4 ˚C, 15 mM sample 
shows a lower concentration in protein-poor phase and higher concentration in protein-rich 
phase (0.8 mg/mL and 132.6 mg/mL, respectively) than the phase separated sample at 50 
mM ionic strength (4.3 mg/mL and 124.2 mg/mL, respectively). Coexistence curve shifts to 
lower temperatures as the ionic strength is increased from 15 mM to 50 mM. 
Phase separation in solution was confirmed by visually observing under microscope. 
Liquid-liquid phase separation is preceded by opalescent appearance of the solution.
39
 Inside 
the coexistence curve and before phase separation occurs (kinetically controlled), both 
protein-rich and protein-poor phases coexist in solution, where protein rich-phase is 
dispersed in protein-poor phase. This results in multiple scattering of light from the solution, 
which makes it appear opalescent. On overcoming the kinetic barrier (either by nucleation 
and growth mechanism by metastable system or spinodal decomposition by unstable system), 
due to the density difference between the two phases, protein-rich phase being denser settles 
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down forming the lower phase, while protein-poor phase forms the upper phase of the phase 
separated system. From Circular Dichroism studies (Figure 6a and 6b), it is confirmed that 
protein does not undergo any secondary or tertiary structural changes (structural change if 
any is reversible in dilute solution) on undergoing phase separation indicating that protein 
retains its native conformation. 
 
5.2. Protein-Protein Interactions Resulting in LLPS 
Attractive interactions in protein solution could be due to the presence of electrostatic 
charge, dipole moments in macromolecules (charge-dipole, charge–induced dipole, and van 
der Waals forces) and/or the hydrophobic patches on the surface of the protein (hydrophobic 
interactions).
37, 40, 41
 Apart from these classical, non-covalent interactions in solutions, there 
may be specific interactions pertaining to surface amino acid residues including cation-π 
interactions.
42, 43
 These specific interactions can be modulated by certain amino acid 
excipients and organic buffers and have been reported to affect the structural stability of the 
proteins in solution.
44
 
Liquid-liquid coexistence curve shifts to upper or lower temperatures with changes in 
the pH or ionic strength of the solution, indicating increase or decrease in attractive 
interactions.
22, 23, 26, 36
 Extensive work has been carried out for determination of colloidal 
stability by assessing shifts in the coexistence curve of protein solutions using PEG-induced 
LLPS.
45-49
 Mechanism by which PEG increases attractive interactions between protein 
molecules is by preferential exclusion/ depletion forces; however, it is also known to bind to 
proteins and/or buffer and salt species in solution resulting in uncertainties in LLPS 
determination.
50
 In our previous study, we have shown that the opalescence measured as a 
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function of temperature for a monoclonal antibody solution is a better measure of interactions 
in solution than that measured at ~25 °C using routine techniques.
37
 In the current study, 
interactions measured in dilute solution by light scattering (Figure 8a) were correlated to 
shifts in Tcloud (Table 1) at fixed concentrations (16 and 60 mg/mL); a low Tcloud value 
indicates weak attractive interactions in solution, or a physically stable product, while high 
Tcloud values or shift to higher temperatures indicate increased attractive interactions in 
solution. 
At pH 5.0, which is away from the pI (~7.0 – 7.5), molecules carry a high net charge 
resulting in repulsive interactions at low ionic strength as indicted by a positive kD (+5.00 
mL/gm). On increasing the ionic strength to 50 mM, charge shielding occurs resulting in a 
decrease in net repulsive interactions, therefore, the net interactions become attractive (kD= -
8.25 mL/gm, B2=-0.49*10
-5
 mol.mL/g
2
). At pH 5.0, Tcloud could not be determined at studied 
temperature at any of the conditions as phase separation may be occurring at temperature 
below 3 °C. The presence of repulsive or weak attractive interactions in solution correlates 
well with the absence of phase separation and opalescence at this pH.  
From light scattering measurements, ionic strength has no effect on attractive 
interactions at pH 6.1. Tcloud is nearly constant (10˚C and 10.5 ˚C) at both 16 and 60 mg/mL 
at 15 mM ionic strength. At 50 mM, Tcloud shifts to a higher temperature; however the shift at 
60 mg/mL (6 ˚C) is more significant than at 16 mg/mL (2 ˚C), indicating that increasing the 
ionic strength increases the attractive interactions more at higher concentrations. 
Hydrophobic interactions are the only short range attractive interactions that are not affected 
by changing the ionic strength of the solution at low salt concentrations. These interactions 
become relatively stronger on increasing the ionic strength due to preferential exclusion of 
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salts from the vicinity of the proteins. Even though these interactions are present in dilute 
solution, they become dominant as protein concentration increases. Both, light scattering and 
Tcloud measurements at pH 6.1 suggest the presence of attractive hydrophobic interactions in 
solution which results in phase separation at this condition.  
Interactions measured at pH 6.5 as a function of ionic strength using light scattering 
(Figure 8b) and Tcloud  measurements (Figure 7), indicate the presence of strong attractive 
interactions at low ionic strength, which decrease on increasing the ionic strength from 5 mM 
to 100 mM. Closer to the pI of the molecule, net charge on the protein decreases; high 
attractive interactions at low ionic strength may be due to dipole on the molecule. Similar 
trend is observed at pH 7.0 and 8.0, i.e. attractive interactions decrease as ionic strength is 
increased from 15 mM to 50 mM. Charge-dipole or charge-induced dipole and van der Waals 
interactions (London, Debye and Keesom) arise due to the presence of dipoles and multipoles 
on the protein molecule and have been previously reported to increase viscosity
51
 and 
opalescence for mAb solutions.
37
 At pI, though the net charge on the protein is minimal, a 
protein molecule carries large number of positive and negative charges. Asymmetric 
distribution of these charges on the protein surface produces a dipole which leads to 
increased protein-protein attractive interactions in the solution. DVD-Ig
TM 
protein has an 
increased asymmetry in shape due to its additional variable domains, which would further 
enhance asymmetric charge distribution on the surface of the protein as compared to a mAb, 
which results in increased tendency to exhibit opalescence and phase separation at low ionic 
strength conditions. These dipoles are shielded on increasing the ionic strength resulting in a 
net decrease in attractive interactions. This dipole-shielding effect is more prominent at pH 
closer to the pI of the molecule.  
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Close to the pI of the molecule, the trend observed for opalescence measured at 25 
°C, (Figure 2) and at 60 mg/mL correlates fairly well with Light scattering and Tcloud 
measurements; maximum opalescence is seen at an ionic strength of 15 mM and decreases on 
increasing the ionic strength. Similarly, interactions are strongly attractive at 15 mM and 
become less attractive at 50 mM ionic strength. Away from the pI, at pH 5.0 where 
interactions are repulsive in nature (from light scattering and absence of phase separation), 
there is no opalescence in solutions. However there is discrepancy at pH 6.1, where solution 
exhibits a low opalescence at both ionic strengths while significant attractive interactions are 
present in the solution. From Figure 2, high opalescence was observed at pH 6.5, 7.0 and 8.0, 
where phosphate buffers are used, while opalescence decreased at pH 6.1, which uses 
histidine buffer. Therefore, the effect of different buffer species on opalescence was 
investigated.  
 
5.3. Effect of Different Buffer Species 
Effect of phosphate and histidine buffer species was studied at a constant pH (6.5) 
and constant ionic strength (15 mM). As observed from Figure 9, solution exhibited high 
opalescence in phosphate buffer which decreased when buffer was changed to histidine. 
Opalescence measurements with sodium chloride confirmed that cationic histidine species 
reduces solution opalescence. The pI of the molecule is around pH 7.0. At pH 6.5, the 
molecule should have a slight net positive charge. Ideally, the protein properties should be 
more impacted by oppositely charged anions than similarly charged cations. For cationic 
histidine species to exert its effect, it must be specifically interacting with certain amino acids 
on the protein surface resulting in reduced opalescence. From light scattering measurements, 
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interactions are highly attractive at all three conditions (Figure 10), however, kD values are 
highly negative and equal for both phosphate and sodium chloride and become less negative 
in the presence of histidine buffer. From temperature studies (Figure 11), Tcloud is high for the 
protein in phosphate buffer at both the concentrations and shifts to lower temperatures in 
histidine buffer, indicating reduced attractive protein-protein interactions and confirming 
specific binding of histidine with the protein in solution. 
Histidine has been reported to improve physical stability of high concentration mAb 
formulations and also reduce its viscosity.
52
 Histidine is a basic amino acid with ionizable 
imidazole moiety (pKa ~ 6.0) in its side chain; pKa of the amino acid varies from ~6.0-6.5 
depending on the neighboring moieties. Interactions of histidine with other amino acids 
depend on its protonated-deprotonated state which varies with solution pH. Interactions of 
the positively charged imidazole group with amino acid on protein surface may be the 
possible mechanism by which it reduces protein-protein interactions and hence opalescence 
in solution. The mechanisms by which histidine interacts with other amino acids include, 
cation-π interaction, π-π stacking interaction, hydrogen-π interaction, coordinate bond 
interaction, hydrogen bond interaction.
43
 Katayama and coworkers attributed reduced 
aggregation of Interferon-tau in histidine buffer relative to phosphate buffer to binding of 
histidine to the native state thereby stabilizing it.
53
 Similar effect was observed by Salinas 
and coworkers on reduced fragmentation of mAb in histidine buffer compared to phosphate 
buffer due to (weak) preferential binding of histidine with mAb.
54
  
Phosphate is a strong kosmotrope in the Hofmeister series and increases 
conformational stability of the proteins while decreasing its solubility in solutions.
55
 
Phosphate is strongly hydrated with high charge density and is known to stabilize proteins 
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(increase its precipitation tendency) by acting as water structure maker. The mechanisms by 
which phosphate and histidine buffers act are different and hence exert different effect on 
solution opalescence; phosphate increases opalescence by salting-out mechanism while 
histidine specifically interacts with amino groups on protein surface and reduce solution 
opalescence. Though, the magnitude of the change in opalescence on switching from 
phosphate to histidine buffer is quite significant (Figure 9); samples at both buffer conditions 
will undergo phase separation on storage at refrigerated conditions (4 ˚C), indicating loss of 
physical stability of the solution. Opalescence in solution is due to scattering of light and can 
be attributed to presence aggregates in solution or liquid-liquid phase separation (LLPS).
37
 
Opalescence measurements are usually conducted at room temperature/25 °C, however 
tendency to phase separate is higher as the temperature is lowered. These results strongly 
suggest that Tcloud may serve as a better indicator of possible phase separation in solutions 
than opalescence measurement (as results may be interpreted as false positive) and can be 
used as an orthogonal technique along with light scattering to screen excipients and salts to 
determine protein-protein interactions and develop a robust protein formulation. Both these 
techniques can be easily optimized for high-throughput analysis; hence is of great 
significance especially for preformulation candidate selection, where only small amount of 
material is available. 
 
6. Conclusion 
Liquid-liquid phase separation is of great significance for formulation development 
from both pharmaceutical and physiological point of view. LLPS is a thermodynamic process 
and protein does not undergo structural changes on phase separation. Mechanism by which 
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different buffers (or excipients) interacts with proteins and influence its physicochemical 
properties is different and hence determining the nature of specific and non-specific protein-
protein interactions is of utmost significance. Strong attractive interactions are observed in 
systems exhibiting liquid-liquid phase separation; presence of hydrophobic interactions in 
addition to dipolar interactions results in liquid-liquid phase separation for DVD-Ig
TM
 protein 
solutions. The measured values of Tcloud and kD are dependent on the solution conditions (pH, 
ionic strength and buffer species) confirming that Tcloud can be utilized as a predictive tool in 
preformulation devolvement. 
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9. Tables and Figures 
Table 1: Tcloud (determined as temperature where transmittance is 70%) for DVD-Ig
TM 
as a 
function of solution conditions. (IS= Ionic strength).  
 
Tcloud (˚C) 
 
IS =15 mM IS =50 mM 
pH 16 mg/mL 60 mg/mL 16 mg/mL 60 mg/mL 
5.0 < 3.0 < 3.0 < 3.0 < 3.0 
6.1 10.0 ± 0.0 10.3 ± 0.4 12.0 ± 0.0 15.8 ± 0.4 
6.5 33.0 ± 0.7 > 37.0 19.3 ± 0.00 24.5 ± 0.0 
7.0 - - 21.0 ± 0.0 25.0 ± 0.0 
8.0 27.5 ± 0.0 32.5 ± 0.0 15.5 ± 0.0 19.5 ± 0.0 
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Figure 1: Percent transmittance for DVD-Ig
TM
 protein as a function of protein concentration 
at various solution pH (pH 5.1- acetate, pH 6.1-histidine, pH 6.5-phosphate, pH 7.0-
phosphate, pH 8.0-phosphate) and at ionic strength of 15 mM. All solutions were analyzed at 
25 ± 1˚C in duplicate. Error bars if not visible are smaller than the symbols used. 
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Figure 2: Percent transmittance for DVD-Ig
TM
 protein at 60 mg/mL as a function of pH and 
ionic strength. Ionic strength of 15 and 50 mM were analyzed at pH 5.0, 6.1 and 8.0, while 
only 50 mM was analyzed at pH 7.0. Ionic strength of 5, 15, 50 and 100 mM were studied at 
pH 6.5. 5 and 15 mM ionic strengths were maintained by preparing solutions with 
appropriate buffer strength. Sodium chloride was added to adjust ionic strength to 50 and 100 
mM. All solutions were analyzed at 25 ± 1˚C in duplicate.  
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Figure 3: Effect of the initial concentration of DVD-Ig
TM
 protein before phase separation on 
the protein concentrations of the protein-rich phase (dashed bars) and protein-poor phase 
(closed bars) at 4°C in sodium phosphate solution at pH 6.5 with ionic strength of 50 mM. 
Numbers over the bars represent the concentration of each phase. Ionic strength was 
maintained by appropriately diluting sodium phosphate stock with ionic strength of 150 mM. 
All solutions were analyzed in duplicate. 
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Figure 4: Effect of the temperature on initial concentration of DVD-Ig
TM
 protein on 
undergoing liquid-liquid phase separation at (a) 15 mM and (b) 50 mM. Initial protein 
concentration was maintained at 16 mg/mL. Numbers over the bars represent the 
concentration of each phase. Ionic strength was maintained by appropriately diluting sodium 
phosphate stock with ionic strength of 150 mM. All solutions were analyzed in duplicate. 
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Figure 5: LLPS for DVD-Ig
TM
 protein observed under Polarized Light Microscope (100x 
magnification) for 16 mg/mL solution at pH 6.5 and at room temperature (23 ± 1 ˚C). Ionic 
strength was maintained by appropriately diluting sodium phosphate stock solution with 
ionic strength of 150 mM. 
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Figure 6: (a) Near-UV and (b) far-UV circular dichroism spectra of DVD-Ig
TM
 protein at pH 
6.5 at 15 mM ionic strength (Phosphate buffer) before phase separation (solid line), and after 
phase separation in protein-rich phase (dotted line) and protein-poor phase (dashed line). The 
ellipticity is represented as molar ellipticity. All solutions were analyzed at room temperature 
(23 ± 1˚C). 
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Figure 7: Temperature ramp studies for DVD-Ig
TM
 protein as a function of ionic strength at 
pH 6.5 at concentrations of (a) 16 mg/mL and (b) 60 mg/mL. At 5 mM ionic strength low 
and high concentrations are 9.8 and 78 mg/mL respectively (represented by closed and open 
circles). Ionic strength of 5 and 15 mM were maintained by preparing phosphate solutions 
with appropriate buffer strength. Sodium chloride was added to maintain ionic strength of 50 
and 100 mM. All solutions were analyzed in duplicate. 
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Figure 8: Plot of kD obtained from Dynamic light scattering as a function of (a) pH (pH 5.1- 
acetate, pH 6.1-histidine, pH 6.5-phosphate, pH 7.0-phosphate, pH 8.0-phosphate) and at 
ionic strengths of 15 mM (solid line) and 50 mM (dotted line) and (b) varying ionic strengths 
at pH 6.5. All solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if not visible are 
smaller than the symbols used. 
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Figure 9: Percent transmittance for DVD-Ig
TM
 protein as a function of different salt/buffer, 
sodium phosphate (♦), histidine hydrochloride (▲) and sodium chloride (■),at pH 6.5 and 
ionic strength of 15 mM. All solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if 
not visible are smaller than the symbols used 
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Figure 10: Dm plot for DVD-Ig
TM
 protein as a function of different salt/buffer, sodium 
phosphate (♦), histidine hydrochloride (▲) and sodium chloride (■), at pH 6.5 and ionic 
strength of 15 mM. All solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if not 
visible are smaller than the symbols used. 
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Figure 11: Temperature ramp studies for DVD-Ig
TM
 protein at 16 mg/mL (dashed line) and 
60 mg/mL (solid line) in 15 mM ionic strength Histidine (▲) and Phosphate (♦) buffers.  
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Chapter 5 
 
Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual 
Variable Domain Immunoglobulin Protein Solutions 
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1. Abstract 
Liquid-liquid phase separation (LLPS) and aggregation can reduce the physical 
stability of therapeutic protein formulations. On undergoing LLPS, the protein-rich phase can 
promote aggregation during storage due to high concentration of the protein. Effects of 
different excipients on aggregation in protein solution is well documented, however data on 
the effect of excipients on LLPS is scarce in the literature. In this study, the effect of three 
excipients (PEG 400, Tween 80 and Sucrose) on liquid-liquid phase separation and 
aggregation in a Dual variable domain immunoglobulin protein (DVD-Ig
TM
) solution was 
investigated. Sucrose suppressed both LLPS and aggregation, Tween 80 had no effect on 
either and PEG 400 increased LLPS and aggregation. However, the mechanism by which 
these excipients exert positive or negative effect on LLPS and aggregation varies. Results 
indicate that, LLPS and aggregation are highly temperature dependent; at low temperature 
protein exhibits LLPS, at high temperature protein exhibits aggregation and at an 
intermediate temperature both phenomena occur simultaneously depending on the solution 
conditions. 
 
Keywords: liquid-liquid phase separation, aggregation, excipients, protein-protein 
interactions, physical stability, protein formulation, sucrose, PEG, temperature effects 
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2. Introduction 
Formulation development of protein therapeutics aims to have efficacious products 
wherein the protein remains in solution and maintains stability across its shelf life. Phase 
separation and aggregate formation in protein solutions can compromise physical stability of 
the formulation.
1, 2
 These solutions can exhibit solid-liquid phase separation resulting in the 
formation of either crystals or amorphous precipitate or a metastable liquid-liquid phase 
separation into a protein-rich and a protein-poor phase.
3-5
 In either case, protein retains its 
native structure in the formulation and the decreased solubility is associated with the change 
in the chemical potential of the protein in solution or increased intermolecular interactions 
between the protein molecules. Aggregation on the other hand is associated both with native 
and/or non-native species and can be reversible or irreversible in nature.
6
 Aggregates can 
result in reduced efficacy of the product and can elicit immunogenic response.
7
 Aggregation 
of the therapeutic proteins has been extensively reported in the literature and readers are 
referred to some excellent reviews on aggregation pathways (physical and chemical)
8, 9
 and 
kinetics
10
 in solution, general terminologies associated with classification of aggregates
11
 and 
assessment of aggregates
12-14
 in protein solutions.
15, 16
   
Excipients play a significant role in maintaining the physical stability of protein 
formulations.
17, 18
 Depending on the concentration and nature, certain excipients can exert 
dual effect, e.g, preferentially excluded co-solutes increase the conformational stability of 
proteins in solution, while they can also promote phase separation (or reduced solubility) if 
the increase in the chemical potential of the protein in solution phase exceeds that in the solid 
phase.
19
 Excipients exert their stabilizing effect by modulating protein-protein interactions in 
solution or by changing conformational stability. Sugars, polyols, polymers, salts, 
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surfactants, amino acids and their derivatives are some of the excipients used in therapeutic 
protein formulations to improve physical stability of the protein.
17, 18
  
The three commonly used excipients PEG 400, Tween 80 and Sucrose were 
investigated for their effect on liquid-liquid phase separation (LLPS) and aggregation in 
DVD-Ig
TM
 protein
 
solution. PEG 400 is a macromolecular crowding agent and is a 
commonly used protein precipitant; it enhances conformational stability of proteins in 
solution by the preferential exclusion mechanism.
20
 Extensive studies for PEG-induced LLPS 
are reported in the literature for therapeutic proteins including mAbs.
21-24
 Tween 80 is a 
surfactant which competes with the protein to adsorb at the air-water interface, thereby, 
reducing its tendency to denature at the interface.
25-27
 Sucrose is a widely used protein 
stabilizing excipient against thermal denaturation, which is preferentially excluded, and 
exerts its effect by increasing the surface tension of water.
28-31
  
Though many reports in the literature highlight the effectiveness of Sucrose and 
Tween in reducing aggregation of the proteins in solution, to the best of our knowledge, there 
are no studies on the effect of these excipients on liquid-liquid phase separation in DVD-Ig
TM
 
protein solution. Therefore, the effect of Sucrose, PEG 400 and Tween 80 on aggregation and 
LLPS in DVD-Ig
TM
 protein solution was studied. The purpose of the current study was (i) to 
understand the effect of excipients on LLPS and aggregation in DVD-Ig
TM
 protein and (ii) to 
understand the relationship between LLPS and aggregate formation in DVD-Ig
TM
 protein 
solution in the presence of the excipients and as a function of temperature. 
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3. Materials and Methods 
3.1. Materials  
All buffer reagents and chemicals used were of the highest purity grade and were 
obtained from commercial sources. Histidine base and histidine hydrochloride were 
purchased from Sigma (St. Louis, MO). Monobasic and dibasic sodium phosphate, sodium 
sulfate, Sucrose, Tween 80 and Polyethylene Glycol 400 were purchased from Fisher 
Scientific (Fair Lawn, New Jersey). Dual Variable Domain protein, DVD-IgTM (pI ~7.0-7.5) 
as 85 mg/mL solution in 15 mM Histidine buffer at pH 5.5 was supplied by Abbvie 
(Worcester, MA). Solutions were prepared with deionized water equivalent to Milli-Q
TM
.  
Histidine buffer was used to maintain pH at 6.6. Ionic strength of 15 mM was 
maintained by selecting appropriate buffer strength without addition of any salts. All the 
excipient stock solutions were prepared in Histidine buffer, filtered through 0.22 μm 
Millipore’s Durapore membrane filters and then diluted down to the required concentrations 
with same buffer (Stock: 50% PEG 400, 40% Sucrose, 0.1% Tween 80). All antibody 
solutions were buffer exchanged with Histidine buffer using Millipore (Billerica, MA) 
Amicon Ultra centrifugation tubes with a molecular weight cutoff of 10 kDa obtained from 
Fisher Scientific. Concentrations of the samples were determined using a UV-vis 
spectrophotometer with an extinction coefficient of 1.5 mg
-1
/mL
-1
cm
-1
 for DVD-Ig
TM
 protein 
at 280 nm for 0.1% (w/v) IgG solutions. The pH of all the above solutions was within ± 0.1 
of the target values as measured by a Denver Instrument pH meter.  
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3.2. Accelerated Stability Studies 
DVD-Ig
TM
 protein samples with a concentration of 33 mg/mL were prepared in 
Histidine buffer, pH 6.6- 15 mM ionic strength and appropriate concentration of excipients 
was maintained (10% Sucrose, 10% PEG, 0.01% Tween). All the solutions were filtered 
through sterile 0.22 μm Millipore’s Durapore membrane filters before incubation. 150 μL 
samples for each condition (in duplicate) were filled in sterile Fischerbrand (Fischer 
Scientific) 0.5 mL microcentrifuge tubes with loop and O-ring and incubated at 4 ˚C in 
refrigerator and at 20 ˚C and 40 ˚C in isotemp oven (Fischer Scientific). At the set time-
points (7, 21 and 45 days), samples were brought to room temperature and thoroughly mixed. 
Appropriate amount of aliquot was withdrawn and diluted to around 2 mg/mL and then 
centrifuged at 6708×g for 5 min using an Eppendorf minispin (Hamburg, Germany).  
Supernatant was further diluted down to 1 mg/mL and directly filtered through 0.22 μm 
syringe filters into HPLC vials.  
At 45 day time-point samples were also analyzed for structural changes by second-
derivative fluorescence spectroscopy (0.2 mg/mL concentration at all conditions was 
analyzed; other steps are similar to that reported for Intrinsic fluorescence). A third set of 
samples was stored at 4 °C, which were analyzed for concentration of protein in protein-rich 
and protein-poor phase (to assess phase separation after 45 days). 
 
3.3. HPLC-Size Exclusion Chromatography 
Analysis of the stability samples was conducted using SEC-HPLC system with an 
inline UV detector set at 280 nm. A TSK G3000 SWXL gel filtration column (Tosoh 
Biosciences) was used for separation. 100 mM sodium phosphate buffer at pH 7 containing 
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200 mM sodium sulfate was used as mobile phase for elution. Flow rate was maintained at 
0.3 mL/min and 10 μL of sample volume was injected into the system. HPLC analysis was 
also performed for samples before subjecting to stress conditions to determine monomer and 
aggregate content (labeled as t0). Samples were collected and analyzed at 7 day, 21 day and 
45 day. Chromatograms obtained were analyzed for percent of monomer, soluble aggregates 
and fragments using ChemStation software. 
 
3.4. Intrinsic Fluorescence 
Fluorescence spectra for protein–excipient samples were acquired using a Photon 
Technology International (PTI) 814 spectrofluorometer, equipped with a turreted 4-position 
Peltier-controlled cell holder. DVD-Ig
TM
 protein samples were prepared at a concentration of 
0.2 mg/mL at pH 6.6 in Histdine buffer (15 mM ionic strength) keeping the excipient 
concentration constant. An excitation wavelength of 295 nm was used and the emission scans 
were recorded from 310 to 450 nm with a step size of 2 nm and a 1-s integration time. The 
excitation and emission slit width was set at 2 nm and eight emission spectra were collected 
and averaged to obtain the final spectrum. Sample volume of 60 μL was placed in 3 mm path 
length quartz cuvettes and measurements were made at 25 ˚C after equilibration for 2 min.  
Buffer peak was subtracted from each spectra and all the emission scans were normalized to 
1.0 (FeliX32™ software, PTI) before obtaining second order derivative spectra for each 
solution condition. 
 
 
 
153 
 
3.5. Thermal Stability Studies 
Onset of aggregation temperature for DVD-Ig
TM
 protein was determined from 
Malvern Instrument’s Zetasizer Nano Series (Worcestershire, UK) at a wavelength of 632.8 
nm and at 173˚. All samples were prepared in pH 6.6 histidine buffer with ionic strength of 
15 mM and protein concentration was maintained at 34 mg/mL. Sample volume of 60 μL 
was placed in 3 mm path length quartz cuvettes and intensity and particle size of the sample 
was recorded from 30-60 °C in increments of 1 °C. All samples were allowed to equilibrate 
at each temperature for 2 min.  
 
3.6. Tcloud Measurements 
Temperature studies were performed using UV-Vis spectrophotometer attached with 
a temperature control peltier plate, where percent transmittance was recorded as temperature 
was lowered in steps from 35 ºC to 3 ˚C. 60 μL of samples were studied in 3 mm quartz 
cuvette and samples were allowed to equilibrate at each temperature for 2 min before 
recording the measurements. Onset of the liquid-liquid phase separation is characterized by a 
dramatic increase in solution turbidity; this temperature is marked as Tcloud. For current study, 
temperature at which percent transmittance is 70 is termed as Tcloud. Protein concentration of 
16 mg/mL was analyzed for Sucrose, PEG and Tween 80. After addition of excipients to 
protein solutions, all the samples were allowed to equilibrate for 2 hours and filtered directly 
into the cuvette before making the measurement.  
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3.7. Dynamic Light Scattering (DLS) 
DLS studies were performed using a Malvern Instrument’s Zetasizer Nano Series at a 
wavelength of a 632.8 nm and at 173˚. All the buffers and sample stock solutions were 
filtered through 0.22 μm Millipore’s Durapore membrane filters before making the dilution to 
required concentrations. Excipient concentration was kept constant and protein concentration 
was varied from 0.25 – 10 mg/mL for each set of measurements in duplicate. The protein and 
excipient solutions were then centrifuged using an Eppendorf minispin mini-centrifuge at 
12,110×g for 5 min before every measurement. Light scattering measurements were made at 
25 ± 0.1˚C.  Linear plot of Dm against concentration was used to calculate self-diffusion 
coefficient (Ds) and interaction parameter (kD) using following relation,                                               
                                               𝐷𝑚 = 𝐷𝑠(1 + 𝑘𝐷𝑐)                                                                                 (1)  
c is the concentration of the protein (g/mL).
32
  
 
4. Results and Discussions 
4.1. Effect of Excipients on Aggregation 
Formation of aggregates in protein solution compromises physical stability of the 
formulation and can also reduce its efficacy and safety. Determining or quantifying the 
amount of aggregates in solution in the presence of different excipients can help in 
optimizing the solution conditions to increase the shelf-life of the product. Mechanism by 
which different excipients exert their stabilizing/destabilizing effects on protein aggregation 
is thoroughly studied and reported in the literature.
17, 18
 Figures 1 through 3 represents effect 
of different excipients on aggregation in DVD-Ig
TM
 protein samples incubated at different 
temperatures over a period of 45 days.  
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4.1.1. Stability Studies at 4 ºC 
Figure 1 show a plot of percent aggregation (Figure 1a) and fragmentation (Figure 
1b) of DVD-Ig
TM
 protein as a function of different excipients after 7, 21, and 45 days at 4 ˚C. 
Before the samples were subjected to stress conditions, a small amount of aggregate was 
present in the solution (t0~ 1.5 %) as analyzed with SEC-HPLC at time t=0. No change in 
percent aggregate or fragmentation was observed after samples were incubated for 45 days.  
 
4.1.2. Stability Studies at 20 ºC 
Percent aggregates and fragmentation for DVD-Ig
TM
 protein after incubation at 20 ˚C 
is plotted in Figure 2 at different time points. From Figure 2a, after 7 days, no change in 
aggregate content was observed in any of the samples (within experimental error). However, 
after 21 days, percent aggregates increased for DVD-Ig
TM
 protein in the presence of PEG 
400, which further increased for samples analyzed after 45 days. There was no change in 
aggregate content in the presence of other excipients. From Figure 2b, no fragmentation was 
observed at any of the conditions after incubation for 45 days. 
 
4.1.3. Stability Studies at 40 ºC 
Figure 3a and 3b shows a plot of percent aggregates and fragmentation, respectively, 
for DVD-Ig
TM
 protein incubated with different excipients at 40 ˚C. From Figure 3a, percent 
aggregate shows an increase after 7 days compared to that analyzed at t=0, and increased 
significantly after 21 and 45 days at all the conditions. In the presence of PEG 400, percent 
aggregates increased significantly (by ~12%) after 7 days compared to protein samples in the 
presence of other excipients. However, the rate of aggregate formation decreased from day 
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21 to day 45. Amount of aggregates in the presence of Tween are almost similar to buffer 
(absence of excipients). Sucrose showed increased thermal stability as percent aggregate 
content was low than in buffer. Percent fragmentation (Figure 3b) for DVD-Ig
TM
 protein 
showed a significant increase at all the conditions after 45 days. For Tween and Sucrose, 
percent fragmentation is almost equal to that observed in the buffer at all the time points. 
However, for PEG, percent fragmentation increased significantly after 21 days and 45 days 
while aggregate formation remained nearly constant from 21 to 45 days. 
 
4.1.4. Structural Changes  
Intrinsic fluorescence and second derivative fluorescence spectroscopy
33, 34
 studies 
were performed for DVD-Ig
TM
 protein in the presence and absence of excipients to determine 
tertiary structural changes after samples were incubated at 40 ºC for 45 days (Appendix 2). 
Fluorescence spectra were also recorded for freshly prepared DVD-Ig
TM
 protein samples at 
similar solution conditions. No shift in intensity or wavelength (blue shift or red shift) in the 
presence or absence of excipients was observed. Similarly, second derivative spectra did not 
show any change in the tertiary structure for samples at any of the conditions studied. 
Hydrophobic amino acids usually reside in the core of the protein (both in native and 
aggregated form) to reduce the free energy of the system and very few amino acids are 
present on protein surface. Small change in signal intensity due to minor structural 
perturbations (which may be reversible on diluting the sample) may not be sufficient to be 
detected by fluorescence spectroscopy for the samples that exhibited aggregation at high 
temperatures.  
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4.1.5. Thermal Stability 
Figure 4 shows a plot for intensity of DVD-Ig
TM
 protein as a function of temperature 
to assess thermal stability in the presence and absence of excipients. Onset of aggregation in 
protein solution is marked by dramatic increase in intensity and size of the protein in 
solution.
35
 The arrows in the Figure 5, indicate the onset of aggregation temperature for 
DVD-Ig
TM
 protein in the current study. Tonset in presence of buffer is 51.8°C and is in 
agreement with onset of aggregation value for DVD-Ig
TM
 protein in buffer reported in the 
literature.
36
 In presence of PEG 400, Tonset decreases to 49.6°C indicating reduced thermal 
stability, while in presence of Sucrose, thermal stability increases as Tonset increases to 54 °C. 
There is no change in Tonset (51.6°C) in presence of Tween 80.   
Sucrose is known to stabilize protein against thermal degradation by preferential 
exclusion mechanism.
31
 Though, the overall amount of aggregates in DVD-Ig
TM
 protein 
solution increased at 40 °C (Figure 3b), aggregation and Tonset (Figure 4) decreased in the 
presence of sucrose compared to buffer which is consistent with literature reports.
28, 29
 PEG 
increases conformational stability of proteins by preferential exclusion mechanism (steric 
effect),
20, 30
 which can also increase attractive protein-protein interactions in solution, 
resulting in increased aggregates in DVD-Ig
TM
 protein solution. Similarly, from Figure 4 
reduced thermal stability was observed in presence of PEG. Though no structural changes 
were observed in solution, increased amount of fragments at 40 °C indicate the possibility of 
covalent interactions (disulfide linkage) between the molecules, resulting in monomer loss at 
high temperature over a period of time. Formation of peroxides and other chemical moieties 
(aldehydes and esters) in PEG solutions due to air exposure/aging and increased temperatures 
has been reported in literature and may promote covalent interactions in protein solutions.
37-
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39
 Tween 80 has no effect on aggregation, fragmentation and thermal stability in solution 
compared to buffer. Surfactants are amphiphilic molecules and adsorb/concentrate at air-
water interface, reducing the concentration in bulk and hence no effect on aggregation was 
observed. Though, Tween 80 stabilizes protein against surface-induced aggregation, it has 
been reported to destabilize proteins against thermal degradation
25, 40
 and is also known to 
induce chemical degradation in proteins via oxidation due to formation of peroxides.
27, 41
  
 
4.2. Effect of Excipients on Liquid-liquid Phase Separation 
Liquid-liquid phase separation (LLPS) is a concern in protein formulation 
development as the protein solutions are generally stored at refrigerated conditions (4-8 ˚C) 
where they show a higher tendency to phase separate. LLPS in solution can be attributed to 
attractive protein-protein interactions (PPI).
42-44
 Excipients that decrease the interactions 
between the protein molecules will reduce their tendency to undergo LLPS in solution.
45
 
Tcloud was determined by measuring percent transmittance as solution temperature was 
lowered to determine the effect of excipients on LLPS in DVD-Ig
TM
 protein solution. PPI in 
the presence of different excipients was further confirmed by well-established light scattering 
studies, where kD or interaction parameter was determined from diffusion coefficient 
measured using Dynamic light scattering. A positive kD value indicates repulsive PPI, while a 
negative kD value indicates attractions between the protein molecules. All the negative kD 
values in the current study are outside the hydrodynamic range (small range where 
interactions are repulsive in nature, indicated by positive B2 values, but kD values are 
negative due to larger hydrodynamic contributions) and hence indicate attractions between 
the molecules.  
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Figure 5 shows a plot of Tcloud on the primary axis and kD on the secondary axis 
against different excipients (10 % PEG 400, 10 % Sucrose and 0.01 % Tween 80) for 16 
mg/mL protein solution. The ionic strength and pH of the solutions were maintained constant 
at pH 6.6 (Histidine buffer) and 15 mM, respectively. In the absence of any excipients, Tcloud 
for DVD-Ig
TM
 protein is around 20 ºC and kD shows a large negative value (-60 mL/g) 
indicating strong attractive interactions in the solution. In the presence of 10 % PEG, Tcloud 
increases to ~25.5 ºC and kD becomes more negative (~ -68 mL/g), both indicating increased 
attractive interactions in the solution and reduced solution stability. As described in the 
previous section, PEG is a crowding agent; hence in the presence of PEG less volume is 
available for the protein molecules, which results in enhanced protein-protein interactions 
(non-covalent). The results are consistent with those reported in the literature, where PEG 
has been shown to shift the coexistence curve for proteins to higher temperatures.
22, 24
  
Tween (0.01%) has no effect on Tcloud (~19.5 ºC) and kD (~-61.5 mL/g) measured for 
DVD-Ig
TM
 protein
 
compared to buffer. The concentration of Tween studied was extremely 
low; and at such low concentrations it may be affecting the surface properties, there are no 
effects on the bulk solution property. Therefore, the effect of a higher concentration of 
Tween (0.05%) on Tcloud and kD was also studied; no change in Tcloud or kD was observed. 
Sucrose (10 % w/v) shows a significant decrease in Tcloud (~ 11 ºC) of the solution as 
compared to DVD-Ig
TM
 protein in buffer. Attractive interactions in solution also decrease as 
indicated by a less negative kD value (~-35 mL/g). While both PEG and Sucrose increase 
thermodynamic stability of the protein in solution by preferential exclusion mechanism, they 
affect the LLPS in solution differently. Although, sugars are polar molecules they have some 
hydrophobicity associated with it, therefore have variable effects on solubility of proteins due 
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to weak binding.
46, 47
 Based on the measurements of transfer free energies (∆gtr), previous 
studies in our lab reported increased solubility for aromatic amino acids
47
 and its derivative 
(negative ∆gtr) and decreased solubility for aliphatic amino acid derivative (positive ∆gtr) in 
the presence of sucrose.
48
 Hydrophobic interactions chromatography studies were performed 
for DVD-Ig
TM
 protein molecule; sharp peaks were observed using phenyl column as opposed 
to broad peaks with butyl column indicating specific binding of the aromatic groups with 
phenyl (Zecca E. et al., unpublished data). Site specific binding of sucrose with the aromatic 
amino acids on protein surface may be responsible for reduced Tcloud and kD for DVD-Ig
TM
 
protein. 
  
4.3. Relationship between Aggregation and LLPS  
Liquid-Liquid phase separation of a solution into a protein-rich and protein-poor 
phase is more likely to promote protein self-association and/or irreversible aggregation since 
these phenomena are concentration dependent. However, LLPS and aggregation respond to 
the temperature in opposite ways; aggregate formation increases with increasing 
temperatures while tendency to phase separate decreases. Earlier sections discussed the effect 
of excipients on aggregation and LLPS; this section discusses the relationship between 
aggregation and LLPS as a function of different excipients and temperature. 
 
4.3.1. Effect of Temperature 
At 4 ˚C, all the samples exhibited liquid-liquid phase separation in the presence of 
excipients studied (Figure 5). On undergoing LLPS, two phases of different protein 
concentrations are formed and due to the Donnan effect excipients will also partition in two 
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phases; concentration of the excipient in the upper phase or protein-poor phase will be much 
higher than in protein-rich phase. Ideally, both, high concentration of the protein and lower 
concentration of the excipient in protein-rich phase should accelerate the aggregation of 
proteins. However, no change in aggregate or fragment content was observed after sample 
was incubated at 4 °C for 45 days (Figure 1). This indicates that LLPS does not result in 
aggregate formation at this temperature during this period (45 days stability studies).  
At 20 °C, increase in aggregate formation was observed for DVD-Ig
TM
 protein 
solution in presence of PEG 400, while at all other conditions monomer content remained 
same after 45 days. From Figure 5, Tcloud for DVD-Ig
TM
 protein in buffer and in the presence 
of Tween 80 is around 20 ˚C. Tcloud marks the onset of phase separation in solution, and in the 
current study, for qualitative analysis temperature where percent transmittance is 70 is 
termed as Tcloud. However, actual separation in two phases may be occurring at temperatures 
slightly away from reported Tcloud and strongly depends on the kinetics of phase separation 
and viscosity of the solution (which may impede phase separation process). At 20 °C, though 
the solution exhibits significant opalescence in buffer and in presence of Tween 80, phase 
separation may be in transient state due to kinetic hindrance. On the other hand, Tcloud for 
PEG is around 25.5 ºC and hence on lowering the temperature, solution phase separates 
(visually confirmed at room temperature, 23 ºC). This indicates that though LLPS can 
accelerate aggregation in solution, temperature is the dominant factor in aggregation kinetics. 
This was further confirmed from SEC analysis of samples incubated at 40 ºC, where, 
significant increase in aggregate and fragment content was observed for DVD-Ig
TM
 protein 
solutions at all conditions. However, all the samples were homogenous and no liquid-liquid 
phase separation was observed at any of the conditions. Hence, at 4 ºC, even though all the 
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samples are phase separated, they do not aggregate as temperature acts as a kinetic barrier for 
aggregate formation; while at 20 ºC, both LLPS and increased temperature promote 
formation of irreversible, soluble aggregates in the solution.  
It is well-known that the rate of protein degradation pathways is accelerated at higher 
temperatures and forms the basis of accelerated stability studies. However prediction of 
degradation rates from higher temperatures may not be representative of the actual storage 
conditions, which is refrigerated conditions for most proteins. Though, many models are 
routinely used to extrapolate accelerated stability conditions to storage conditions and predict 
shelf-life, several literature reports have cited the inefficiency of these models.
49
 In a recent 
paper, Saluja et al., have reemphasized the inadequacy of these models and have also 
highlighted the fact that these models do not take into consideration structure of multi-
domain proteins which do not follow simple two-step transition; hence, predicting 
aggregation rate for such molecules is even more challenging.
50
 Though, we do not attempt 
to determine or correlate the aggregation kinetic behavior at different temperature conditions, 
current study highlights the facts that at low temperatures, possible liquid-liquid phase 
separation may alter the protein aggregation kinetics (especially for DVD-Ig
TM
 protein as 
observed at 20 ºC) over long period of time. At 4 ºC, aggregation kinetics are slow; hence 
sample analysis after 45 days may not be representative of long-term stability at this 
condition. For better prediction of protein shelf-life either real time stability studies needs to 
be performed or better predictive models, which take into account other physical instabilities 
at low temperatures, needs to be developed.  
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4.3.2. Effect of Excipients and Interactions in Solution  
Figure 6 represents LLPS (Figure 6a) and aggregation (Figure 6b) measured in 33 
mg/mL DVD-Ig
TM
 protein solutions in the presence of different excipients, after sample was 
incubated for 45 days at 4 °C and 40 °C, respectively. Concentration of the protein in 
protein-poor phase  at 4° C indicating LLPS (Figure 6a) and percent monomer loss at 40 °C 
(Figure 6b) are correlated to the kD values (first secondary axis) measured in dilute solutions 
(<10 mg/mL) and Tcloud (second secondary axis) measured at 16 mg/mL. From the earlier 
sections it was established that at 4 °C, DVD-Ig
TM
 protein exhibited only LLPS and no 
aggregation, while at 40 °C all the solutions were homogenous (no LLPS was observed) and 
percent monomer loss/aggregation is significant over 45 days. 
From Figure 6a, LLPS for PEG 400 at 4 °C shows a good correlation with Tcloud; 
higher the Tcloud value lower is the concentration in the protein-poor phase. Percent monomer 
loss (Figure 6b) in the presence of PEG is also significantly higher than in presence of buffer. 
Similarly, DVD-Ig
TM
 protein solution has most negative kD value in the presence of PEG, 
indicating strong attractive protein-protein interactions which increases both aggregation and 
phase separation in solution. PEG increases LLPS by preferential exclusion mechanism; 
however, it also increases the formation of irreversible aggregates in solution possibly due to 
covalent interactions at high temperatures. Tween 80 has no effect on either LLPS (Figure 
6a) or aggregation (Figure 6b) in solution. The concentration of the protein in the upper-
phase in the presence of Tween is almost similar to that in buffer. Also, the Tcloud and kD 
values are similar to values in buffer. Low concentration of Tween in monomeric form is the 
possible reason that it has no effect on either phenomena. In the presence of sucrose, 
concentration of the protein in the upper-phase after phase separation increases compared to 
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that in buffer which is in agreement with lower Tcloud value. Attractive interactions between 
the protein molecules also reduce significantly as measured using DLS. Sucrose is a thermal 
stabilizer and reduces the percent monomer loss by preferential exclusion effect, while it 
reduces LLPS in solution by increasing solubility of the aromatic amino groups on the 
protein surface. Although used as a stabilizer, sucrose shows a high tendency to degrade and 
form glucose and fructose which may degrade protein by glycation (Maillard reaction) of 
Lysine residues.
51, 52
 Hence, it is more frequently used in freeze-dried protein formulation, 
where degradation is suppressed in the absence of water, than in liquid formulations.  
After incubation for 45 days, the phase separated samples exhibited stability of the 
individual phases indicated by a good correlation with Tcloud values (measured at t=0) at all 
the conditions. Our studies indicate that the mechanism for LLPS and aggregation in protein 
solution is different and shows strong temperature dependence. Similarly, any excipient used 
in a formulation may interact with the protein by more than one mechanism depending on the 
protein itself (specific amino acids on protein surface) and other extrinsic factors, including 
but not limited to pH, ionic strength, protein concentration, excipient concentration and 
temperature. Hence the selection of a suitable excipient for a formulation may not be 
straightforward and has to be investigated on a case by case basis. 
 
5. Conclusion 
Tween has no effect on phase separation temperature, attractive interactions or 
aggregate formation in solution. PEG adversely affects both phase separation and aggregate 
formation in solution, while, Sucrose has positive effect and reduces both phase separation 
temperature for DVD-Ig
TM
 protein as well as percent aggregates in solution. However, the 
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mechanism by which these different excipients exert their effect (positive or negative) on 
aggregation and LLPS is different. Though, no aggregate formation was observed at 4 ºC, 
where solution exhibited phase separation, 20 ºC data suggests that aggregate formation is 
accelerated on phase separation. Temperature plays a dominant role in both, liquid-liquid 
phase separation and formation of soluble, irreversible aggregates in solution. 
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8. Figures 
 
 
Figure 1: (a) Percent soluble aggregates and (b) fragmentation observed for DVD-Ig
TM 
protein stored at 4 ºC in the presence and absence of excipients, at t=0, 7, 21 and 45 days. 
Samples were analyzed at a concentration of 1 mg/mL. Percent aggregates were calculated 
by SE-HPLC using Chemstation software. All solutions were prepared in pH 6.6 Histidine 
buffer with ionic strength of 15 mM. All samples were analyzed at 25 ± 1 ºC in duplicate. 
Mobile Phase: 100 mM sodium phosphate buffer at pH 7 containing 200 mM sodium sulfate. 
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Figure 2: (a) Percent soluble aggregates and (b) fragmentation observed for DVD-Ig
TM
 
protein stored at 20 ºC in presence and absence of excipients, at t=0, 7, 21 and 45 days 
Samples were analyzed at a concentration of 1 mg/mL. Percent aggregates were calculated 
by SE-HPLC using Chemstation software. All solutions were prepared in pH 6.6 Histidine 
buffer with ionic strength of 15 mM. All samples were analyzed at 25 ± 1 ºC in duplicate. 
Mobile Phase: 100 mM sodium phosphate buffer at pH 7 containing 200 mM sodium sulfate. 
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Figure 3: (a) Percent soluble aggregates and (b) fragmentation observed for DVD-Ig
TM
 
protein incubated at 40 ºC in presence and absence of excipients, at t=0, 7, 21 and 45 days. 
Samples were analyzed at a concentration of 1 mg/mL. Percent aggregates were calculated 
by SE-HPLC using Chemstation software. All solutions were prepared in pH 6.6 Histidine 
buffer with ionic strength of 15 mM. All samples were analyzed at 25 ± 1 ºC in duplicate. 
Mobile Phase: 100 mM sodium phosphate buffer at pH 7 containing 200 mM sodium sulfate. 
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Figure 4: Plot of Intensity as a function of temperature for DVD-Ig
TM
 protein at a 
concentration of 34 mg/mL determined from Light scattering in presence and absence of 
excipients. Stock solutions of PEG 400, Sucrose and Tween 80 were prepared in histidine 
buffer at pH 6.6 with ionic strength of 15 mM and then diluted appropriately to obtain final 
concentrations of 10 % PEG, 10% Sucrose and 0.01% Tween. Tonset (temperature marking 
onset of aggregation) is indicated by arrows (1-Buffer, 2-PEG, 3-Tween and 4- Sucrose). Plot 
represents averages of intensity measured at all conditions in duplicate. 
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Figure 5: Plot of Tcloud (primary axis) for DVD-Ig
TM
 protein at a concentration of 16 mg/mL 
determined from Temperature studies and kD (secondary axis) determined from Dynamic 
light scattering in presence and absence of excipients. Stock solutions of PEG, Sucrose and 
Tween were prepared in histidine buffer at pH 6.6 with ionic strength of 15 mM and then 
diluted appropriately to obtain final concentrations of 10 % PEG, 10% Sucrose and 0.01% 
Tween. Tcloud is termed as the temperature where percent transmittance is 70. kD is obtained 
from slope/intercept of the linear plot of mutual diffusion coefficient (Dm) against protein 
concentration. Light scattering measurements were made at 25 ± 0.1˚C. All solutions were 
analyzed in duplicate. Error bars if not visible are smaller than the symbols used. 
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Figure 6: (a) Concentration of protein in protein-poor phase for DVD-Ig
TM
 protein sample 
stored at 4°C for 45 days and (b) Percent monomer loss for DVD-Ig
TM
 protein after sample 
was incubated at 40 °C for 45 days, as a function of different excipients. Initial protein 
concentration was maintained at 33 mg/mL in pH 6.6 Histidine buffer with ionic strength of 
15 mM. Interaction parameter, kD, (dashed line) obtained from Dynamic light scattering at 25 
°C is plotted on first secondary axis and Tcloud (solid line) measured at similar solution 
conditions at a concentration of 16 mg/mL is plotted on second secondary axis. All solutions 
were analyzed in duplicate. Error bars if not visible are smaller than the symbols used. 
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Chapter 6 
 
Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of 
Size, Electroviscous Effect and Protein-Protein Interactions 
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1. Abstract 
Purpose: Increased solution viscosity results in difficulties in manufacturing and delivery of 
therapeutic protein formulations, increasing both the time and production costs, and leading 
to patient inconvenience. The solution viscosity is affected by the molecular properties of 
both the solute and the solvent. The purpose of this work was to investigate the effect of the 
size, charge and protein-protein interactions on the viscosity of Dual Variable Domain 
Immunoglobulin (DVD-Ig
TM
) protein solutions. 
 
Method: The effect of size of the protein molecule on solution viscosity was investigated by 
measuring intrinsic viscosity and excluded volume calculations for monoclonal antibody 
(mAb) and DVD-Ig
TM 
protein solutions. The role of the electrostatic charge resulting in 
electroviscous effects for DVD-Ig
TM
 protein was assessed by measuring zeta potential. Light 
scattering measurements were performed to detect protein-protein interactions affecting 
solution viscosity as a function of formulation factors.  
 
Results: DVD-Ig
TM
 protein exhibited significantly higher viscosity compared to mAb. 
Intrinsic viscosity values and excluded volume calculations indicated that the size of the 
molecule affects solution viscosity significantly at higher concentrations, while the effect was 
minimal at intermediate concentrations. Electroviscous contribution to the viscosity of DVD-
Ig
TM
 protein varied depending on the presence or absence of ions in the solution. In buffered 
solutions, negative kD and B2 values indicated the presence of attractive interactions which 
resulted in high viscosity for DVD-Ig
TM
 protein at certain pH and ionic strength conditions. 
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Conclusion: Results show that more than one factor contributes to the increased viscosity of 
DVD-Ig
TM
 protein and interplay of these factors modulates the overall viscosity behavior of 
the solution, especially at higher concentrations.   
 
Keywords: monoclonal antibody, bispecific antibody, excluded volume, charge, hydration, 
protein formulation 
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2. Introduction 
Monoclonal antibodies (first-generation) and their derivatives (second-generation) are 
ever growing class of bio-therapeutics and have been successfully implemented in the 
treatment of several terminal diseases.
1,2
 For better patient compliance, these proteins are 
generally administered by the subcutaneous route, preferably in pre-filled syringes; however, 
SC administration has a low volume restriction of <1.5 mL. This combined with the lower 
potency and high dose requirements make it necessary for the therapeutic proteins to be 
formulated at higher concentrations. High viscosity is often observed for high concentration 
formulations. Viscous protein formulations result in difficulties in manufacturing processes 
such as pumping, filtration, recovery of the product from the vessels, leading to the increased 
time and production costs. In preformulation development process, high viscosity hinders the 
biophysical characterization of proteins in solution.
3-5
 Viscous solutions also require higher 
injection forces to deliver the formulation through pre-filled syringe resulting in patient 
inconvenience.
6,7
 
Viscosity of a macromolecular solution can be expressed as a virial expansion,
8
  
                                        
𝜂𝑠𝑝
𝑐
= ([𝜂] + 𝑘1[𝜂]
2𝑐 + 𝑘2[𝜂]
3𝑐2 + 𝑘3[𝜂]
4𝑐3 + ⋯                              (1) 
where, 𝜂𝑠𝑝 is the specific viscosity (𝜂𝑠𝑝=1-ƞ/ƞ0, ƞ is the solution viscosity and η0 is the 
solvent viscosity), [𝜂] is the intrinsic viscosity, c is the solute concentration, k1 k2, k3 are 
higher order virial coefficients. In dilute solution, higher order terms are neglected and 
intrinsic viscosity is the only contributor to the solution viscosity. Excluded volume effect 
(crowding in solution)
9,10
 also includes contribution from the intrinsic viscosity, which is 
mainly due to the size of the molecule,
11,12
 and results in a significant increase in solution 
viscosity at high concentrations. 
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Charge on the protein molecule is another major factor contributing to the viscosity 
due to the electroviscous effect. Protein carries a net positive or negative charge at pH 
conditions below or above its pI. Electroviscous effect is the overall contribution of three 
effects; primary, secondary and tertiary effect. Primary effect is due to the presence of diffuse 
double layer around the protein molecule. Secondary effect is essentially due to the 
intermolecular repulsions between the two double layers. Tertiary effect is the change in the 
effective shape of the macromolecule due to the repulsive forces. These three effects result in 
increased drag on the molecule in solution causing increased viscosity.
13-15
 
Viscosity shows an exponential increase with concentration due to the contribution of 
higher order terms in equation 1 and can be attributed to increased tendency of the molecules 
to interact with each other (self-associate), due to specific and/or non-specific interactions in 
solution.
16-21
 Asymmetric charge distribution/anisotropy on the molecule significantly affects 
its dipole-multipole and has been reported to increase viscosity for mAbs due to increased 
self-association between the molecules.
20,22,23
 Viscous behavior of the solution due to non-
specific protein-protein interactions (electrostatic, charges, dipole-mediated) can be 
modulated by changing the pH and ionic strength of the solution and has been extensively 
reported in the literature.
16-18,22,24-26
 Hydrophobic salts
27,28
 and certain solvents (DMSO, 
DMA)
29
 that disrupt the transient network between protein molecules, which is due to 
hydrophobic interactions, have also been shown to significantly diminish solution viscosity. 
Similarly, amino acids and their derivatives have been reported to effectively reduce 
viscosity of monoclonal antibody solutions at high concentrations by specifically interacting 
with protein molecules.
16,30-32
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Investigating factors resulting in increased viscosity for protein solutions (especially 
mAbs) has been a subject of interest for over a decade, and several models have been 
proposed to predict the viscosity behavior or underline the cause for increased viscosity at 
higher concentrations. However, the assumptions made for these models do not fit to all 
molecules, which are becoming a challenge especially with the advent of newer molecules 
which show increased asymmetry in shape, charge distribution, surface hydrophobic patches 
and larger size.
23,33,34
 DVD-Ig
TM
 protein is a bispecific antibody-like molecule, where 
variable domains of a mAb are linked to the variable domain of a second mAb making it 
specific for dual targeting. Increased size of the molecule in comparison to mAb is 
hypothesized to increase the formulation related difficulties for DVD-Ig
TM
 protein including 
increased viscosity. The purpose of the current study was to investigate and rank-order the 
effect of, the size of the molecule with respect to the excluded volume effect, charges on the 
molecule resulting in the electroviscous effects and contribution of attractive protein-protein 
interactions on viscosity of DVD-Ig
TM
 protein solutions.  
 
3. Material and Methods 
3.1. Materials 
Dual Variable Domain Immunoglobulin, DVD-Ig
TM
 protein (pI ~7.5) as 85 mg/mL 
solution and monoclonal antibody, mAb (pI ~6.5) as 65 mg/mL solution in 15 mM Histidine 
buffer at pH 5.5 was supplied by Abbvie (Worcester, MA). Histidine base and histidine 
hydrochloride were obtained from Sigma (St. Louis, MO). Sodium chloride was obtained 
from Fisher Scientific (Fair Lawn, NJ). All chemicals used were reagent grade or higher. 
Solutions were prepared with deionized water equivalent to Milli-Q
TM
. 
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Histidine buffer was prepared to maintain pH of the solution at 5.1, 6.1, 6.6 and 7.1, 
and appropriate buffer strength was selected so as to maintain ionic strength at 15 mM 
without addition of any salt. Sodium chloride was added to adjust the ionic strength to 50 
mM. To prepare salt-free solutions (0 mM), proteins were extensively dialyzed in water in 
dialysis cassette over a period of 24 hrs. All antibody solutions were buffer exchanged with 
appropriate buffers using Millipore (Billerica, MA) Amicon Ultra centrifugation tubes with a 
molecular weight cutoff of 10 kDa obtained from Fisher Scientific. Concentrations of the 
samples were determined using a UV-vis spectrophotometer with an extinction coefficient of 
1.4 mg
-1
/mL
-1
cm
-1 
for mAb and 1.5 mg-1/mL
-1
cm
-1
 for DVD-Ig
TM
 protein at 280 nm for 
0.1% (w/v) IgG solutions. The pH of all the above solutions was within ± 0.1 of the target 
values as measured by a Denver Instrument pH meter.  
 
3.2. Viscosity Measurements  
Viscosity measurements were performed using VISCOlab 500 viscometer system 
(Cambridge Viscometer, Medford, MA) in which a piston is propelled repeatedly through the 
sample chamber by a controlled magnetic field. Average time travelled by the piston then 
measures the viscosity of the sample. Pistons measuring viscosity in the range of 0.5–5.0, 
2.5–50 and 5–100 cP were calibrated using appropriate standards. A sample volume of 70 μL 
was used and the temperature was precisely controlled at 25 ± 0.1˚C by a peltier plate. All 
the samples were analyzed in duplicate and the sample chamber was thoroughly cleaned with 
double distilled water and dried with nitrogen before each measurement.  
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3.3. Intrinsic/Reduced Viscosity 
Intrinsic viscosity (or reduced viscosity) of the sample was measured using Malvern’s 
Viscotek  GPCmax assembly (Worcestershire, UK) connected to model 305 Triple Detector 
Array (TDA) with a 7˚ angle light scattering detector (LALS), a 90˚angle light scattering 
detector (RALS), a refractive index detector (RI, concentration detector set at 670 nm), and a 
four-capillary differential viscometer (DP). A stainless steel tubing coil of ~25ft was used 
between auto-injector and detector for viscosity measurements. Buffer in which intrinsic 
viscosity was to be determined was used as the mobile phase; flow rate was maintained at 0.8 
mL/min and runtime at 15 min. All the injections were made in duplicate and temperature 
was controlled at 25 ± 1˚C. OmniSEC software program was used for the acquisition and 
analysis of the Viscotek data. 
 
3.4. Zeta Potential Measurements  
Zeta potential measurements were performed using Malvern Zetasizer Nano Series 
(Worcestershire, UK). Dip cell (ZEN1002) and a glass cuvette assembly was used to make 
the measurements that required a sample volume of 800 μL. Measurements were made in 
duplicate at 25 ± 0.1 ˚C, and at concentrations of 4 mg/mL and 2 mg/mL for mAb and DVD-
Ig
TM
 protein, respectively. Zeta potential is calculated from electrophoretic mobility using 
Henry’s equation,  
𝜇𝐸 =
2𝜀𝜉𝑓1(𝜅𝑎)
3𝜂
                                                                             (2) 
where, 𝜇𝐸 is the electrophoretic mobility under the applied voltage, ε is the dielectric 
constant or the permittivity of the medium, η is the viscosity of the dispersant, ξ is the zeta 
potential in Volts and 𝑓1(𝜅𝑎) is the Henry’s function. Value of 𝑓1(𝜅𝑎) depends upon the 
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ratio of the radius of curvature (a) to the thickness of the electrical double layer around the 
particle (𝜅). For zeta potential measurements in this study Smoluchowski approximation of 
1.5 was used.
35
  
 
3.5. Dynamic Light Scattering (DLS) 
DLS studies were performed using a Malvern Instrument’s Zetasizer Nano Series. A 
detailed procedure and experimental set-up is similar to our previous studies.
36
 Malvern’s 
DTS software was used to analyze the acquired correlogram (correlation function vs. time) 
and obtain the mutual diffusion coefficient (Dm). Self-diffusion coefficient (Ds) and 
interaction parameter (kD) were then calculated from the measured Dm using following 
relation,                                                    
                                         𝐷𝑚 = 𝐷𝑠(1 + 𝑘𝐷𝑐 + 𝑘2𝐷𝑐
2 + 𝑘3𝐷𝑐
3 + ⋯ )                                           (3) 
c is the concentration of the protein (g/mL).
37
 In dilute solution higher order terms are 
neglected and linear plot of Dm as a function of concentration can be used to determine Ds 
and kD from intercept and slope respectively.
38
  
 
3.6. Static Light Scattering (SLS) 
SLS studies were conducted at 25 ± 0.1˚C using a Malvern Instrument’s Zetasizer 
NanoS to determine B2, which signifies first deviation from ideality.
39
 Sample preparation 
and experimental steps were similar to those used for DLS. A detailed procedure to obtain 
correct SLS parameters using a Malvern Zetasizer is discussed elsewhere.
40
 The average 
scattered intensities were used to calculate B2 by constructing the Debye plot according to the 
following equation,
41
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𝐾𝑐
𝑅𝜃
=
1
𝑀𝑤
+ 2𝐵2𝑐 + 3𝐵3𝑐 
2 + 4𝐵4𝑐 
3 + ⋯                                    (4) 
where,  K is the optical constant given by 
𝐾 =
[2𝜋𝜂 (
𝑑𝜂
𝑑𝑐)]
2
𝑁𝐴𝜆0
4                                                                                (5) 
In the above equation, Rθ is the excess Rayleigh ratio, i.e., a measure of light scattered by the 
solute, η is the solvent refractive index, dη/dc is the refractive index increment of the solute, 
NA is the Avogadro number, and λ0 is the wavelength of the incident light.  
 
4. Results and Discussion  
Several factors contribute to the increased viscosity of a therapeutic protein 
formulation, and understanding the effect of these factors is necessary to develop a solution 
with minimal viscosity. The effect of the size of the protein molecule taking into account the 
excluded volume effect, protein-protein interactions and charges on the proteins as a function 
of solution conditions on the increased viscosity of DVD-Ig
TM
 protein was investigated in 
this study. All these factors are inter-related, and changing certain conditions can positively 
impact one factor, while negatively affecting the other. For example, increasing charges on 
the protein molecule can increase the repulsive interactions or decrease the attractions 
between the molecules; however, they can still result in increased viscosity because of the 
electroviscous effect. Hence, rank-ordering these factors can provide valuable information on 
how to approach the high viscosity problem for protein formulations.  
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Viscosity Measurements 
Viscosity for mAb and DVD-Ig
TM
 protein solutions was analyzed for samples 
prepared in water and buffer. Samples dialyzed in water are also referred to as 0 mM ionic 
strength solution or salt-free solutions; pH of the solution was measured to be pH 6.1 ± 0.1. 
Figure 1 show viscosity profiles of mAb and DVD-Ig
TM
 protein as a function of 
concentration at pH 6.1 at 0 mM (water) and at 15 mM ionic strength (30 mM histidine 
buffer). Compared to mAb, DVD-Ig
TM
 protein exhibited significantly higher viscosity which 
increased sharply with increasing concentration. For both the molecules higher viscosity was 
observed at 0 mM (solid line), which decreases as the ionic strength was increased to 15 mM 
(dashed line).  
 
4.1. Size of the Protein Molecule 
DVD-Ig
TM 
protein is a bispecific antibody-like molecule with an additional variable 
domain resulting in increased size and asymmetry with respect to mAb. This increase in the 
size of the molecule can result in an inherent increase in the viscosity as observed in Figure 1 
and was investigated further by measuring intrinsic viscosity and hydrodynamic size of the 
molecule. 
 
4.1.1. Reduced/ Apparent Intrinsic Viscosity 
Intrinsic viscosity [𝜂] is the intrinsic volume contribution of the dissolved or 
dispersed solute to viscosity of the solution. It is the property of the shape and size/hydration 
of the protein molecule and can be represented as;
42
  
                                                                    [𝜂] = 𝜈. 𝑉𝑠                                                                            (6) 
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where, 𝜈 is the Simha shape parameter43 and Vs indicates the size or hydrated or swollen 
volume. Intrinsic viscosity is usually determined by linear extrapolation of reduced viscosity 
(ηred) or inherent viscosity (ηinh) to zero concentration. It can also be directly determined 
using single point determination methods (Viscotek) at extremely dilute conditions.
44,45
 From 
Figure 2a, reduced viscosity for DVD-Ig
TM
 protein determined from Viscotek increases with 
increasing concentrations (up to 1.0 mg/mL) and is significantly higher for 1.0 mg/mL; hence 
is not the true intrinsic viscosity for the solution. Further lower concentrations could not be 
analyzed due to low signal to noise ratio.  
For comparative analysis, reduced viscosity at 1.0 mg/mL is considered as the 
apparent intrinsic viscosity [η]app, and is plotted in Figure 2b at 0 and 15 mM ionic strength 
for mAb and DVD-Ig
TM
 protein. Viscosity obtained from extrapolation to c→0 for mAb and 
DVD-Ig
TM
 protein (from Figure 2a) at 0 mM ionic strength is also plotted in Figure 2b as 
extrapolated intrinsic viscosity ([η]exp). At 0 mM ionic strength, [η]exp for DVD-Ig
TM
 protein 
is higher (9.97 mL/g) than for mAb (6.2 mL/g), indicating that the size and shape of the 
molecule is larger for DVD-Ig
TM
 protein. Similar trend is observed at 15 mM ionic strength, 
where [η]app for DVD-Ig
TM
 protein and mAb is 8.65 mL/g and 5.9 mL/g, respectively. The 
intrinsic viscosity value obtained for mAb is around 6.0 mL/g and is similar to the values 
reported in the literature.
19,22
 There are no reports for viscosity or intrinsic viscosity values 
for DVD-Ig
TM
 protein in the literature. At 0 mM ionic strength, non-ideality of the DVD-
Ig
TM
 protein solution even at low protein concentration of ~1.0 mg/mL was observed from 
both reduced viscosity measurements (Figure 2a) as well as light scattering measurements 
(Figure 4), while 15 mM ionic strength solutions are fairly linear over a higher concentration 
range. For intrinsic viscosity measurements (by linear extrapolation or single point method), 
189 
 
ideality of the solution is a required condition and none of the available techniques are 
sensitive enough to measure the true intrinsic viscosity of the protein in water due to its non-
ideal behavior even at extremely dilute conditions. The intrinsic viscosity values obtained at 
15 mM, for both mAb and DVD-Ig
TM
 protein, are used for further analysis.  
Shape parameter presented in equation 6 is 2.5 for spherical particles
11
 and values 
larger than 2.5, indicate increased asymmetric shape of the macromolecule. mAb is an 
asymmetric molecule due to its Y-like shape and has larger intrinsic viscosity (~6 mL/g)
19,22
 
than globular proteins which are spherical in shape. DVD-Ig
TM
 protein, exhibits further 
increased asymmetry compared to mAb due to the additional variable domain, and can 
further result in increased intrinsic viscosity of the molecule, which is around ~8.7 mL/g 
(Figure 2b). Intrinsic viscosity measurements ([η]app and [η]exp) at both the conditions (0 mM 
and 15 mM ionic strength) indicate that the inherent contribution of DVD-Ig
TM
 protein to the 
overall solution viscosity is higher than mAb due to both its increased size (hydration) as 
well as increased asymmetry.  
 
4.1.2. Hydrodynamic Radius 
Hydrodynamic diameter (dH) for mAb and DVD-Ig
TM
 protein solutions was 
calculated from self-diffusion coefficient (Ds), using the Stokes–Einstein equation; 
𝐷𝑠 =
𝑘𝑇
3𝜋𝜂 𝑑𝐻
                                                                                     (7) 
where, k is the Boltzmann constant, T is the absolute temperature, and η is the solution 
viscosity.  
Ds is obtained from the intercept of a linear plot of mutual diffusion coefficient (measured 
using Dynamic light scattering) against concentration. Values for Ds and hydrodynamic 
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diameter (dH) at different solution conditions are compiled in Table 1. Hydrodynamic 
diameter (dH) in the salt-free solutions are lower than in buffered solutions due to non-
linearity at low concentrations (linear and polynomial fit will be discussed in the next 
section). At 15 mM ionic strength, dH for DVD-Ig
TM
 protein is ~14 nm and is larger than that 
for mAb, which is ~11 nm, indicating that as the size of the molecule increases, protein 
diffuses slowly resulting in the increased drag in the solution, increasing its viscosity.  
 
4.1.3. Excluded Volume Effect 
Excluded volume or crowding in protein solutions results in a significant contribution 
to the increased viscosity at higher concentrations. Excluded volume (volume of the solution 
not available to another molecule) is roughly calculated as 6.7 times the molecular volume of 
an equivalent sphere (taking into account surface roughness).
46
 Assuming, mAb (rmAb ~ 5.5 
nm) and DVD-Ig
TM
 protein (rDVD ~ 7 nm) represent equivalent spheres, ratio of the excluded 
volume contribution can be represented as, 
𝑉𝑒𝑥,𝑚𝐴𝑏
𝑉𝑒𝑥,𝐷𝑉𝐷
=  
𝑟𝑚𝐴𝑏
3
𝑟𝐷𝑉𝐷
3 = 0.54                                                                     (8) 
Assuming only hard-sphere interactions are present in protein solutions at higher 
concentrations, from equation 8, excluded volume by itself results in roughly twice the 
contribution to the viscosity for DVD-Ig
TM
 protein than mAb. 
The contribution of excluded volume to viscosity of the protein solutions was further 
evaluated using the modified Ross and Minton equation, which includes the concentration 
effect on molecular crowding and intrinsic viscosity;
19
 
𝜂𝑖𝑛ℎ =
𝑘
𝜈
[𝜂]𝑙𝑛(𝜂𝑟𝑒𝑙) + [𝜂]                                                           (9)      
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where, 𝜂𝑖𝑛ℎ (𝜂𝑖𝑛ℎ  =𝜂𝑟𝑒𝑙/c)is the inherent viscosity, k is the crowding factor, 𝜈 is the shape 
parameter, [η] is the intrinsic viscosity and 𝜂𝑟𝑒𝑙 (𝜂𝑟𝑒𝑙=ƞ/ƞ0) is the relative viscosity of the 
solution. A linear plot of 𝜂𝑖𝑛ℎ against 𝑙𝑛(𝜂𝑟𝑒𝑙) indicates only excluded volume contribution 
to the viscosity and deviation from linearity indicates that interactions other than excluded 
volume are present in the solution resulting in increased viscosity. A curvature with 
increasing concentration indicates that the slope is changing either due to change in shape 
factor (due to increased asymmetry or self-association) or increased crowding in the 
solution.
19,47
  
The intrinsic viscosity value of 8.7 mL/g, determined from Viscotek measurements 
(Figure 2b), was used for calculations of inherent viscosity for DVD-Ig
TM
 protein. Simha 
shape parameter (𝜈) for sphere is 2.5; as the asymmetry of the molecule increases, ν deviates 
from 2.5.
42,43
 Crowding factor (k) varies from 1.35 to 1.91 and represents the inverse of 
maximum packing density (Φ) which is usually between 0.52-0.74 (0.74 being maximum for 
spherical particles).
48
 The k/𝜈 ratio are varied from 0.2 to 0.5 to take into account change in 
shape and/or crowding in the solution. Figure 3a shows calculated relative viscosity for 
DVD-Ig
TM
 protein only due to excluded volume contribution using Equation 9. An 
exponential increase in the relative viscosity was observed at higher k/𝜈 ratio (0.5) at higher 
concentrations. Relative viscosity was also calculated for mAb ([η] = 5.9 mL/g) at highest 
k/𝜈 value (0.5) and compared with relative viscosity of DVD-IgTM protein (Figure 3b). 
Excluded volume contribution to relative viscosity for DVD-Ig
TM
 protein is higher than that 
for mAb, however, this significant difference in viscosity is observed at concentration >100 
mg/mL. Relative viscosities are less than 5 cP (Figure 3b inset) in the lower concentration 
range (< 100 mg/mL) where measured viscosities of the two proteins are compared in Figure 
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1. This indicates that though the size of the molecule is an important factor contributing to 
the solution viscosity, its effect is significant only at higher concentrations, and increased 
viscosity of DVD-Ig
TM
 protein is due to the contribution from additional factors/forces in the 
solution.  
 
4.2. Electroviscous Effect 
Charges regulate the electroviscous effect, which are repulsive interactions in 
solution, and influence the viscosity behavior especially at pH conditions away from the pI of 
the molecule. High viscosity at 0 mM was observed for both mAb and DVD-Ig
TM
 protein, 
which decreased on increasing the ionic strength. This can be attributed to the electroviscous 
effects in solution and was investigated further by measuring zeta potential of the molecule 
and interactions in the solution.  
 
4.2.1. Lights Scattering 
Second virial coefficient (B2) and interaction parameter (kD) determined from Static 
and Dynamic Light scattering, respectively, are routinely used to characterize the nature of 
intermolecular interactions in dilute solutions. Correlation between viscosity and protein-
protein interactions measured by light scattering is well documented in the 
literature.
18,21,24,25,49-51
 A positive B2 indicates repulsive interactions in solution, while a 
negative B2 indicates attractive interactions. The interaction parameter, kD is represented as,  
𝑘𝐷 = 2𝐵2𝑀𝑤 − (𝜁1 + 2𝜈𝑠𝑝)                                                                      (10) 
where, 𝜁1is the coefficient of the linear term in the virial expansion of the frictional 
coefficient as a function of solute concentration and νsp is the partial specific volume of the 
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solute. kD has contributions from both the thermodynamic (B2) and hydrodynamic (𝜁1 +
2𝜈𝑠𝑝) parameters. Similar to B2, a positive kD implies repulsive interactions and a negative kD 
implies attractive intermolecular interactions in solution. There is a small range of negative 
kD values where interactions are repulsive in nature, i.e., hydrodynamic contribution is larger 
than the thermodynamic contribution. 
Figure 4a shows a plot of scattering intensity measured as Kc/Rθ against concentration 
(Static light scattering) and Figure 4b shows a plot of Dm or mutual diffusion coefficient 
against concentration (Dynamic light scattering) for mAb and DVD-Ig
TM
 protein at 0 and 15 
mM ionic strengths. Both, mAb and DVD-Ig
TM
 protein molecules show positive slopes at 0 
mM indicating repulsive interactions, while 15 mM ionic strength solutions show negative 
slopes indicating attractive interactions.  
At 0 mM, DVD-Ig
TM
 protein has a larger positive slope compared to mAb, indicating 
stronger repulsive interactions. Slopes for both mAb and DVD-Ig
TM
 protein show non-
linearity with increasing concentration (in the range of 2-10 mg/mL). At this condition, 
higher order terms dominate as represented in equations 3 and 4 (for DLS and SLS, 
respectively) and cannot be neglected. A linear plot of intensity (SLS) or mutual diffusion 
coefficient (DLS) is a required condition for the calculation of protein-protein interactions 
(kD and B2) and other parameters (Mw, Ds, rH) from light scattering. Therefore, all the 
parameters measured from Static and Dynamic light scattering studies, considering both 
linear part (in low concentration range) and polynomial fit (over the entire concentration 
range) were calculated and are summarized in Table 1. For both the molecules, values 
obtained from linear fit and polynomial fit are in close agreement. Both kD and B2 values for 
DVD-Ig
TM
 protein are roughly three times larger than for mAb at 0 mM ionic strength. At 15 
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mM ionic strength, the slopes are negative for both the molecules, but the difference in the 
attractive interactions is not as significant as that observed at 0 mM ionic strength.  
 
4.2.2. Zeta Potential Measurements and Charge Calculations 
Effective charge on the molecule is calculated from the measured zeta potential 
values (𝜉) using linearized Poisson–Boltzmann equation, also known as the Debye–Huckel 
approximation, assuming an equivalent sphere,
35
 
𝑧 =
4𝜋𝜀𝑎(1 + 𝜅𝑎)𝜉
𝑒
                                                                           (11) 
where, e is the electronic charge, a is the particle radius and 𝜅 is the inverse Debye length. 
Radius “a” is substituted by rH or hydrodynamic radius for equivalent sphere calculated from 
Ds (self-diffusion coefficient), using Stokes-Einstein equation (eq 7). The inverse Debye 
length, 𝜅, is related to the square-root of the ionic strength of the solution; on increasing ionic 
strength, 𝜅 decreases, thereby reducing the effective charge on the molecule. For calculation 
purposes, 0 mM solution is considered to have an ionic strength of 0.1 mM. 
Figure 5 shows a plot of measured zeta potential values for mAb and DVD-Ig
TM
 
protein at 0 mM and 15 mM ionic strength at pH 6.1. The isoelectric point (pI) for the mAb 
molecule is 6.5 and for DVD-Ig
TM
 protein is around 7.0-7.5. The zeta potential values for 
mAb and DVD-Ig
TM
 protein are similar at 0 mM (~16.5 mV). However, the effective charge 
values are significantly higher for DVD-Ig
TM
 protein (116 Z) than mAb (87 Z), as the 
Poisson Boltzman equation (eq 11) takes into account the size (hydrodynamic radius) of the 
protein molecule which is larger for DVD-Ig
TM
 protein (~7 nm) compared to mAb (~5.5 nm). 
Higher the charge associated with the molecule, larger will be the hydration and hence strong 
repulsive interactions as indicated by large positive kD and B2 values (Figure 4) at 0 mM. At 
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15 mM ionic strength, zeta potentials are positive for both the molecules, and DVD-Ig
TM
 
protein has higher value than mAb, 4.9 mV and 2.2 mV, respectively. On increasing the ionic 
strength to 15 mM, charges on the molecule decrease significantly and interactions become 
attractive in nature, thereby, reducing the electroviscous effects and viscosity of the solution. 
High viscosity at 0 mM is due to the electroviscous effect, for both mAb and DVD-
Ig
TM
 protein solutions. Both, intrinsic viscosity values and hydrodynamic radius indicate 
increased size of DVD-Ig
TM
 protein compared to mAb. However, the excluded volume 
calculations show that the effect of the size of the molecule on viscosity is dominant only at 
higher concentrations (>100 mg/mL). At concentrations below 100 mg/mL, there may be 
additional contributions to the increased viscosity of DVD-Ig
TM
 protein compared to mAb 
and therefore the effect of pH and ionic strength was further studied. 
 
4.3. Protein-Protein Interactions- Formulation factors 
Formulation factors (pH, ionic strength, salt-type, excipients) significantly affect 
protein properties such as charges, dipoles, hydrophobic patches, etc., resulting in changes in 
physicochemical properties. The effect of pH and ionic strength was investigated on the 
solution viscosity (Figure 6) for DVD-Ig
TM
 protein and was correlated to zeta potential 
(Figure 7) at different pHs, intermolecular protein-protein interactions as measured by light 
scattering (Figure 8) and Tcloud (Figure 9). Detailed experimental procedure to determine 
Tcloud of a solution is described in Chapter 4. Briefly, percent transmittance for a sample is 
measured at 510 nm using UV-vis spectrophotometer as the temperature of the solution is 
lowered. In the current study, for comparative evaluation, temperature where percent 
transmittance reaches 70 is termed as Tcloud.
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4.3.1. Viscosity Measurements 
Figure 6 shows a plot of viscosity for DVD-Ig
TM
 protein as a function of 
concentration at different pHs and at ionic strength of 15 mM (solid line) and 50 mM (dotted 
line). At pH 5.1, viscosity values for DVD-Ig
TM
 protein are lower compared to the other pHs. 
Ionic strength has no effect on the viscosity at pH 5.1. At a lower ionic strength of 15 mM, 
viscosity values are significantly higher at pH conditions close to the pI of the molecule (pH 
6.1, 6.6 and 7.1). Viscosities of the protein do not change with change in the pH (within 
experimental error). On increasing the ionic strength to 50 mM, viscosity decreases 
compared to 15 mM at all pH conditions.  
 
4.3.2. Interactions in DVD-IgTM Solutions 
Figure 7 shows a plot of zeta potential for DVD-Ig
TM
 protein as a function of pH at 
15 mM ionic strength. Molecules carry a net positive charge at all pH conditions studied. At 
pH 5.1, molecules have a higher zeta potential value (+8.76 mV) which decreases gradually 
as the pH is adjusted close to the pI of the molecule (~7.0-7.5). At pH 7.1, though the 
molecules have low zeta potential value (+1.30 mV), there is no crossover to negative values; 
pI of the molecule is above pH 7.1. 
Figures 8a and 8b shows plots of interactions measured as B2 and kD in dilute solution 
for DVD-Ig
TM
 protein as a function of pH at ionic strength of 15 mM (solid line) and 50 mM 
(dashed line). B2 and kD show similar trends with changing solution conditions. Interactions 
in solutions were also assessed by measuring Tcloud of the solution as a function of pH and 
ionic strength and are plotted in Figure 9a and 9b for 16 and 60 mg/mL protein 
concentrations, respectively. In our previous studies, we have established a good correlation 
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between shifts in Tcloud (temperature that marks the onset of liquid-liquid phase separation in 
solution) and change in attractive interactions with change in solution conditions; low Tcloud 
values indicate weak attractive interactions in solution, while high Tcloud values indicate 
strong attractions in solution (Chapter 4). The change in Tcloud with change in pH and ionic 
strength is consistent at both 16 and 60 mg/mL protein concentration; Tcloud values at 60 
mg/mL are slightly higher than at 16 mg/mL. 
At pH 5.1, which is away from the pI of the molecule, viscosity is minimal compared 
to other pH conditions and is not affected by the ionic strength. Zeta potential measurement 
indicate presence of significant effective charge on the molecule at 15 mM ionic strength, 
which results in repulsion as indicated by positive kD and B2 values (B2= +1.28*10
-4 
mol.mL/g
2
, kD= +6.38 mL/g). On increasing the ionic strength to 50 mM, negative B2 and kD 
values indicate weak attractive interactions in solution (B2= -0.27*10
-4 
mol.mL/g
2
, kD=-11.08 
mL/g) and can be attributed to charge shielding at high ionic strength. However, these 
attractive interactions are not strong enough to have any significant effect on solution 
viscosity. At low ionic strength, high charge and repulsive interactions indicate 
electroviscous effect in solution, which decreases on increasing the ionic strength. However, 
contribution from electroviscous effect to the overall solution viscosity is not as significant 
(compared to other pHs) and is opposite to our previous observation of high viscosity in salt-
free solutions/0 mM ionic strength at pH 6.1 (Figure 1). This contradiction in the 
electroviscous contribution to the viscosity of DVD-Ig
TM
 protein in presence and absence of 
ions will be discussed later. 
At pH 6.1, 6.6 and 7.1, there is no change in viscosity with change in pH of the 
solution at both 15 mM and 50 mM ionic strength (Figure 6); however, DVD-Ig
TM
 protein 
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has significant attractive interactions as seen from light scattering measurements (Figure 8). 
At pH 6.1, attractive interactions are present, which do not change with ionic strength (B2= ~-
1.1*10
-4 
mol.mL/g
2
, kD=~-35 mL/g). At pH 6.6 and 15 mM ionic strength, interactions are 
strongly attractive compared to the other pH conditions as indicated by larger negative B2 and 
kD values (B2= -2.3*10
-4 
mol.mL/g
2
, kD=-61.46 mL/g) and decreases at 50 mM ionic strength. 
Similar trend is observed at pH 7.1, where attractive interactions decrease on increasing the 
ionic strength. At 50 mM ionic strength, significant attractive interactions are present in the 
solution and are almost similar in magnitude at pH 6.1, 6.6 and 7.1 (B2 ~ -1.0*10
-4 
mol.mL/g
2
). From Figure 9a and 9b, at pH 6.1, Tcloud shifts to higher temperatures on 
increasing the ionic strength indicating increased attractive interactions in solution. 
Hydrophobic interactions are the only short-range attractive interactions that become 
dominant as the ionic strength of the solution is increased, thereby increasing the Tcloud at pH 
6.1. Tcloud values and hence attractive interactions decrease at pH 6.6 and 7.1, on increasing 
the ionic strength from 15 to 50 mM. The decrease is more significant at pH 7.1 than at pH 
6.6, possibly due to the presence of significant dipoles on the molecule close to its pI (> pH 
7.1). In Chapter 4, we have discussed that both hydrophobic interactions and dipole-mediated 
interactions results in increased tendency of DVD-Ig
TM
 protein to undergo phase separation 
(hence indicating shifts in Tcloud). These attractive interactions also result in increased 
viscosity of DVD-Ig
TM
 protein solution and contribution of each type of interaction was 
investigated further. 
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4.3.3. Contribution of Dipole and Hydrophobic Interactions 
Charge-dipole interactions are mid-range (show r
-4
 distance dependence)
36,52,53
 and 
hence result in strong attractions even in dilute solutions as observed from light scattering. 
Increasing ionic strength decreases charge and dipolar interactions in solutions, while ionic 
strength has no effect on hydrophobic interactions. For further understanding the contribution 
of dipole and hydrophobic interactions, kD obtained from DLS is plotted against B2 obtained 
from SLS at different pH conditions and as a function of ionic strength (Figure 10). All 
samples prepared for viscosity measurements are in histidine buffer while, the DVD-Ig
TM
 
protein samples prepared at pHs where kD and B2 from DLS and SLS was determined (for 
Figure 10) are in different buffer systems (pH 5.1-acetate, pH 6.1-histidine, pH 6.6, 7.0 and 
8.1-phosphate buffer). Plots are linear at all three ionic strengths studied; 15 mM (♦), 50 mM 
(∆) and 150 mM (○). Slopes are fairly constant; however, the intercept for all the three 
conditions vary. From equation 10, a linear plot of kD vs. B2 gives 2Mw as the slope while the 
intercept represents the hydration parameter (ζ1+2 νsp). As the ionic strength is increased the 
hydration on the protein molecules decreases and the effect is significant from 15 mM (12.97 
units) to 50 mM (6.87 units), while on increasing the ionic strength further to 150 mM (5.22 
units), hydration decreases to lesser extent. At 150 mM, hydrodynamic contribution to kD 
decreases significantly compared to 15 mM, however the thermodynamic contribution results 
in overall attractive interactions in solution, which are hydrophobic in nature. 
Depending on the solution conditions, i.e., pH and ionic strength, contribution of 
these interactions changes; at pH 6.1 hydrophobic interactions are dominant, while at pH 7.1 
dipole interactions contribute significantly to the solution viscosity. At pH 6.6, both 
hydrophobic and dipole-charge mediated interactions are present in the solution. At low ionic 
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strength, more than one intermolecular protein interactions contribute to attractions and 
hence increased solution viscosity, while at high ionic strengths, where dipole and charge 
mediated interactions are shielded, hydrophobic interactions dominate solution viscosity.  
 
4.4. Electroviscous Effect in Presence and Absence of Ions 
Electroviscous effect contribution to the overall solution viscosity is opposite for 
DVD-Ig
TM
 protein at two different conditions; pH 6.1-0 mM ionic strength, where viscosity 
is significantly higher (Figure 1), and at pH 5.1- 15 mM ionic strength, where viscosity is 
minimal (Figure 6). Electroviscous effect at pH 6.1 (0 mM ionic strength) resulting in 
significantly high viscosity is also contradictory to the majority of the studies in the 
literature, where, the electroviscous effect contribution to the viscosity are significant only in 
relatively dilute solutions and contribution of attractive interactions to viscosity increases as 
protein concentration increases.
24,54
  
From light scattering studies, interactions are repulsive at both the conditions; 
however, kD and B2 in the buffered solutions at pH 5.1- 15 mM ionic strength (kD = + 5.90 
mL/g, B2= +0.64*10
-4 
mol.mL/g
2
) are lower than at pH 6.1- 0 mM ionic strength (kD = + 
1890 mL/g, B2= +63.5*10
-4 
mol.mL/g
2
). The measured zeta potential values at pH 5.1- 15 
mM ionic strength and at pH 6.1- 0 mM ionic strength are +8.76 mV and +16.7 mV, 
respectively. The pI of the molecule is in the range of pH 7.0-7.5; therefore, DVD-Ig
TM
 
protein should carry a higher positive charge (surface potential) at pH 5.1 than at pH 6.1. 
However, according to the double layer theory, the measured zeta potential (potential at the 
boundary of the slipping plane), which is influenced by the concentration and charge of ions 
in solution, is higher at low ionic strength than at high ionic strength (irrespective of the pH 
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of the solution).
41
 As previously described (Figure 10), hydrodynamic contribution in protein 
solution decreases on increasing the ionic strength. At pH 5.1 and 15 mM ionic strength, the 
presence of oppositely charged ions from buffer species results in the formation of a double 
layer associated with the molecule which gives rise to the primary electroviscous effect. The 
thickness of this double layer (also known as inverse Debye length) is inversely related to the 
square-root of the ionic strength of the solution and is ~2.5 nm at 15 mM ionic strength. 
While at 0 mM ionic strength, there is no double layer associated with the molecule. Hence, 
for salt-free solutions only OH
-
 and H
+
 species are associated with proteins which results in 
an extended field that is affected by the charge on the molecule, as compared to the double 
layer at 15 mM ionic strength which has a finite thickness. This in turn, results in structuring 
of the water molecules around the protein which significantly increases viscosity in the 
absence of ions. Results indicate that, though pH of the solution is an important factor that 
determines the presence of charges on the molecule, ionic strength has a more significant 
impact on hydration and hence the viscosity of the protein solution. 
 
4.5. Contributions of Individual Factors 
Viscosity is influenced by many factors, and the net effect involves interplay of these 
factors. Figure 11 provides an overview of the contribution of the dominant individual forces 
to the solution viscosity. For positive kD values, the electroviscous contribution is minimal in 
the presence of ions and it is maximum in the absence of ions. At pH 7.1, close to the pI of 
DVD-Ig
TM
 protein where kD values are negative, both the dipole-mediated interactions and 
hydrophobic interactions contribute to the attractive interactions, but as the ionic strength is 
increased from 15 to 50 mM the dipole contribution is significantly reduced and hydrophobic 
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contribution becomes dominant. The excluded volume contribution is always present in the 
solution; however, its effect on viscosity is minimal at lower concentrations (approximately 
100 mg/mL or less) compared to other forces. At higher concentrations, excluded volume 
contribution shows an exponential increase as seen in Figure 3a. Based on these studies, 
contribution from various factors to increased viscosity of DVD-Ig
TM
 protein can be rank 
ordered for solutions with protein concentrations of less than 100 mg/mL as: electroviscous 
effects in absence of ions > dipole-mediated attractive interactions>hydrophobic 
interactions> electroviscous effects in presence of ions>size of the molecule ~excluded 
volume effects. 
 
5. Conclusion  
DVD-Ig
TM
 protein shows higher viscosity compared to a monoclonal antibody 
molecule at similar solution conditions. Large size of the molecule inherently contributes to 
the increased viscosity due to larger intrinsic viscosity (also considering increased 
asymmetry of the molecule); however the size effects are significant only at higher 
concentrations. Protein molecules exhibit a unique behavior in absence of any ions or in 
water, where significantly high solution viscosity is due to high charge on the molecule and 
hydration. Ionic strength plays a dominant role in modulating solution viscosity for DVD-
Ig
TM
 protein than pH of the solution. Attractive protein-protein interactions also contribute 
significantly to increased viscosity of DVD-Ig
TM
 protein; contribution of dipole-mediated 
interactions is greater than hydrophobic interactions. However, interplay of more than one 
type of interactions at high concentrations contributes to the overall solution viscosity.  
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8. Table and Figure 
Table 1: Parameters measured from Dynamic and Static Light scattering using equation 3 
and 4, respectively, for mAb and DVD-Ig
TM
 protein. 
Parameter mAb DVD-Ig
TM
 
 
0 mM 
(linear fit) 
0 mM 
(polynomial 
fit) 
15 mM 
0 mM 
(linear 
fit) 
0 mM 
(polynomial 
fit) 
15 mM 
kD (mL/g) 592 650 -35 1890 2017 -35.8 
B2 *10
-4 
(mol.mL/g
2
) 
19.5 21.72 -1.92 63.5 70.3 -1.15 
Ds (cm
2
/s) 4.65 4.68 4.39 3.84 3.93 3.58 
dH (nm) 10.56 10.51 11.2 12.77 12.5 13.73 
Mw (KDa) 118 118 135 151 150 192 
kD :Interaction parameter, B2: second virial coefficient, Ds: self-diffusion coefficient, dH: Hydrodynamic 
diameter, Mw: Molecular weight 
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Figure 1: Relative viscosity of mAb (■) and DVD-IgTM protein (▲) as a function of protein 
concentration at 0 mM (solid line) and at 15 mM (dashed line) ionic strength at pH 6.1. All 
solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if not visible are smaller than the 
symbols used. 
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Figure 2: (a) Reduced viscosity of mAb and DVD-Ig
TM
 protein as a function of protein 
concentration at 0 mM ionic strength. (b) Reduced viscosity at a concentration of 1.0 mg/mL 
for mAb (dashed bars) and DVD-Ig
TM
 protein (closed bars) at 0 mM and 15 mM ionic 
strengths. The numbers on the bar represent the reduced viscosity values. [η]exp is the reduced 
viscosity extrapolated to c=0 (from Figure 2a) at 0 mM ionic strength. All solutions were 
analyzed at 25 ± 1˚C in duplicate. Error bars if not visible are smaller than the symbols used. 
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Figure 3: (a) Relative viscosity against concentration calculated from equation 9 for DVD-
Ig
TM
 protein. k/ν ratio was varied to account for change in shape and crowding parameter. (b) 
Calculated relative viscosity for mAb and DVD-Ig
TM
 protein plotted against concentration at 
a constant k/ν ratio of 0.5. Intrinsic viscosity values of 8.7 mL/g and 5.9 mL/g were used for 
mAb and DVD-Ig
TM
 protein, respectively. Inset shows relative viscosity up to concentrations 
of 100 mg/mL.    
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Figure 4: (a) Debye Plot and (b) Dm Plot for mAb (■) and DVD-Ig
TM
 protein (▲) as a 
function of protein concentration at 0 mM (solid symbol) and at 15 mM (open symbols) ionic 
strengths at pH 6.1. The lines are the polynomial fit to the data points at 0 mM and linear fits 
to 15 mM ionic strength solutions. All solutions were analyzed at 25 ± 1˚C in duplicate. Error 
bars if not visible are smaller than the symbols used.  
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Figure 5: Zeta potential in mV for mAb (dashed bars) and DVD-Ig
TM
 protein (closed bars) at 
0 mM and 15 mM ionic strength at pH 6.1. The numbers on the bars represents the zeta 
potential values measured at that condition. Concentrations of 4 mg/mL and 2 mg/mL were 
analyzed for mAb and DVD-Ig
TM
 protein, respectively. All solutions were analyzed at 25 ± 
1˚C in duplicate. Error bars if not visible are smaller than the symbols used. 
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Figure 6: Relative viscosity of DVD-Ig
TM
 protein plotted as a function of protein 
concentration at 15 mM (solid line) and 50 mM (dotted line) ionic strengths and varying pH 
conditions. Histidine buffers with appropriate concentrations were prepared to maintain the 
ionic strength of 15 mM. Sodium chloride was added to adjust ionic strength to 50 mM. All 
solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if not visible are smaller than the 
symbols used. 
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Figure 7: Zeta potential in mV for DVD-Ig
TM
 protein as a function of pH at 15 mM ionic 
strength. The numbers on the bars represents the zeta potential values in mV. Concentrations 
of 2 mg/mL were analyzed at 25 ± 1˚C in duplicate. Error bars if not visible are smaller than 
the symbols used. 
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Figure 8: Plot of (a) B2 from Static Light scattering and (b) kD from Dynamic light scattering 
for DVD-Ig
TM
 protein as a function of pH and ionic strengths of 15 mM (solid line) and 50 
mM (dashed line). All solutions were analyzed at 25 ± 1˚C in duplicate. Error bars if not 
visible are smaller than the symbols used. 
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Figure 9: Tcloud (determined as temperature where percent transmittance is 70) for DVD-Ig
TM
 
protein
 
at concentration of (a) 16 mg/mL and (b) 60 mg/mL, as a function of pH and at ionic 
strengths of 15 mM (solid bar) and 50 mM (dashed bar). All solutions were analyzed in 
duplicate. Error bars if not visible are smaller than the symbols used.  
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Figure 10: Plot of kD measured from DLS against B2 obtained from SLS at different pHs and 
ionic strengths of 15 mM (♦), 50 mM (∆) and 150 mM (○) for DVD-IgTM protein. The lines 
are linear fits to the data and extrapolated to x-axis to obtain hydration parameter from 
intercept (equation 10). The values are average of the measurements performed at 25 ± 1˚C 
in duplicate.  
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Figure 11: Plot of relative viscosity against concentration for DVD-Ig
TM
 protein at different 
solution conditions indicating contribution of dominant protein-protein interactions in 
solution at those conditions. 
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Chapter 7 
 
Summary 
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Physical instabilities associated with therapeutic protein solutions presents challenges 
in the formulation development and reduce shelf-life of the product. Opalescence, phase 
separation, aggregation and high viscosity are a concern for high concentration protein 
solutions and are affected by the formulation factors; pH, ionic strength, buffer species and 
excipients. These formulation factors exert their effect by modulating physical interactions 
(non-covalent/specific) between the protein molecules. Recently, opalescence due to liquid-
liquid phase separation has been reported for mAb solutions, and is a concern in formulation 
development as it can promote formation of irreversible aggregates in solution compromising 
its physical stability. However, the data for understanding the underlying factors and protein-
protein interactions resulting in opalescence and liquid-liquid phase separation is scarce in 
the literature. These formulation challenges are further exaggerated in newer molecules like 
Dual variable domain immunoglobulins (DVD-Ig
TM
) protein, which are relatively large 
molecules (MW~ 200 kDa) with increased asymmetry because of their extended Y-like 
shape. Thus, the objective of the current work was to investigate the effect of formulation 
factors and nature of intermolecular interactions resulting in opalescence and liquid-liquid 
phase separation (LLPS) for mAb and DVD-Ig
TM
 protein, and to understand their relation 
with increased aggregation and high viscosity of the solution.   
 
The project is summarized in few key points as: 
1. Opalescence due to LLPS in Solution 
The theoretical basis for opalescence due to liquid-liquid phase separation 
(fluctuations in solution) and due to aggregation (presence of particles in solution) is 
presented in Chapter 2.  Percent transmittance for mAb (Chapter 3) and DVD-Ig
TM
 protein 
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(Chapter 4) was measured as a function of solution conditions to determine if aggregation or 
LLPS results in opalescence in the solution. Strong temperature dependence for both the 
molecules confirmed that LLPS resulted in solution opalescence. LLPS and opalescence was 
also visually confirmed for both the molecules by changing solution conditions. The 
theoretical concepts for thermodynamic and kinetics of liquid-liquid phase separation were 
provided in Chapter 2. Equilibrium studies for DVD-Ig
TM
 protein in Chapter 4, confirmed the 
thermodynamic basis of phase separation in protein solutions.  
 
2. Effect of Formulation Factors on Physical Instabilities 
Literature examples related to formulation factors affecting opalescence and phase 
separation were briefly reviewed in Chapter 2. Formulation factors like pH, ionic strength 
and concentration have a significant effect on solution opalescence for mAb as presented in 
Chapter 3; opalescence increases close to the pI of the molecule, in an intermediate 
concentration range and at an intermediate ionic strength. In Chapter 4, similar studies were 
performed for DVD-Ig
TM
 protein, where pH, ionic strength and buffer species increased or 
decreased the tendency of protein to phase separate by modulating specific and/ or non-
specific interactions in solution. Effect of commonly used excipients (PEG, Sucrose and 
Tween) on LLPS and aggregation for DVD-Ig
TM
 protein solutions were investigated and 
presented in Chapter 5. Sucrose suppressed both LLPS and aggregation, Tween 80 had no 
effect on either and PEG 400 increased LLPS and aggregation. In Chapter 6, effect of 
formulation factors on viscosity of DVD-Ig
TM
 protein solution was investigated. Ionic 
strength plays a dominant role in modulating viscosity for DVD-Ig
TM
 protein compared to 
the pH of the solution. Protein molecules exhibit a unique behavior in absence of any ions or 
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in water, where significantly high viscosity is due to high charge on the molecule 
(electroviscous effect) and hydration, while, the electroviscous effects in the presence of 
buffered solution exhibits minimal viscosity.  
 
3. Molecular Properties of Protein 
In Chapter 4, opalescence measurements for DVD-Ig
TM
 protein as a function of 
concentration confirm the hypothesis that the width and asymmetry of coexistence curve (or 
concentration range in which solution exhibits opalescence and LLPS) increases as the size 
of the molecule increases; DVD-Ig
TM
 protein shows increased tendency to phase separate at 
lower concentrations. In Chapter 6, the effect of the size of the molecule, on the viscosity of 
DVD-Ig
TM
 protein solutions were investigated. DVD-Ig
TM
 protein with a larger intrinsic 
viscosity (8.7 mL/g) and hydrodynamic diameter (~14 nm) exhibited significantly high 
viscosity compared to mAb ([ƞ] ~5.9 mL/g and dH ~11 nm). However, the excluded volume 
calculations show that the effect of size of the molecule on solution viscosity is significant 
only at higher concentrations (> 100 mg/mL). 
 
4. Relation between Aggregation and LLPS in Solution 
While protein retains its native structure on phase separation, aggregation is 
associated with formation of native and/or non-native species in solution. From Circular 
Dichroism studies in Chapter 4, there were no structural changes observed for DVD-Ig
TM
 
protein, before and after phase separation. In Chapter 5, relationship between LLPS and 
formation of aggregates in protein-rich phase was investigated by performing stability studies 
at different temperatures (4, 20 and 40 °C) over a period of 45 days. Though, no aggregate 
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formation was observed at 4 ºC, where solution exhibited phase separation, 20 ºC data 
suggests that aggregate formation is accelerated on phase separation. Temperature plays a 
dominant role in both, liquid-liquid phase separation and formation of soluble, irreversible 
aggregates in solution; at low temperature protein exhibits LLPS, at high temperature protein 
exhibits aggregation and at an intermediate temperature both phenomena occur 
simultaneously depending on the solution conditions.  
 
5. Protein-Protein Interactions Affecting Physical Stability 
A brief overview on the nature of the intermolecular forces present in protein 
solutions was discussed in Chapter 2. In Chapter 3, opalescence in mAb solution was 
correlated to intermolecular interactions measured in dilute solution and at high 
concentrations; however, there was discrepancy in attractive interactions and solution 
opalescence. Temperature dependence of opalescence, suggested that thermodynamic 
contribution is significant and hence, Tcloud is a better parameter to assess attractive 
interactions resulting in phase separation. Results indicate that though, the presence of 
attractive interactions in solution is an important criterion for phase separation to occur, 
enthalpy-entropy balance is what controls the phase separation process. In Chapter 4, 
interactions in DVD-Ig
TM
 solution were investigated by measuring kD and Tcloud as a function 
of solution conditions. Results implies that a protein can show a higher tendency to undergo 
phase separation in presence of additional forces (hydrophobic interactions for DVD-Ig
TM
 in 
this study), than for protein molecules which show only dipole-mediated attractive 
interactions in solution. Investigation of effect of histidine and phosphate buffers at constant 
pH and ionic strength indicated presence of specific interactions in solution. From this study 
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we also established the utility of Tcloud (temperature that marks onset of phase separation) as a 
predictive tool/ orthogonal technique along with light scattering, for preliminary screening of 
solution conditions for biologic candidates in preformulation development. Effect of 
excipients on protein-protein interactions in DVD-Ig
TM
 protein solutions are presented in 
Chapter 5. Results indicate that, Sucrose decreased attractive PPI by specific binding to 
aromatic amino acids on protein surface. PEG increased attractive PPI, while Tween 80 had 
no effect on interactions in solution. Attractive protein-protein interactions resulting in phase 
separation also contribute significantly to increased viscosity of DVD-Ig
TM 
protein and are 
presented in Chapter 6. Contribution of dipole-mediated interactions to the overall solution 
viscosity was observed to be greater than hydrophobic interactions. In addition to attractive 
interactions, presence of repulsive excluded volume effect and electroviscous effect (due to 
charge on the molecule) also contributed to the increased viscosity of DVD-Ig
TM
 solutions. 
 
Overall, this project highlights the importance and/or concerns related to liquid-liquid phase 
separation in protein solution, which is related to both, solubility of the proteins and 
formation of aggregates, resulting in physical instability in the formulation. 
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Appendix 1 
A.1.     High Frequency Rheology  
Ultrasonic shear rheometer with quartz crystals vibrating at a fundamental frequency 
of 10 MHz was employed to determine the rheological properties of the protein molecule. 
The rheometer is based on piezoelectric effect and employs a quartz crystal, which is 
sensitive to the mechanical properties of the liquid placed on top of it. The change in 
mechanical properties of a liquid including its viscosity and moduli can be determined by 
measuring the change in the electrical properties of the crystal in presence and absence of 
liquid.  
Any interactions between the molecules are associated with a temperature-dependent 
relaxation process characterized by a relaxation time (τ). PPI affect conformational 
rearrangements and segmental motions in protein solutions and thus alter their characteristic 
τ. PPI occurs at the timescales of 10-7-10-9 s, and to study such processes measurements at 
MHz frequencies need to be conducted, since τ is inversely related to frequency (ω). Storage 
(G') and loss (G") modulus are related to τ by following relationship, 
                                                                 𝐺′
𝜔2𝜏2
1 + 𝜔2𝜏2
                                                                           (𝐴1) 
                                                               𝐺"
𝜔𝜏
1 + 𝜔2𝜏2
                                                                             (𝐴2) 
For low shear viscosity measurements, ie, lower frequency strain is applied, 
molecules have enough time to reorient and relax within a single strain cycle, resulting in 
complete dissipation or loss of the applied energy. Consequently, G" (viscous component) 
has a finite value but G' (elastic component) is nonexistent. As ω increases (MHz range) and 
approaches τ, molecules cannot relax completely and the system begins to store a part of the 
applied energy resulting in a finite value of G'. Strongly interacting systems, which are more 
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viscoelastic in nature, take more time to relax on removal of strain than dilute and non-
interacting solute systems. Hence, at high measurement frequencies, strongly interacting 
solutions are not able to relax completely and would store a larger fraction of applied energy 
and exhibit a higher value of G'.
1,2
 
 
A.2.     Zeta Potential and Charge Measurements  
Values for the measured zeta potential and calculated charges are compiled in Table 
A1. At pH 5.1, zeta potential is positive and the values are higher than those measured at 
other pHs at 5 mM (+9.32 mV) and 15 mM (+7.62 mV) ionic strengths. The magnitude of 
the change in zeta potential as ionic strength is increased from 5 to 15 mM is small; however, 
the experimental charge reduces almost to half from +8.13 Z at 5 mM to +4.02 Z at 15 mM 
ionic strength. This can be attributed to the change in Debye length on addition of salts. 
Debye length is inversely related to the square root of ionic strength and reduces as the ionic 
strength increases. At pH 6.1, which is closer to the pI of the molecule, zeta potential of 
+3.43 mV was observed at 5 mM ionic strength.  The increase in ionic strength to 15 mM 
showed minimal decrease in zeta potential values (+2.19 mV). Similarly, net charge on the 
molecule is positive, but the values are smaller compared to other pH conditions (+2.83 Z at 
5 mM and +1.13 Z at 15 mM). At pH 7.0, protein is negatively charged; a zeta potential 
value at 5 mM is -6.23 mV and at 15 mM is -5.85 mV. Net negative charges are present on 
the molecule at pH 7.0 (-5.59 Z at 5 mM and -3.17 Z at 15 mM).  
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A.3.     Light Scattering: kD Measurements 
Light scattering techniques are routinely used to characterize the nature of 
intermolecular interactions in dilute solution. SLS is used for the determination of the second 
virial coefficient (B2), which characterizes solute-solute interactions and indirectly solute-
solvent interactions. Good correlation has been established between B2 and protein 
solubility,
3,4
 crystallization,
5-7
 and protein precipitation,
8
 which characterize phase separation 
in protein solutions. Virial expansion for the osmotic pressure is given by the following 
equation, 
𝜋 = 𝑅𝑇𝑐 (
1
𝑀𝑤
+ 𝐵2𝑐 + ⋯ )                                                                  (𝐴3) 
where, π is osmotic pressure, R is the universal gas constant, T is absolute temperature, c is 
solute concentration, and Mw is the weight average molecular weight. At infinite dilutions, 
higher order terms vanish and the equation reduces to the van’t Hoff equation for ideal 
solution. B2 is the first measure of the deviation from ideality in the solution and 
characterizes interactions between solute molecules. The value of B2 reflects the magnitude 
of deviation from ideality, while its sign reflects the nature of this deviation. A positive value 
corresponds to net repulsive interactions between the solute molecules wherein the osmotic 
pressure increases above that for an ideal solution whereas a negative value corresponds to 
net attractive interactions between the solute molecules with a consequent decrease in 
solution osmotic pressure below that for an ideal solution.
9
  
DLS measures the diffusion coefficient of a solute molecule in solution and is used to 
find the interaction parameter kD using equation 2 (from Chapter 1). kD is a measure of inter-
particle interaction and is represented by,
10
  
   𝑘𝐷 = 2𝐵2𝑀𝑤 − 𝜁1 − 2𝜈𝑠𝑝                                                                       (𝐴4) 
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where, ζ1 is the coefficient of the linear term in the virial expansion of the frictional 
coefficient as a function of solute concentration and νsp is the partial specific volume of the 
solute. kD has contributions from both the thermodynamic and hydrodynamic parameter, and 
therefore, equation (A4) can be rewritten as,
11,12 
                                                         𝑘𝐷 = 𝑘𝑇 − 𝑘𝐻                                                                             (𝐴5) 
The contribution of B2 to kD arises from the role of chemical potential in driving the 
diffusion process, whereas the last two terms represent the hydrodynamic drag. Similar to B2, 
a positive kD implies repulsive interactions and a negative kD implies attractive 
intermolecular interactions in solution. 
Figure A1a, shows a plot of Dm as a function of concentration at varying ionic 
strengths at pH 5.1. At 5 mM ionic strength, the slope is negative indicating attractive 
protein-protein interactions (kD = -18.04 mL/g). Slope becomes slightly more negative as the 
ionic strength is increased from 5 to 15 mM (kD = -26.69 mL/g) and then becomes less 
negative as the ionic strength is further increased to 150 mM (kD = -17.95 mL/g). Dm versus 
concentration curves for 5 and 150 mM ionic strength are almost overlapping. Figure S1b is a 
Dm plot for mAb A at pH 6.1. Ds or self-diffusion coefficient is determined by linear 
extrapolation to zero concentration. At low ionic strength of 5 mM, plot from 2-10 mg/mL 
protein concentration shows a curvature and it’s not possible to determine the Ds by linear 
extrapolation, higher order virial coefficients need to be considered in this concentration 
range. Therefore, Dm was measured at low concentrations (below 2 mg/mL) to make a linear 
extrapolation. The kD values measured from slope is most negative at this condition (-99.92 
mL/g) indicating strong attractive PPI. As the ionic strength is further increased from 5 to 15 
mM (kD = -35.04 mL/g) and 150 mM (kD = -11.24 mL/g), slope becomes less negative. 
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Similar trend is observed at pH 7.0. (Figure A1c) where slope is negative at an ionic strength 
of 5 mM (kD = -35.42 mL/g) indicating strong attractive interactions which decrease on 
increasing the ionic strength to 15 (kD = -20.46 mL/g) and 150 mM (kD = -7.20 mL/g). B2 
was measured from SLS as a function of pH and ionic strengths of 5, 15 and 150 mM.   
 
A.4.     Effect of Ionic Strength on Interaction Parameter (kD) and Charges on Molecule 
Interactions in dilute solutions were measured using DLS for mAb A at pH 6.1 and 
varying ionic strengths from 0-150 mM (Figure A2a). As discussed previously, Ds or self-
diffusion coefficient is determined by linear extrapolation to zero concentration, hence, Dm 
was measured at low concentrations (below 2 mg/mL) at 0-5 mM ionic strengths to make a 
linear extrapolation (Figure A2b). From Figure A2b, at pH 6.1 and ionic strength of 0 mM, 
slope is highly positive indicating strong repulsive interactions in the absence of any ions (kD 
= +591.98 mL/g). On addition of salt and increasing the ionic strength to 1 mM, slope 
becomes highly negative indicating the presence of strong attractive interactions (kD = -
143.89 mL/g). At ionic strength of 2.5 mM, attractive interactions decrease as indicated by a 
less negative slope (kD = -118.67 mL/g) as compared to 1 mM. As the ionic strength is 
further increased from 5 mM (kD = -99.92 mL/g) to 10 mM (kD = -42.53 mL/g) and 15 mM 
(kD =-35.04 mL/g), slope becomes less negative i.e., either attractive interactions decrease or 
repulsive interactions increases with increase in ionic strength. At the ionic strength of 150 
mM, the slope is least negative and close to zero, indicating weak attractive protein-protein 
interactions at this solution condition (kD =-11.24 mL/g).  
Charges on the molecule were also calculated from the zeta potential measurements 
as a function of ionic strength at pH 6.1 and complied in Table A2. At pH 6.1, zeta potential 
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is positive at all ionic strengths and the values of zeta potential and charges calculated 
decreases with increase in ionic strength. Zeta potential has large positive value at 0 mM 
ionic strength (+16.60 mV). This zeta potential value relates to the surface potential of the 
molecule in the absence of any counter-ions in solution. When ions are added to the solution 
and ionic strength is increased to 1 mM (+7.51 mV), zeta potential becomes approximately 
half of that at 0 mM. This is caused by the extensive ion binding to the protein surface and 
charge shielding because of the ionic cloud. When ionic strength is further increased to 5 
mM, zeta potential value decreases in magnitude by almost half (+3.43 mV). As ionic 
strength is increased to 10 (+2.69 mV) and 15 mM (+2.19 mV), change in zeta potential is 
not as significant. At 0 mM ionic strength, for the calculation of charges, ionic strength is 
assumed to be 0.1 mM. In the absence of any ions, the calculated true charges on the 
molecule will be much larger as the Debye length is much lower than that assumed with 0.1 
mM (+87.39 Z). The calculated charge reduces by nearly 5 fold when ionic strength is 
increased to 1 mM (+14.54 Z).  Decrease in the calculated charge form zeta potential is again 
significant as ionic strength is increased from 1 to 5 mM (+2.83 Z). Above 5 mM, decrease in 
charges with increase in ionic strength to 10 mM (+1.82 Z) and 15 mM (+1.13 Z) is not as 
significant.  
 
 
 
 
 
 
233 
 
References 
1. Macosko C. Rheology: Principles, measurements, and applications. 1994. VCH, New 
York. 
2. Larson RG. 1999. The Structure and Rheology of Complex Fluids. ed., New York: 
Oxford University Press. 
3. Demoruelle K, B. Guo, S. Kao, M. McDonald Heather, B. Nikic Dragan, C. Holman 
Steven, and W. W. Wilson. 2002. Correlation between the osmotic second virial 
coefficient and solubility for equine serum albumin and ovalbumin. . Acta Crystallogr. D 
Biol. Crystallogr.  58:1544-1548. 
4. Valente JJ, R. W. Payne, M. C. Manning, W. W. Wilson, and C. S. Henry. 2005. 
Colloidal behavior of proteins: Effects of the second virial coefficient on solubility, 
crystallization and aggregation of proteins in aqueous solution. Curr. Pharm. Biotechnol.  
6:427-436. 
5. Rosenbaum DF, and C. F. Zukoski. 1996. Protein interaction and crystallization. J. 
Cryst. Growth.  169:752-758. 
6. George A, Y. Chiang, B. Guo, A. Arabshahi, Z. Cai, and W. W. Wilson. 1997. Second 
virial coefficient as predictor in protein crystal growth. Methods Enzymol  276:100-110. 
7. Neal BL, D. Asthagiri, O. D. Velev, A. M. Lenhoff, and E. W. Kaler. 1999. Why is the 
osmotic second virial coefficient related to protein crystallization? J. Cryst. Growth.  
196:377-387. 
8. Curtis RA, Prausnitz JM, Blanch HW. 1998. Protein-protein and protein-salt interactions 
in aqueous protein solutions containing concentrated electrolytes. Biotechnol Bioeng  
57(1):11-21. 
9. Neal BL, D. Asthagiri, and A. M. Lenhoff. 1998. Molecular origins of osmotic second 
virial coefficients of proteins. Biophys. J.  75:2469-2477. 
10. Narayanan J, and X. Y. Liu. . 2003. Protein interactions in undersaturated and 
supersaturated solutions: a study using light and x-ray scattering. Biophys. J.  84:523-
532. 
11. JA. B. 1976. Correlations for interacting Brownian particles. J Chem Phys 64:242-246. 
12. Placidi M CS. 1998. A dynamic light scattering study on mutual diffusion coefficient of 
BSA in concentrated aqueous solutions. Europhys Lett  43(4):476. 
 
 
 
 
 
 
 
 
234 
 
Figures and Tables 
Table A1.1: Measured zeta potential (millivolts) and calculated experimental charges 
(coulombs) for mAb A at various pHs and ionic strengths 
pH 
Ionic strength 
(mM) 
Zeta 
Potential(mV) 
Experimental 
charge 
5.1 5 +9.32 ± 0.48 +8.13 ± 0.42 
5.1 15 +7.6 2± 0.16 +4.02 ± 0.09 
6.1 5 +3.43 ± 0.12 +2.83 ± 0.09 
6.1 15 +2.19 ± 0.03 +1.13 ± 0.02 
7.0 5 -6.23 ± 0.12 -5.59 ± 0.10 
7.0 15 -5.85 ± 0.13 -3.17 ± 0.01 
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Table A1.2: Measured Zeta potential and calculated experimental charges for MAb A at pH 
6.1 and ionic strengths 
pH 
Ionic 
strength(mM) 
Zeta 
Potential(mV) 
Experimental 
charge 
6.1 0 16.60 ± 0.28 87.39 ± 1.49 
6.1 1 7.51 ± 0.70 14.54 ± 1.34 
6.1 5 3.43 ± 0.12 2.83 ± 0.09 
6.1 10 2.69 ± 0.23 1.82 ± 0.16 
6.1 15 2.19 ± 0.03 1.13 ± 0.02 
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Figure A1.1: Mutual diffusion coefficient (Dm) for mAb A as a function of concentration, at 
(a) pH 5.1, (b) pH 6.1 and (c) pH 7.0 and ionic strengths of 5 mM (♦), 15 mM (▲) and 150 
mM (■). All the solutions were analyzed at 25 ± 0.1 ˚C in duplicate. Error bars if not visible 
are smaller than the symbols used. 
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Figure A1.2: (a) Mutual diffusion coefficient (Dm) for mAb A as a function of concentration 
(0.1-10 mg/mL), at pH6.1 and various ionic strengths. The lines are linear best fits with slope 
and intercept representing DskD and Ds (self-diffusion coefficient), respectively. (b) Dm plots 
at low concentrations (0.0001-0.001 g/mL) at pH 6.1 and 0-5 mM ionic strength. All the 
solutions were analyzed at 25 ± 0.1 ˚C in duplicate. Error bars if not visible are smaller than 
the symbols used. 
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Appendix 2 
Intrinsic Fluorescence 
Intrinsic fluorescence and second derivative fluorescence spectroscopy study were 
performed for DVD-Ig
TM
 in presence and absence of excipients to determine tertiary 
structural changes after samples were incubated at 40 ºC for 45 days. Figure A2a and A2b are 
plots of emission scans normalized to fluorescence intensity of 1.0 at λmax and second 
derivative spectra of the normalized emission scans for protein, respectively Spectra are 
presented only for samples  incubated in buffer and PEG, other excipients show overlapping 
spectrums and are not plotted. Fluorescence spectra were also recorded for freshly prepared 
DVD-Ig
TM
 samples at similar solution conditions. No shift in intensity or wavelength (blue 
shift or red shift) in presence or absence of excipients was observed. Similarly, no change in 
tertiary structure was observed for samples at any of the conditions studied. 
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Figure A2: (a) Emission scans normalized to fluorescence intensity of 1.0 at λmax  and (b) 
second derivative spectra of the normalized emission scans of DVD-Ig
TM
 in buffer and for 
samples incubated at 40 ºC in buffer and 10% PEG. Excitation wavelength was set to 295 nm 
to determine Trp fluorescence. 0.2 mg/mL samples were prepared in histidine buffer at pH 
6.6 with ionic strength of 15 mM. Excipient stocks were prepared in same buffer and diluted 
to required final concentration in solution. Plot represents averages of emission scans 
obtained at all conditions in triplicate at 25 ± 0.1 ˚C. 
